{"title":"Liquid Formulas","description":"\u003ch3 data-start=\"570\" data-end=\"628\"\u003e\u003cstrong data-start=\"574\" data-end=\"628\"\u003eHigh-Quality Liquid Peptides for Advanced Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"630\" data-end=\"1111\"\u003eThe Liquid Formulas Collection was assembled for laboratories that benefit from having materials arrive already prepared in solution. Instead of spending time dissolving powders, verifying concentrations, or correcting inconsistent mixtures, researchers can begin their work with solutions that have already been measured and checked. Each item is produced with attention to reproducibility, allowing teams to focus on their experiments rather than troubleshooting their materials.\u003c\/p\u003e\n\u003cp data-start=\"1113\" data-end=\"1550\"\u003eEvery liquid peptide and buffer in this lineup is examined through analytical testing before it leaves production. Ingredient identity and composition are verified carefully, since reliable data depends heavily on stable and well-characterized materials. From the point of preparation to the moment each vial is delivered, measures are in place to maintain consistency and keep the solutions in the condition intended for laboratory use.\u003c\/p\u003e\n\u003ch3 data-start=\"1557\" data-end=\"1599\"\u003e\u003cstrong data-start=\"1561\" data-end=\"1599\"\u003eWhat Are Liquid Research Peptides?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1601\" data-end=\"1898\"\u003eLiquid research peptides are pre-dissolved formulations prepared to simplify early laboratory steps. Many investigators working under time constraints—or those running repeated assays—prefer this format because it eliminates one of the most common sources of experimental variation: manual mixing.\u003c\/p\u003e\n\u003cp data-start=\"1900\" data-end=\"2162\"\u003eWhen a solution arrives ready to use, its concentration has already been confirmed, and the formulation follows a standardized protocol. This consistency is particularly valuable when experiments must be repeated, scaled, or compared across multiple time points.\u003c\/p\u003e\n\u003ch3 data-start=\"2169\" data-end=\"2226\"\u003e\u003cstrong data-start=\"2173\" data-end=\"2226\"\u003eFeatured Materials in the Liquid Formulas Catalog\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2228\" data-end=\"2344\"\u003eBelow are several solutions included in this collection, each with established relevance across laboratory research:\u003c\/p\u003e\n\u003cp data-start=\"2346\" data-end=\"2449\"\u003e\u003cstrong data-start=\"2346\" data-end=\"2373\"\u003eL-Glutathione – 3000 mg\u003c\/strong\u003e\u003cbr data-start=\"2373\" data-end=\"2376\"\u003eA widely referenced antioxidant used in cellular and biochemical studies.\u003c\/p\u003e\n\u003cp data-start=\"2451\" data-end=\"2536\"\u003e\u003cstrong data-start=\"2451\" data-end=\"2478\"\u003eNAD+ – 1000 mg per vial\u003c\/strong\u003e\u003cbr data-start=\"2478\" data-end=\"2481\"\u003eA key coenzyme in metabolic and mitochondrial modeling.\u003c\/p\u003e\n\u003cp data-start=\"2538\" data-end=\"2703\"\u003e\u003cstrong data-start=\"2538\" data-end=\"2616\"\u003eSS-31 Peptide – High Purity Mitochondrial Research Peptide (20 mg \/ 50 mg)\u003c\/strong\u003e\u003cbr data-start=\"2616\" data-end=\"2619\"\u003eSelected for studies involving mitochondrial function and membrane-related dynamics.\u003c\/p\u003e\n\u003cp data-start=\"2705\" data-end=\"2822\"\u003e\u003cstrong data-start=\"2705\" data-end=\"2748\"\u003ePhosphate-Buffered Saline (PBS) – 20 ml\u003c\/strong\u003e\u003cbr data-start=\"2748\" data-end=\"2751\"\u003eA foundational buffer that maintains pH under physiological conditions.\u003c\/p\u003e\n\u003cp data-start=\"2824\" data-end=\"2932\"\u003e\u003cstrong data-start=\"2824\" data-end=\"2867\"\u003eHistidine-Buffered Saline (HBS) – 20 ml\u003c\/strong\u003e\u003cbr data-start=\"2867\" data-end=\"2870\"\u003eUsed when controlled buffering behavior is required in assays.\u003c\/p\u003e\n\u003cp data-start=\"2934\" data-end=\"3062\"\u003eEach solution undergoes consistency verification, and packaging is structured to support integrity during storage and transport.\u003c\/p\u003e\n\u003ch3 data-start=\"3069\" data-end=\"3121\"\u003e\u003cstrong data-start=\"3073\" data-end=\"3121\"\u003eWhy Researchers Value Liquid Peptide Formats\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3123\" data-end=\"3407\"\u003eLiquid formulations offer practical advantages: predictable composition, reduced preparation time, and fewer opportunities for small handling errors. These factors contribute to more consistent data, particularly in projects that involve repeated measurements or multi-step workflows.\u003c\/p\u003e\n\u003cp data-start=\"3409\" data-end=\"3699\"\u003eHaving ready-to-use materials can also streamline more complex studies. Whether the focus is mitochondrial modeling, nutrient signaling, peptide-specific pathways, or other biochemical processes, starting with pre-measured solutions allows research teams to move more quickly into analysis.\u003c\/p\u003e\n\u003ch3 data-start=\"3706\" data-end=\"3755\"\u003e\u003cstrong data-start=\"3710\" data-end=\"3755\"\u003eImportant Solutions for Research Settings\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3757\" data-end=\"4043\"\u003eQuality control is central to this catalog. Each batch is examined through independent analytical testing to verify identity and confirm alignment with research-grade expectations. Packaging protects the solutions from contamination, temperature fluctuations, or damage during shipment.\u003c\/p\u003e\n\u003cp data-start=\"4045\" data-end=\"4068\"\u003eKey safeguards include:\u003c\/p\u003e\n\u003cul data-start=\"4070\" data-end=\"4191\"\u003e\n\u003cli data-start=\"4070\" data-end=\"4113\"\u003e\n\u003cp data-start=\"4072\" data-end=\"4113\"\u003ethird-party confirmation of composition\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4114\" data-end=\"4144\"\u003e\n\u003cp data-start=\"4116\" data-end=\"4144\"\u003etamper-resistant packaging\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4145\" data-end=\"4191\"\u003e\n\u003cp data-start=\"4147\" data-end=\"4191\"\u003eshipping practices that preserve stability\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4193\" data-end=\"4327\"\u003eThese measures support laboratories using both staple solutions and specialized materials such as retatrutide or bacteriostatic water.\u003c\/p\u003e\n\u003ch3 data-start=\"4334\" data-end=\"4381\"\u003e\u003cstrong data-start=\"4338\" data-end=\"4381\"\u003eSupporting Innovation in the Laboratory\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"4383\" data-end=\"4783\"\u003eAs research directions shift, the need for well-characterized, adaptable materials continues to grow. The Liquid Formulas Collection was developed with this in mind, offering solutions designed to integrate smoothly into a variety of experimental designs. The emphasis is on reliability and ease of use—qualities that help reduce procedural complexity across different branches of laboratory science.\u003c\/p\u003e\n\u003cp data-start=\"4785\" data-end=\"4974\"\u003eWhether an investigation centers on oxidative models, peptide pathway analysis, mitochondrial studies, or high-precision workflows, these ready-made liquids can help streamline the process.\u003c\/p\u003e\n\u003ch3 data-start=\"4981\" data-end=\"5024\"\u003e\u003cstrong data-start=\"4985\" data-end=\"5024\"\u003eHandling and Storage Considerations\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5026\" data-end=\"5451\"\u003eUpon receiving your shipment, confirm that each vial is intact and sealed. Store solutions in an appropriate environment, away from direct light or elevated temperatures. If a liquid has settled, gently mix before use. Standard aseptic technique remains essential, particularly when the materials are incorporated into multi-stage protocols, retatrutide 20 mg studies, bacteriostatic water workflows, or long-duration assays.\u003c\/p\u003e\n\u003cp data-start=\"5453\" data-end=\"5551\"\u003eThese steps help maintain the quality and precision required for dependable experimental outcomes.\u003c\/p\u003e\n\u003ch3 data-start=\"5558\" data-end=\"5604\"\u003e\u003cstrong data-start=\"5562\" data-end=\"5604\"\u003eExplore the Complete Liquid Collection\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5606\" data-end=\"5985\"\u003eThis catalog was designed for research teams seeking dependable, ready-to-use materials. From core buffers to specialized peptide solutions, the collection supports systematic and efficient laboratory work. As the catalog expands—including options such as the retatrutide pen for specific applications—we remain committed to supporting clear, repeatable scientific investigation.\u003c\/p\u003e\n\u003cp data-start=\"5987\" data-end=\"6107\"\u003eThe Liquid Formulas Collection aims to reduce preparation time and support smoother transitions from setup to discovery.\u003c\/p\u003e","products":[{"product_id":"epithalon-25mg","title":"Epithalon 25mg – Research Peptide","description":"\u003ch3 data-section-id=\"178uri\" data-start=\"443\" data-end=\"503\"\u003eEpithalon – Telomere and Pineal Signaling Research Peptide\u003c\/h3\u003e\n\u003ch3 data-section-id=\"rzkdgm\" data-start=\"505\" data-end=\"516\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"518\" data-end=\"847\"\u003eEpithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). The peptide was originally developed by Professor Vladimir Khavinson and colleagues based on the amino acid composition of epithalamin, a natural peptide complex derived from the pineal gland.\u003c\/p\u003e\n\u003cp data-start=\"849\" data-end=\"1051\"\u003eIn research settings, Epithalon is frequently studied for its interaction with cellular aging pathways, telomere regulation, and neuroendocrine signaling mechanisms associated with the pineal gland.\u003c\/p\u003e\n\u003cp data-start=\"1053\" data-end=\"1337\"\u003eDue to its small molecular size (≈390 Da), Epithalon demonstrates high cellular permeability and has been observed in laboratory models to interact with intracellular targets including DNA binding motifs, histone complexes, and amino acid transport systems such as LAT1 and PEPT1.\u003c\/p\u003e\n\u003cp data-start=\"1339\" data-end=\"1519\"\u003eThese characteristics have made the peptide a subject of investigation in studies exploring epigenetic regulation, cellular longevity pathways, and circadian signaling systems.\u003c\/p\u003e\n\u003cp data-start=\"1649\" data-end=\"1813\"\u003eEpithalon is a short tetrapeptide capable of entering cells and interacting with nuclear regulatory elements involved in gene expression and chromatin organization.\u003c\/p\u003e\n\u003cp data-start=\"1815\" data-end=\"2040\"\u003eExperimental models have suggested that the peptide may interact with specific DNA binding motifs, including sequences such as ATTTC and CAG, potentially influencing transcriptional regulation and chromatin accessibility.\u003c\/p\u003e\n\u003ch3 data-section-id=\"10gl7hx\" data-start=\"2047\" data-end=\"2093\"\u003eCellular Mechanisms Investigated in Research\u003c\/h3\u003e\n\u003cp data-start=\"2095\" data-end=\"2222\"\u003eMultiple studies in human cell cultures and in vitro systems have explored several biological pathways influenced by Epithalon.\u003c\/p\u003e\n\u003ch3 data-section-id=\"hkl10f\" data-start=\"2224\" data-end=\"2273\"\u003eTelomerase Activation and Telomere Regulation\u003c\/h3\u003e\n\u003cp data-start=\"2275\" data-end=\"2521\"\u003eIn laboratory studies involving telomerase-negative human fibroblasts, Epithalon exposure has been associated with increased expression of the hTERT catalytic subunit, along with measurable telomerase enzymatic activity using TRAP assays.\u003c\/p\u003e\n\u003cp data-start=\"2523\" data-end=\"2725\"\u003eThese findings were accompanied by measurable changes in telomere length and cellular replicative lifespan, suggesting that the peptide may influence mechanisms associated with telomere maintenance.\u003c\/p\u003e\n\u003cp data-start=\"2727\" data-end=\"2955\"\u003eSimilar observations have been reported in lymphocyte models and additional human cell lines, where Epithalon exposure was associated with activation of telomerase-related pathways or alternative telomere lengthening mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"2957\" data-end=\"3101\"\u003eThese findings have positioned Epithalon as a compound frequently examined in research focused on cellular senescence and genomic stability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1vk4t1c\" data-start=\"3108\" data-end=\"3153\"\u003ePineal Signaling and Circadian Regulation\u003c\/h3\u003e\n\u003cp data-start=\"3155\" data-end=\"3250\"\u003eThe peptide has also been studied for its interaction with pineal gland signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3252\" data-end=\"3474\"\u003eExperimental research indicates that Epithalon may influence biochemical pathways associated with serotonin, N-acetylserotonin, and melatonin synthesis, molecules that play central roles in circadian rhythm regulation.\u003c\/p\u003e\n\u003cp data-start=\"3476\" data-end=\"3668\"\u003eAnimal models have reported restoration of melatonin rhythmicity and circadian hormone patterns in aged organisms following exposure to pineal peptides including Epithalon and epithalamin.\u003c\/p\u003e\n\u003cp data-start=\"3670\" data-end=\"3820\"\u003eHuman studies exploring pineal signaling have also observed increased melatonin-related markers and modulation of circadian clock gene expression.\u003c\/p\u003e\n\u003cp data-start=\"3822\" data-end=\"3948\"\u003eThese findings have led to interest in Epithalon within studies examining circadian biology and neuroendocrine regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6dtfz0\" data-start=\"3955\" data-end=\"4000\"\u003eAntioxidant and Cellular Stress Signaling\u003c\/h3\u003e\n\u003cp data-start=\"4002\" data-end=\"4089\"\u003eEpithalon has been investigated in research models examining oxidative stress pathways.\u003c\/p\u003e\n\u003cp data-start=\"4091\" data-end=\"4146\"\u003eExperimental findings have associated the peptide with:\u003c\/p\u003e\n\u003cul data-start=\"4148\" data-end=\"4361\"\u003e\n\u003cli data-section-id=\"fzci8c\" data-start=\"4148\" data-end=\"4201\"\u003e\n\u003cp data-start=\"4150\" data-end=\"4201\"\u003ereduced levels of reactive oxygen species (ROS)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1d5dk6f\" data-start=\"4202\" data-end=\"4240\"\u003e\n\u003cp data-start=\"4204\" data-end=\"4240\"\u003edecreased lipid peroxidation markers\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"f8zrky\" data-start=\"4241\" data-end=\"4361\"\u003e\n\u003cp data-start=\"4243\" data-end=\"4361\"\u003eactivation of cellular antioxidant systems including Nrf2, superoxide dismutase (SOD), catalase, and ceruloplasmin\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4363\" data-end=\"4522\"\u003eSeveral studies have also examined the peptide’s influence on p53-related signaling, a pathway involved in genomic stability and cellular stress responses.\u003c\/p\u003e\n\u003ch3 data-section-id=\"5luq3p\" data-start=\"4529\" data-end=\"4565\"\u003eImmune and Epigenetic Regulation\u003c\/h3\u003e\n\u003cp data-start=\"4567\" data-end=\"4728\"\u003eResearch exploring immune signaling has suggested that Epithalon may influence thymic signaling pathways and T-lymphocyte maturation in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"4730\" data-end=\"4975\"\u003eAt the chromatin level, studies have reported changes in heterochromatin condensation states, suggesting that Epithalon may influence gene expression by altering chromatin accessibility and reactivating genes that become suppressed with age.\u003c\/p\u003e\n\u003cp data-start=\"4977\" data-end=\"5127\"\u003eThese epigenetic observations have led to increased interest in Epithalon in research investigating cellular aging and transcriptional regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1nisyld\" data-start=\"5134\" data-end=\"5165\"\u003ePreclinical Research Findings\u003c\/h3\u003e\n\u003cp data-start=\"5167\" data-end=\"5313\"\u003eExtensive experimental work has investigated Epithalon in a variety of biological models including mice, rats, primates, and invertebrate systems.\u003c\/p\u003e\n\u003cp data-start=\"5315\" data-end=\"5374\"\u003eResearch has explored several biological domains including:\u003c\/p\u003e\n\u003ch3 data-section-id=\"nipbeu\" data-start=\"5376\" data-end=\"5415\"\u003eLongevity and Cellular Aging Models\u003c\/h3\u003e\n\u003cp data-start=\"5417\" data-end=\"5562\"\u003eAnimal studies have reported measurable changes in lifespan markers and age-associated biological parameters following exposure to Epithalon.\u003c\/p\u003e\n\u003cp data-start=\"5564\" data-end=\"5747\"\u003eFor example, experiments in Drosophila and rodent models reported increases in mean and maximal lifespan, along with delayed onset of certain age-associated physiological changes.\u003c\/p\u003e\n\u003cp data-start=\"5749\" data-end=\"5869\"\u003eAdditional studies have observed reductions in chromosomal abnormalities and preservation of cellular genomic stability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1itszh3\" data-start=\"5876\" data-end=\"5902\"\u003eTumor Biology Research\u003c\/h3\u003e\n\u003cp data-start=\"5904\" data-end=\"5995\"\u003ePreclinical research has examined Epithalon in models of chemically induced carcinogenesis.\u003c\/p\u003e\n\u003cp data-start=\"5997\" data-end=\"6234\"\u003eIn certain experimental systems, Epithalon exposure was associated with changes in tumor incidence, tumor multiplicity, and gene expression markers linked to tumor signaling pathways, including HER-2 related transcriptional activity.\u003c\/p\u003e\n\u003cp data-start=\"6236\" data-end=\"6361\"\u003eThese studies are frequently cited in research exploring cellular stress responses, genomic stability, and tumor biology.\u003c\/p\u003e\n\u003ch3 data-section-id=\"jbg307\" data-start=\"6368\" data-end=\"6404\"\u003eAntioxidant and Immune Signaling\u003c\/h3\u003e\n\u003cp data-start=\"6406\" data-end=\"6598\"\u003eExperimental investigations have reported that Epithalon may influence oxidative stress markers and immune cell populations, including T- and B-lymphocyte activity and antibody production.\u003c\/p\u003e\n\u003cp data-start=\"6600\" data-end=\"6756\"\u003eThe peptide has also been studied in models examining pineal-immune interactions and the relationship between circadian signaling and immune regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"11i1ubz\" data-start=\"6763\" data-end=\"6806\"\u003eNeural and Reproductive Research Models\u003c\/h3\u003e\n\u003cp data-start=\"6808\" data-end=\"6917\"\u003eAdditional research has explored Epithalon’s influence on neurological signaling and reproductive physiology.\u003c\/p\u003e\n\u003cp data-start=\"6919\" data-end=\"7113\"\u003eAnimal studies have reported measurable changes in learning behavior, neuronal stress resistance, mitochondrial function in reproductive cells, and chromatin activation in aging lymphocytes.\u003c\/p\u003e\n\u003cp data-start=\"7115\" data-end=\"7271\"\u003eThese findings have contributed to interest in Epithalon within studies investigating neurobiology, reproductive biology, and cellular stress responses.\u003c\/p\u003e\n\u003ch3 data-section-id=\"ep46tr\" data-start=\"7278\" data-end=\"7305\"\u003eClinical Research Context\u003c\/h3\u003e\n\u003cp data-start=\"7307\" data-end=\"7508\"\u003eClinical investigations of pineal peptides including epithalamin and Epithalon analogs have explored their influence on circadian signaling, immune markers, and age-related physiological processes.\u003c\/p\u003e\n\u003cp data-start=\"7510\" data-end=\"7722\"\u003eStudies involving elderly populations have reported measurable changes in melatonin signaling, chromatin activation in lymphocytes, and immune system markers following exposure to pineal peptide preparations.\u003c\/p\u003e\n\u003cp data-start=\"7724\" data-end=\"7909\"\u003eAdditional clinical research examining retinal disorders reported improvements in visual function parameters following administration of pineal peptides in controlled clinical settings.\u003c\/p\u003e\n\u003cp data-start=\"7911\" data-end=\"8066\"\u003eThese studies have contributed to ongoing interest in Epithalon in research focused on circadian biology, cellular aging, and pineal hormone signaling.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1yxgta6\" data-start=\"8073\" data-end=\"8112\"\u003eSafety Profile in Research Literature\u003c\/h3\u003e\n\u003cp data-start=\"8114\" data-end=\"8308\"\u003eAcross experimental and clinical research programs, Epithalon has demonstrated a favorable safety profile, with studies reporting no significant genotoxic, nephrotoxic, or mutagenic effects.\u003c\/p\u003e\n\u003cp data-start=\"8310\" data-end=\"8512\"\u003eLong-term animal studies and clinical observations have reported good tolerability, supporting continued investigation of the peptide in research exploring aging biology and cellular signaling pathways.\u003c\/p\u003e\n\u003ch3\u003eResearch context\u003c\/h3\u003e\n\u003cp\u003eEpithalon is frequently referenced in experimental models examining cellular homeostasis, telomere dynamics, and circadian signaling pathways. These research frameworks explore how gene expression, metabolic balance, and regulatory systems interact to support long-term cellular stability.\u003c\/p\u003e\n\u003cp\u003eFor a broader overview of how peptides and small molecules are studied in health maintenance and longevity-related research models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2257\" data-end=\"2280\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2283\" data-end=\"2296\"\u003eSynonyms:\u003c\/strong\u003e  Epithalon, Epithalone, UNII-O65P17785G, alanyl-glutamyl-aspartyl-glycine\u003cbr data-start=\"2382\" data-end=\"2385\"\u003e\u003cstrong data-start=\"2385\" data-end=\"2407\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003c\/span\u003e\u003csub\u003e14\u003c\/sub\u003e\u003cspan\u003eH\u003c\/span\u003e\u003csub\u003e22\u003c\/sub\u003e\u003cspan\u003eN\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003eO\u003c\/span\u003e\u003csub\u003e9\u003c\/sub\u003e\u003cbr data-start=\"2418\" data-end=\"2421\"\u003e\u003cstrong data-start=\"2421\" data-end=\"2436\"\u003eMolar Mass:\u003c\/strong\u003e 390.35 g\/mol\u003cbr data-start=\"2449\" data-end=\"2452\"\u003e\u003cstrong data-start=\"2452\" data-end=\"2467\"\u003eCAS Number:\u003c\/strong\u003e \u003cspan\u003e307297-39-8\u003c\/span\u003e\u003cbr data-start=\"2479\" data-end=\"2482\"\u003e\u003cstrong data-start=\"2482\" data-end=\"2494\"\u003ePubChem:\u003c\/strong\u003e 219042\u003cbr data-start=\"2501\" data-end=\"2504\"\u003e\u003cstrong data-start=\"2504\" data-end=\"2532\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 25 mg (1 vial)\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003eEpithalon \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Epitalon.png?v=1755244759\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/219042\" title=\"PubChem_Epithalon\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52642219196682,"sku":"epithalon25mg-1","price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52642219229450,"sku":"epithalon25mg-2","price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/epithalon_25mg_2.png?v=1773049932"},{"product_id":"retatrutide-20-mg","title":"Retatrutide – Advanced Research Peptide (20mg)","description":"\u003ch2 data-start=\"44\" data-end=\"101\"\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a next-generation triple-agonist peptide examined in metabolic and energy regulation research models. It is studied for its interaction with GLP-1, GIP, and glucagon-related signaling pathways, making it a central compound in experimental systems exploring glucose regulation, appetite signaling, and energy balance.\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRetatrutide peptide is designed to bind three critical metabolic receptors for enhanced therapeutic effect. Activating \u003cem data-start=\"135\" data-end=\"143\"\u003eGLP‑1R\u003c\/em\u003e improves insulin secretion and satiety, \u003cem data-start=\"184\" data-end=\"190\"\u003eGIPR\u003c\/em\u003e enhances insulin response and may promote healthy fat metabolism, while \u003cem data-start=\"263\" data-end=\"269\"\u003eGCGR\u003c\/em\u003e activation increases energy expenditure. As a next-generation peptide, Retatrutide represents a leap forward in metabolic pharmacotherapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRetatrutide is available in both lyophilized vial format for laboratory reconstitution (This format is typically selected for controlled preparation within research environments.) and pre-filled research pen format for immediate experimental handling. (This format allows immediate experimental handling without additional preparation steps.)\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eFor detailed storage and handling guidance, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"181\" data-end=\"218\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-peptide-research\"\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003cstrong data-start=\"1005\" data-end=\"1083\"\u003eRetatrutide in Research: Stability, Storage, and Experimental Optimization\u003c\/strong\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1635\" data-end=\"1679\"\u003eMechanism Overview in Experimental Models\u003c\/h3\u003e\n\u003cp data-start=\"1681\" data-end=\"1760\"\u003eRetatrutide demonstrates activity across three interconnected receptor systems:\u003c\/p\u003e\n\u003cp data-start=\"1762\" data-end=\"2005\"\u003e• GLP-1 receptor signaling – studied in glucose and satiety pathway research\u003cbr data-start=\"1838\" data-end=\"1841\"\u003e• GIP receptor signaling – examined in insulin response models\u003cbr data-start=\"1903\" data-end=\"1906\"\u003e• Glucagon receptor signaling – explored in energy expenditure and metabolic flexibility research\u003c\/p\u003e\n\u003cp data-start=\"2007\" data-end=\"2124\"\u003eThe combined activation profile supports integrated metabolic pathway analysis rather than isolated receptor studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrimary research pairing\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn experimental research settings, Retatrutide is frequently examined alongside compounds involved in growth hormone–related signaling pathways.\u003c\/p\u003e\n\u003cp\u003e→\u003cstrong\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003eCJC-1295 – Growth hormone signaling research\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAlternative hormonal research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSome experimental models explore Retatrutide in parallel with other compounds involved in growth hormone axis modulation.\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003eIpamorelin – GHRP-related signaling research\u003c\/a\u003e \u003c\/strong\u003e \u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong\u003eTesamorelin – GH axis modulation research\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg-ipamorelin-5-mg-research-peptide-blend\"\u003e\u003cstrong\u003eTesamorelin + Ipamorelin – GH-axis research model\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic and cellular research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdditional research frameworks examine metabolic efficiency and cellular balance alongside signaling-focused studies.\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong\u003eSLU-PP-332 – Exercise-mimetic metabolic research  \u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong\u003eL-Glutathione – Redox balance and antioxidant research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"397\" data-end=\"474\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"481\" data-end=\"506\"\u003eProduct Description\u003c\/h3\u003e\n\u003cul data-start=\"507\" data-end=\"922\"\u003e\n\u003cli data-start=\"507\" data-end=\"548\"\u003e\n\u003cp data-start=\"509\" data-end=\"548\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"13\" data-is-only-node=\"\"\u003eSynonyms:\u003c\/strong\u003e Retatrutide, LY‑3437943, GLP1‑R\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"549\" data-end=\"592\"\u003e\n\u003cp data-start=\"551\" data-end=\"592\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"22\" data-is-only-node=\"\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC₂₂₁H₃₄₂N₄₆O₆₈\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"593\" data-end=\"676\"\u003e\n\u003cp data-start=\"595\" data-end=\"676\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"21\" data-is-only-node=\"\"\u003eMolecular Weight:\u003c\/strong\u003e ~\u003cspan\u003e4731.33 g\/mol\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"677\" data-end=\"760\"\u003e\n\u003cp data-start=\"679\" data-end=\"760\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-start=\"0\" data-end=\"15\" data-is-only-node=\"\"\u003eCAS Number:\u003c\/strong\u003e 2381089‑83‑2\u003c\/span\u003e \u003cspan class=\"\" data-state=\"closed\"\u003e\u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"845\" data-end=\"892\"\u003e\n\u003cp data-start=\"847\" data-end=\"892\"\u003e\u003cstrong data-start=\"847\" data-end=\"875\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"893\" data-end=\"922\"\u003e\n\u003cp data-start=\"895\" data-end=\"922\"\u003e\u003cstrong data-start=\"895\" data-end=\"910\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003ca title=\"about reta peptide\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-retatrutide\" style=\"color: #ff8000;\"\u003e\u003cstrong\u003eWhat is Retatrutide? - Read More\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #000000;\"\u003eExplore how Retatrutide compares to Tirzepatide in current research →\u003cstrong\u003e \u003cspan style=\"color: #ff8000;\"\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-tirzepatide\" style=\"color: #ff8000;\"\u003eRetatrutide vs Tirzepatide.\u003c\/a\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eRetatrutide is studied in research models involving multi-pathway metabolic signaling and energy regulation.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo explore how peptide-based compounds compare with oral approaches:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/oral-vs-injectable-metabolic-peptides-research\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 128, 0);\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/a\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 128, 0);\"\u003eOral vs Injectable Compounds (Orforglipron, Tirzepatide, Retatrutide)\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #000000;\"\u003e\u003cspan style=\"color: #ff8000;\"\u003e\u003cspan style=\"color: #000000;\"\u003eProper buffer selection is critical for peptide stability. Learn more in our\u003c\/span\u003e\u003c\/span\u003e\u003cstrong\u003e\u003cspan style=\"color: #ff8000;\"\u003e \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-end=\"1276\" data-start=\"1217\"\u003e\u003cspan style=\"color: #ff8000;\"\u003ePBS vs HBS vs bacteriostatic water reconstitution guide\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"color: #ff8000;\"\u003e.\u003c\/span\u003e\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how metabolic signaling pathways intersect with muscle preservation and adaptive regeneration research, see:\u003cbr\u003e→ \u003cspan style=\"color: #ff8000;\"\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\" style=\"color: #ff8000;\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen ( 1 )","offer_id":51899984838922,"sku":"retatrutide20mg-1","price":205.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":51899984871690,"sku":"retatrutide20mg-2","price":180.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/retatrutide20mg_12-pen.png?v=1778073877"},{"product_id":"nad-plus-1000mg","title":"NAD+ 1000mg – Research Compound","description":"\u003ch3 data-start=\"329\" data-end=\"931\"\u003e\u003cstrong data-start=\"329\" data-end=\"342\"\u003eOverview:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade compound is supplied exclusively for laboratory and experimental use. NAD⁺ is widely studied in experimental models focused on cellular energy metabolism, mitochondrial function, and longevity-related pathways. Research interest centers on its role as a core coenzyme supporting metabolic and repair processes at the cellular level.\u003cstrong data-start=\"329\" data-end=\"342\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"240\" data-start=\"192\"\u003ePrimary metabolic and redox research pairing\u003c\/h3\u003e\n\u003cp data-end=\"441\" data-start=\"242\"\u003eIn experimental and laboratory research settings, NAD+ is commonly examined alongside compounds involved in cellular energy metabolism, redox regulation, and mitochondrial signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"512\" data-start=\"443\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"462\" data-start=\"445\"\u003eL-Glutathione\u003c\/strong\u003e – redox balance and antioxidant system research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"569\" data-start=\"519\"\u003eNAD⁺ metabolism and signaling research context\u003c\/h3\u003e\n\u003cp data-end=\"732\" data-start=\"571\"\u003eSome experimental models explore NAD+ in parallel with compounds studied for NAD⁺ biosynthesis, salvage pathways, and intracellular signaling regulation.\u003c\/p\u003e\n\u003cp data-end=\"804\" data-start=\"734\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-end=\"751\" data-start=\"736\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"877\" data-start=\"811\"\u003eMitochondrial energy and metabolic efficiency research context\u003c\/h3\u003e\n\u003cp data-end=\"1052\" data-start=\"879\"\u003eAdditional research frameworks reference NAD+ alongside compounds examined for mitochondrial energy signaling, energy expenditure, and systemic metabolic regulation.\u003c\/p\u003e\n\u003cp data-end=\"1128\" data-start=\"1054\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-end=\"1070\" data-start=\"1056\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"329\" data-end=\"931\"\u003eNicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in every living cell, playing a central role in energy production, redox reactions, and cellular signaling. NAD+ supports mitochondrial efficiency, influences gene expression through sirtuin activation, and contributes to DNA repair. Research shows NAD+ levels decline with age, which may contribute to metabolic disorders, cognitive decline, and other age-related conditions. Supplementation aims to restore optimal levels, potentially improving resilience to oxidative stress and supporting overall cellular health.\u003c\/p\u003e\n\u003ch3 data-start=\"933\" data-end=\"1683\"\u003e\u003cstrong data-start=\"933\" data-end=\"946\"\u003eResearch:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"933\" data-end=\"1683\"\u003eStudies have demonstrated that NAD+ participates in critical oxidation–reduction reactions, acting as a cofactor for enzymes in glycolysis, the Krebs cycle, and oxidative phosphorylation. Beyond its metabolic role, NAD+ regulates signaling pathways involved in calcium homeostasis, inflammation, and chromatin remodeling. Declines in NAD+ during aging have been linked to increased oxidative stress, DNA damage, and mitochondrial dysfunction. This creates a cycle of metabolic decline, contributing to cellular senescence and impaired tissue function. Enhancing NAD+ availability has been shown to activate DNA repair enzymes, boost mitochondrial biogenesis, and improve metabolic performance in various models of aging and disease.\u003c\/p\u003e\n\u003cp data-start=\"933\" data-end=\"1683\"\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"1794\" data-start=\"1761\"\u003eFurther NAD⁺ Research Reading\u003c\/h3\u003e\n\u003cp data-end=\"2018\" data-start=\"1796\"\u003eFor an in-depth overview of NAD⁺ biochemistry and its role in cellular energy metabolism, see our article \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-nad-plus\"\u003e\u003cstrong data-end=\"1919\" data-start=\"1902\"\u003eWhat Is NAD⁺?\u003c\/strong\u003e\u003c\/a\u003e, which examines the molecular mechanisms underlying NAD⁺ function in experimental research models.\u003c\/p\u003e\n\u003cp data-end=\"2192\" data-start=\"2020\"\u003eTo explore how NAD⁺ is studied in the context of aging-related pathways, autophagy, and cellular renewal, refer to our research overview on \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/longevity-and-nad-plus\"\u003e\u003cstrong data-end=\"2191\" data-start=\"2160\"\u003eNAD⁺ and longevity research\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eNAD⁺ metabolism is also closely associated with NNMT-related regulatory pathways in experimental research models. Certain small-molecule research compounds are frequently examined for their role in modulating NAD⁺ availability through NNMT activity.\u003c\/p\u003e\n\u003cp\u003eFor a research-focused overview of NNMT modulation and its relationship with NAD⁺ metabolism, see:\u003cbr\u003e→\u003cstrong\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-5-amino-1mq\"\u003eWhat is 5-Amino-1MQ? – Research overview of NNMT-related metabolic pathways\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNAD⁺ is central to cellular energy production, redox balance, and metabolic regulation across multiple biological systems.\u003c\/p\u003e\n\u003cp\u003eTo explore how metabolic energy pathways and fat metabolism are investigated in research:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eExplore the role of mitochondrial bioenergetics, ATP production, and exercise-responsive cellular pathways.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1685\" data-end=\"1711\"\u003e\n\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003ch3 data-start=\"1685\" data-end=\"1711\"\u003e\n\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003eNAD+ Product Description:\u003c\/strong\u003e\u003cstrong data-start=\"1685\" data-end=\"1709\"\u003e\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cul data-start=\"1712\" data-end=\"2015\"\u003e\n\u003cli data-start=\"1712\" data-end=\"1798\"\u003e\n\u003cp data-start=\"1714\" data-end=\"1798\"\u003e\u003cstrong data-start=\"1714\" data-end=\"1727\"\u003eSynonyms:\u003c\/strong\u003e nadide, coenzyme I, beta-NAD, beta-nicotinamide adenine dinucleotide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1799\" data-end=\"1839\"\u003e\n\u003cp data-start=\"1801\" data-end=\"1839\"\u003e\u003cstrong data-start=\"1801\" data-end=\"1823\"\u003eMolecular Formula:\u003c\/strong\u003e C21H27N7O14P2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1840\" data-end=\"1871\"\u003e\n\u003cp data-start=\"1842\" data-end=\"1871\"\u003e\u003cstrong data-start=\"1842\" data-end=\"1857\"\u003eMolar Mass:\u003c\/strong\u003e 663.4 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1872\" data-end=\"1899\"\u003e\n\u003cp data-start=\"1874\" data-end=\"1899\"\u003e\u003cstrong data-start=\"1874\" data-end=\"1889\"\u003eCAS Number:\u003c\/strong\u003e 53-84-9\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1900\" data-end=\"1921\"\u003e\n\u003cp data-start=\"1902\" data-end=\"1921\"\u003e\u003cstrong data-start=\"1902\" data-end=\"1914\"\u003ePubChem:\u003c\/strong\u003e 5892\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1922\" data-end=\"1985\"\u003e\n\u003cp data-start=\"1924\" data-end=\"1985\"\u003e\u003cstrong data-start=\"1924\" data-end=\"1966\"\u003eTotal Amount of the Active Ingredient:\u003c\/strong\u003e 1000 mg (1 vial)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1986\" data-end=\"2015\"\u003e\n\u003cp data-start=\"1988\" data-end=\"2015\"\u003e\u003cstrong data-start=\"1988\" data-end=\"2003\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eNAD+ structure: \u003c\/h3\u003e\n\u003cp\u003e\u003cimg alt=\"Chemical structure of nucleotides with labeled components\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_plus_stuctures.jpg?v=1758966119\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5419884\/\" title=\"PubMed_NAD+1000\"\u003ePubMed\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1325\" data-end=\"1363\"\u003eRelated Metabolic Research Context\u003c\/h3\u003e\n\u003cp data-start=\"1365\" data-end=\"1708\"\u003eNAD⁺ is frequently studied in experimental models alongside compounds involved in metabolic regulation and NAD⁺-dependent signaling pathways. In preclinical research, small molecules such as \u003cstrong data-start=\"1556\" data-end=\"1571\"\u003e5-Amino-1MQ\u003c\/strong\u003e are investigated for their role in pathways that influence intracellular NAD⁺ availability, metabolic flux, and cellular energy balance.\u003c\/p\u003e\n\u003cp data-start=\"1710\" data-end=\"1883\"\u003eResearchers examining NAD⁺ metabolism, redox regulation, and energy-related signaling may reference related research materials explored within these experimental frameworks.\u003c\/p\u003e\n\u003cp data-start=\"1710\" data-end=\"1883\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-start=\"1556\" data-end=\"1571\"\u003e5-Amino-1MQ\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51896117166346,"sku":"nadplus_1000mg-1","price":210.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":51896117199114,"sku":"nadplus_1000mg-2","price":235.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_1000_7-pen.png?v=1760890423"},{"product_id":"l-glutathione-3000-mg","title":"L-Glutathione – 3000mg","description":"\u003ch3\u003eOverview:\u003c\/h3\u003e\n\u003cp\u003eThis research-grade compound is supplied exclusively for laboratory and experimental use. L-Glutathione is studied in experimental systems examining antioxidant balance, cellular protection, and detoxification-related signaling. Research models often focus on how cells manage oxidative stress and maintain redox stability.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlutathione (GSH) \u003c\/strong\u003eis a tripeptide composed of glutamate, cysteine, and glycin.\u003cbr\u003eGlutathione levels decrease with aging, alcohol consumption, environmental factors,\u003cbr\u003eand sleep disturbances. Glutathione oral administration is not effective due to low\u003cbr\u003ebioavailability.\u003cbr\u003eIn mitochondria, GSH neutralizes reactive oxygen species (ROS) to prevent\u003cbr\u003emitochondrial DNA damage and collapse of the mitochondrial membrane potential\u003cbr\u003ebelow 100 mV.\u003cbr\u003eGSH, by reducing oxidative stress, can improve muscle recovery and reduce fatigue.\u003cbr\u003eGSH regenerates Vitamins C and E, protects mitochondrial membranes.\u003cbr\u003eIf you’re experimenting with mitochondrial agents like \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\" title=\"SLU-PP-332 200 mg capsules\"\u003eSLU-PP-332\u003c\/a\u003e and \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-peptide-20-mg\" title=\"SS-31 20mg vials\"\u003eSS-31\u003c\/a\u003e, GSH\u003cbr\u003ehelps you cover the ROS angle.\u003c\/p\u003e\n\u003ch3\u003eGlutathione effect boosters in clinical settings:\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003eVit-D, Selenium 25mcg, L-Glycine 3000mg, NAC 1200mg, Calcium Alpha\u003cbr\u003eCetoglutarate 300mg, Molybdenum 50 mcg\u003c\/p\u003e\n\u003ch3\u003eDetailed description:\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, GSH acts as a primary cellular antioxidant by donating\u003cbr\u003eelectrons from its thiol group (-SH) in cysteine to neutralize reactive oxygen species\u003cbr\u003e(ROS), such as hydrogen peroxide and superoxide radicals.\u003cbr\u003eThrough enzymatic catalysis by glutathione peroxidase (GPx), GSH reduces\u003cbr\u003ehydroperoxides to water or alcohols, forming oxidized glutathione (GSSG) as a\u003cbr\u003ebyproduct in the process.\u003cbr\u003eGSSG is then regenerated back to GSH by glutathione reductase (GR), which\u003cbr\u003eutilizes NADPH as a reducing equivalent, maintaining the cellular redox balance.\u003cbr\u003eGSH participates in detoxification by conjugating with xenobiotics and electrophilic\u003cbr\u003ecompounds via glutathione S-transferases (GSTs), forming glutathione S-conjugates\u003cbr\u003ethat are more water-soluble and easier to excrete.\u003c\/p\u003e\n\u003cp\u003eNon-enzymatically, GSH can directly react with electrophiles, such as lipid peroxides\u003cbr\u003eor reactive nitrogen species, to prevent oxidative damage to proteins, lipids, and\u003cbr\u003eDNA.\u003cbr\u003eIn protein glutathionylation, GSH forms mixed disulfides with protein thiols under\u003cbr\u003eoxidative stress, reversibly modifying protein function to protect against irreversible\u003cbr\u003eoxidation.\u003cbr\u003eAt the molecular level, GSH supports nutrient metabolism by facilitating the reduction\u003cbr\u003eof dehydroascorbate to ascorbate (vitamin C), thereby recycling this antioxidant.\u003cbr\u003eGSH regulates redox-sensitive transcription factors, such as NF-κB and AP-1, which\u003cbr\u003eare crucial in immune responses and inflammatory processes. Low GSH levels\u003cbr\u003einhibit T-cell proliferation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eRead about oxidative stress, mitochondrial defense systems, and the cellular benefits of exercise.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2310\" data-start=\"2061\"\u003e\u003cstrong data-end=\"2084\" data-start=\"2061\"\u003eGlutathione Product Description:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2310\" data-start=\"2061\"\u003e\u003cstrong data-end=\"2100\" data-start=\"2087\"\u003e\u003cbr\u003eSynonyms:\u003c\/strong\u003e γ-L-Glutamyl-L-cysteinylglycine, GSH\u003cbr data-end=\"2140\" data-start=\"2137\"\u003e\u003cstrong data-end=\"2155\" data-start=\"2140\"\u003eMolar Mass:\u003c\/strong\u003e 307.32 g\/mol\u003cbr data-end=\"2171\" data-start=\"2168\"\u003e\u003cstrong data-end=\"2186\" data-start=\"2171\"\u003eCAS Number:\u003c\/strong\u003e 70-18-8\u003cbr data-end=\"2197\" data-start=\"2194\"\u003e\u003cstrong data-end=\"2209\" data-start=\"2197\"\u003ePubChem:\u003c\/strong\u003e 124886\u003cbr data-end=\"2219\" data-start=\"2216\"\u003e\u003cstrong data-end=\"2261\" data-start=\"2219\"\u003eTotal Amount of the Active Ingredient:\u003c\/strong\u003e 3000mg per serving\u003cbr data-end=\"2283\" data-start=\"2280\"\u003e\u003cstrong data-end=\"2298\" data-start=\"2283\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-end=\"2310\" data-start=\"2061\"\u003eGlutathione \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Gluthatione structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Glutathione.png?v=1755187970\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eSource: \u003ca title=\"PubChem_Glutathione3000\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/124886\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51896146952458,"sku":"lglutathione_3000mg-1","price":90.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 3 )","offer_id":51896146985226,"sku":"lglutathione_3000mg-2","price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/glutathione3000mg_7-pen.png?v=1760890228"},{"product_id":"ss-31-20mg","title":"SS-31 20mg – Research Peptide","description":"\u003ch3\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. SS-31 is studied in experimental systems focused on mitochondrial stability, oxidative stress modulation, and cellular energy preservation. Research models examine its role in maintaining mitochondrial efficiency under stress conditions.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"400\" data-end=\"442\"\u003ePrimary mitochondrial research pairing\u003c\/h3\u003e\n\u003cp data-start=\"444\" data-end=\"649\"\u003eIn experimental and laboratory research settings, SS-31 (Elamipretide) is examined either as a standalone mitochondrial-targeting compound or within specific growth hormone–related research models.\u003c\/p\u003e\n\u003ch3 data-start=\"656\" data-end=\"711\"\u003eGrowth hormone–related research context\u003c\/h3\u003e\n\u003cp data-start=\"713\" data-end=\"848\"\u003eSome experimental frameworks explore SS-31 alongside compounds involved in GHRH-mediated metabolic and mitochondrial signaling.\u003c\/p\u003e\n\u003cp data-start=\"850\" data-end=\"935\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-start=\"852\" data-end=\"871\"\u003eCJC-1295 \u003c\/strong\u003e– GHRH-related metabolic and mitochondrial signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"942\" data-end=\"999\"\u003eAlternative GH-axis research context \u003c\/h3\u003e\n\u003cp data-start=\"1001\" data-end=\"1142\"\u003eOther experimental models reference SS-31 in parallel with compounds studied for GH-axis modulation without long-acting GHRH analogs.\u003c\/p\u003e\n\u003cp data-start=\"1144\" data-end=\"1271\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-start=\"1146\" data-end=\"1161\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-start=\"1205\" data-end=\"1208\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-start=\"1210\" data-end=\"1224\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1278\" data-end=\"1349\"\u003eMitochondrial and cellular energy research context \u003c\/h3\u003e\n\u003cp data-start=\"1351\" data-end=\"1559\"\u003eIn research frameworks not centered on growth hormone signaling, SS-31 is commonly examined alongside compounds involved in mitochondrial efficiency, cellular energy balance, and metabolic regulation.\u003c\/p\u003e\n\u003cp data-start=\"1561\" data-end=\"1726\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-start=\"1563\" data-end=\"1577\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic efficiency research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1733\" data-end=\"1790\"\u003eRedox balance and metabolic cofactor research context\u003c\/h3\u003e\n\u003cp data-start=\"1792\" data-end=\"1943\"\u003eSome experimental discussions reference SS-31 alongside compounds examined for oxidative stress regulation and intracellular redox homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"1945\" data-end=\"2080\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1947\" data-end=\"1964\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003cbr data-start=\"2007\" data-end=\"2010\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-start=\"2012\" data-end=\"2027\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"2087\" data-end=\"2146\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"2148\" data-end=\"2293\"\u003eIn specialized experimental models, SS-31 may be referenced alongside compounds studied for neurotrophic signaling and synaptic function.\u003c\/p\u003e\n\u003cp data-start=\"2295\" data-end=\"2356\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"2297\" data-end=\"2307\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"2363\" data-end=\"2410\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"2412\" data-end=\"2576\"\u003eCertain research discussions reference SS-31 alongside alternative peptide formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-start=\"2578\" data-end=\"2642\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"2580\" data-end=\"2602\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eSS-31 Peptide, also known as elamipretide, MTP-131, or Bendavia, is a synthetic tetrapeptide that selectively targets and penetrates the inner mitochondrial membrane. Its unique structure allows it to bind cardiolipin, a critical phospholipid involved in maintaining mitochondrial structure and function. Research suggests that SS-31 pepptide can reduce mitochondrial oxidative damage, improve ATP production, and stabilize electron transport chain efficiency.\u003c\/p\u003e\n\u003cp\u003eStudies have investigated SS-31 peptide in the context of age-related mitochondrial decline, cardiovascular dysfunction, neurodegeneration, and metabolic disorders, making it a promising compound in longevity and cellular health research.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMitochondrial Protection:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBinds and stabilizes cardiolipin to maintain mitochondrial cristae structure.\u003c\/li\u003e\n\u003cli\u003eReduces production of reactive oxygen species (ROS), limiting oxidative damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eEnergy Metabolism:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEnhances efficiency of oxidative phosphorylation, increasing ATP synthesis.\u003c\/li\u003e\n\u003cli\u003eRestores mitochondrial membrane potential in models of mitochondrial dysfunction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCardiovascular Studies:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eImproves cardiac bioenergetics and function in preclinical models of ischemia-reperfusion injury and heart failure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNeuroprotection:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePreserves mitochondrial function in neuronal cells, with potential benefits in neurodegenerative disease models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic Health:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInvestigated for reversing age-associated declines in mitochondrial performance, potentially improving muscle endurance and metabolic flexibility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e D-Arg-Tyr(2,6-diMe)-Lys-Phe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₄₉N₉O₅\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 639.8 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePubChem CID:\u003c\/strong\u003e 11764719\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 736992-21-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynonyms:\u003c\/strong\u003e elamipretide, MTP-131, Bendavia\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eScientific background and research context:\u003c\/strong\u003e\u003cbr data-end=\"1271\" data-start=\"1268\"\u003e\u003cstrong\u003e→ \u003ca title=\"ss 31 research background\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ss-31-peptide\"\u003eSS-31 (Elamipretide): Mitochondrial function and energy research overview\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003e\u003cstrong\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eDiscover how mitochondrial protection, oxidative stress regulation, and exercise influence long-term cellular resilience.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Peptide Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Elamipretide.png?v=1755186474\" alt=\"ss-31 structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003c\/strong\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11764719\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cstrong\u003ePubChem\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-end=\"620\" data-start=\"589\"\u003eRelated research compounds:\u003c\/strong\u003e\u003cbr data-end=\"623\" data-start=\"620\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cstrong data-end=\"695\" data-start=\"625\"\u003eNAD⁺ – Research-Grade Compound for mitochondrial energy metabolism\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51900001288458,"sku":"ss31_20mg-1","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ss-31_20mg_7-pen.png?v=1760890079"},{"product_id":"5-amino-1mq-50mg","title":"5-Amino-1MQ – High Purity Research Molecule (50mg)","description":"\u003ch2\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. 5-Amino-1MQ is studied in experimental models exploring NNMT-related metabolic pathways and cellular energy regulation. Research interest includes how NAD⁺ availability and metabolic signaling intersect in energy balance and aging-related research.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"1077\" data-start=\"574\"\u003e5-Amino-1MQ is a small-molecule compound that inhibits the enzyme nicotinamide N-methyltransferase (NNMT), a key regulator of cellular energy balance and metabolic pathways, with notable activity in adipose tissue. Inhibition of NNMT has been associated with increased availability of nicotinamide adenine dinucleotide (NAD⁺), an essential cofactor in cellular metabolism, which may influence mitochondrial activity and support NAD⁺-dependent signaling processes, including sirtuin-1 (SIRT1) activation.\u003c\/p\u003e\n\u003cp data-end=\"1648\" data-start=\"1079\"\u003eSIRT1, often studied in the context of metabolic regulation and cellular stress response, has been linked in research literature to pathways relevant to metabolic health, lipid metabolism, and age-associated cellular function. In preclinical research models, modulation of NNMT activity has been examined for its potential effects on adipocyte metabolism and energy utilization under controlled experimental conditions. These findings suggest that altered NNMT signaling may influence fat cell biology and metabolic efficiency without directly affecting caloric intake.\u003c\/p\u003e\n\u003ch3 data-start=\"106\" data-end=\"175\"\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"177\" data-end=\"460\"\u003e\u003cstrong data-start=\"177\" data-end=\"190\"\u003eSynonyms:\u003c\/strong\u003e 5-amino-1-methylquinolinium, SCHEMBL6403148, CHEMBL4116828, ZINC552049, STL196667\u003cbr data-start=\"272\" data-end=\"275\"\u003e\u003cstrong data-start=\"275\" data-end=\"290\"\u003eMolar Mass:\u003c\/strong\u003e 159.21 g\/mol\u003cbr data-start=\"303\" data-end=\"306\"\u003e\u003cstrong data-start=\"306\" data-end=\"321\"\u003eCAS Number:\u003c\/strong\u003e 42464-96-0\u003cbr data-start=\"332\" data-end=\"335\"\u003e\u003cstrong data-start=\"335\" data-end=\"350\"\u003ePubChem ID:\u003c\/strong\u003e 950107\u003cbr data-start=\"357\" data-end=\"360\"\u003e\u003cstrong data-start=\"360\" data-end=\"388\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 6000 mg per container (50 mg per capsule) 2 x 60 capsules\u003cbr data-start=\"430\" data-end=\"433\" data-is-only-node=\"\"\u003e\u003cstrong data-start=\"433\" data-end=\"448\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-start=\"177\" data-end=\"460\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3\u003eResearch context:\u003c\/h3\u003e\n\u003cp\u003e5-Amino-1MQ is commonly referenced in experimental studies investigating NNMT activity, metabolic regulation, and NAD⁺-associated cellular pathways. For a detailed research-focused overview of its mechanisms and experimental context, see:\u003c\/p\u003e\n\u003cp\u003e→\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-5-amino-1mq\"\u003e \u003cstrong\u003eWhat is 5-Amino-1MQ? – Research overview of NNMT-related metabolic pathways\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/nad-metabolism-5-amino-1mq-vs-1-mna\"\u003e5-Amino-1MQ vs 1-MNA in NAD+ metabolism\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e5-Amino-1MQ is frequently studied in the context of metabolic regulation, particularly within research models exploring energy utilization, lipid metabolism, and cellular efficiency.\u003c\/p\u003e\n\u003cp\u003eTo understand how metabolic energy systems and fat metabolism pathways are examined in experimental research:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003e\u003cstrong\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eLearn how exercise-associated metabolic pathways influence mitochondrial efficiency and cellular energy regulation.\u003cbr\u003e\u003cspan\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"177\" data-end=\"460\"\u003e\u003cstrong\u003e5-Amino-1MQ Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"5-Amino-1MQ structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/5-Amino-1-methylquinolinium.png?v=1755157132\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSources \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5-Amino-1-methylquinolinium\" title=\"PubChem\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1552\" data-end=\"1576\"\u003e\u003cstrong data-start=\"1556\" data-end=\"1576\"\u003eResearch Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1578\" data-end=\"1973\"\u003eNicotinamide N-methyltransferase (NNMT) has been widely studied as a regulator of cellular metabolism and energy balance, with particular relevance in adipose tissue and metabolic signaling pathways. NNMT activity influences the flux of nicotinamide and S-adenosylmethionine (SAM) within the NAD⁺ salvage pathway and methionine cycle, positioning it as an important enzyme in metabolic research.\u003c\/p\u003e\n\u003cp data-start=\"1975\" data-end=\"2385\"\u003eIn laboratory investigations, small-molecule NNMT inhibitors have been evaluated for membrane permeability, selectivity, and biochemical activity. In vitro studies have demonstrated that NNMT inhibition can reduce intracellular levels of 1-methylnicotinamide (1-MNA), while increasing NAD⁺ and SAM availability and modulating lipogenic signaling in cultured adipocytes under controlled experimental conditions.\u003c\/p\u003e\n\u003cp data-start=\"2387\" data-end=\"2784\"\u003ePreclinical research models have further explored the metabolic effects of NNMT modulation, highlighting its role in adipocyte function, lipid metabolism, and systemic energy regulation. These findings have established NNMT inhibition as an active area of investigation in metabolic and cellular energy research, particularly in studies examining NAD⁺-dependent pathways and metabolic homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"2786\" data-end=\"2881\"\u003e\u003cstrong data-start=\"2786\" data-end=\"2813\"\u003eRelated research focus:\u003c\/strong\u003e\u003cbr data-start=\"2813\" data-end=\"2816\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cem data-start=\"2818\" data-end=\"2881\"\u003eNAD⁺ – Research-Grade Compound for cellular energy metabolism\u003c\/em\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-end=\"1501\" data-start=\"1060\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/nad_metabolic_diagram.jpg?v=1758966221\" alt=\"Diagram of metabolic pathways with various chemicals and their interactions on a white background.\" width=\"1590\" height=\"831\"\u003e\u003c\/p\u003e\n\u003cp data-end=\"1537\" data-start=\"1508\"\u003eSource: \u003ca title=\"ScienceDirect_1\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006295217306718\"\u003eScienceDirect\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"3338\" data-start=\"2903\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Capsules","offer_id":52963575365898,"sku":"5amino1mq-1","price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52963575398666,"sku":"5amino1mq-2","price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen","offer_id":52963575431434,"sku":"5amino1mq-3","price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/5amino_cap_vial_1.png?v=1777626095"},{"product_id":"bacteriostatic-water-20-ml","title":"Bacteriostatic Water - 20 ml","description":"\u003ch2 data-start=\"525\" data-end=\"609\"\u003e\u003cstrong data-start=\"529\" data-end=\"609\"\u003eBacteriostatic Water (BAC) for Laboratory Reconstitution Workflows\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"611\" data-end=\"989\"\u003eBacteriostatic Water (BAC) is a sterile, laboratory-grade water preparation containing 0.9% benzyl alcohol, a compound that helps inhibit bacterial proliferation inside multi-use vials. Because of this stabilizing effect, BAC is widely used across research laboratories that require reliable reconstitution fluids for peptides, small molecules, and various investigative agents.\u003c\/p\u003e\n\u003cp data-start=\"991\" data-end=\"1355\"\u003eUnlike single-use sterile water, bacteriostatic water maintains its integrity over multiple entries, allowing researchers to withdraw aliquots at different points in an experiment without compromising the remaining volume. This characteristic makes BAC particularly useful in studies where repeated dilution, reagent preparation, or multi-phase setup is necessary.\u003c\/p\u003e\n\u003ch3 data-start=\"1362\" data-end=\"1426\"\u003e\u003cstrong data-start=\"1366\" data-end=\"1426\"\u003eRole in Research Reconstitution and Solution Preparation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1428\" data-end=\"1498\"\u003eIn controlled laboratory environments, BAC is frequently selected for:\u003c\/p\u003e\n\u003cul data-start=\"1500\" data-end=\"1733\"\u003e\n\u003cli data-start=\"1500\" data-end=\"1559\"\u003e\n\u003cp data-start=\"1502\" data-end=\"1559\"\u003ereconstituting peptides and other lyophilized materials\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1560\" data-end=\"1607\"\u003e\n\u003cp data-start=\"1562\" data-end=\"1607\"\u003epreparing dilutions for experimental assays\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1608\" data-end=\"1666\"\u003e\n\u003cp data-start=\"1610\" data-end=\"1666\"\u003esupporting workflows that involve repeated vial access\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1667\" data-end=\"1733\"\u003e\n\u003cp data-start=\"1669\" data-end=\"1733\"\u003emaintaining sterility during multi-step experimental timelines\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1735\" data-end=\"2053\"\u003eIts composition is designed to preserve solution stability, minimize contamination risk, and support reproducibility across multiple experimental runs. Because BAC contains no sodium or buffering components, it provides a neutral base that does not interfere with biochemical signaling pathways or analytical readouts.\u003c\/p\u003e\n\u003ch3 data-start=\"2060\" data-end=\"2111\"\u003e\u003cstrong data-start=\"2064\" data-end=\"2111\"\u003eWhy Researchers Prefer Bacteriostatic Water\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2113\" data-end=\"2233\"\u003eLaboratories working with peptide studies, molecular biology, or metabolic models often rely on BAC because it provides:\u003c\/p\u003e\n\u003cul data-start=\"2235\" data-end=\"2523\"\u003e\n\u003cli data-start=\"2235\" data-end=\"2298\"\u003e\n\u003cp data-start=\"2237\" data-end=\"2298\"\u003e\u003cstrong data-start=\"2237\" data-end=\"2280\"\u003eextended usability within a single vial\u003c\/strong\u003e, reducing waste\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2299\" data-end=\"2363\"\u003e\n\u003cp data-start=\"2301\" data-end=\"2363\"\u003e\u003cstrong data-start=\"2301\" data-end=\"2325\"\u003econsistent sterility\u003c\/strong\u003e, even during multi-access workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2364\" data-end=\"2426\"\u003e\n\u003cp data-start=\"2366\" data-end=\"2426\"\u003e\u003cstrong data-start=\"2366\" data-end=\"2424\"\u003ecompatibility with a broad range of research compounds\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2427\" data-end=\"2523\"\u003e\n\u003cp data-start=\"2429\" data-end=\"2523\"\u003e\u003cstrong data-start=\"2429\" data-end=\"2469\"\u003ea clear, predictable solvent profile\u003c\/strong\u003e that integrates smoothly into established protocols\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2525\" data-end=\"2714\"\u003eThese properties help reduce preparation variability, a critical factor in studies where experimental accuracy depends on maintaining uniform solution conditions from one trial to the next.\u003c\/p\u003e\n\u003ch3 data-start=\"2721\" data-end=\"2772\"\u003e\u003cstrong data-start=\"2725\" data-end=\"2772\"\u003eLaboratory Handling and Application Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2774\" data-end=\"3142\"\u003eAs with all reconstitution materials intended for scientific investigation, bacteriostatic water should be handled according to standard laboratory aseptic techniques. Researchers typically incorporate BAC into workflows involving lyophilized peptides, reference standards, or small-molecule models, ensuring precise concentration control during experimental planning.\u003c\/p\u003e\n\u003cp data-start=\"3144\" data-end=\"3357\"\u003eBAC’s predictable performance and multi-use stability have made it a staple reagent across peptide facilities, molecular research teams, and biochemical laboratories seeking reliability in their preparation steps.\u003c\/p\u003e\n\u003cp data-start=\"3402\" data-end=\"3595\"\u003eTo support a wider range of laboratory workflows, researchers can also explore additional reconstitution materials such as PBS and HBS, along with other ready-to-use solutions available in our Liquid Formulas Collection.\u003c\/p\u003e\n\u003cp data-start=\"3402\" data-end=\"3595\"\u003eLearn \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003ehow bacteriostatic water compares to PBS and HBS in peptide preparation.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51729853284618,"sku":null,"price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/BACwater5.png?v=1760888733"},{"product_id":"phosphate-buffer-pbs-20-ml","title":"Phosphate Buffered Saline (PBS) - 20 ml","description":"\u003ch3 data-start=\"117\" data-end=\"177\"\u003e\u003cstrong data-start=\"121\" data-end=\"175\"\u003eOverview: Phosphate Buffered Saline (PBS)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"179\" data-end=\"470\"\u003ePhosphate Buffered Saline is one of the most commonly used solutions for peptide or small molecule reconstitution in laboratory research. By maintaining a constant pH and osmolarity, PBS provides a controlled environment that preserves the structure and function of biological samples.\u003c\/p\u003e\n\u003cp data-start=\"472\" data-end=\"901\"\u003eIn \u003cstrong data-start=\"475\" data-end=\"500\"\u003ecell culture research\u003c\/strong\u003e, PBS is essential for washing and resuspending cells without causing osmotic stress. In \u003cstrong data-start=\"589\" data-end=\"630\"\u003eprotein and molecular biology studies\u003c\/strong\u003e, it serves as a reliable diluent that minimizes interference in downstream assays. Because of its compatibility with \u003cstrong data-start=\"748\" data-end=\"790\"\u003eenzymes, antibodies, and nucleic acids\u003c\/strong\u003e, PBS is a standard reagent in fields ranging from immunology and biochemistry to microscopy and diagnostics.\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eResearch has consistently demonstrated that PBS’s isotonic properties support reproducibility and reduce variability across experiments, making it an indispensable tool in modern laboratories.\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eSee other buffered saline solution:  \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/histidine-buffered-saline-hbs\"\u003eHistidine Buffered Saline (HBS) - 20 ml\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"903\" data-end=\"1097\"\u003eNot sure which buffer to use? Explore how \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-start=\"1356\" data-end=\"1424\"\u003ebacteriostatic water compares to PBS and HBS in peptide research\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51729970135306,"sku":null,"price":18.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Phosphate5.png?v=1760888824"},{"product_id":"histidine-buffered-saline-hbs","title":"Histidine Buffered Saline (HBS) - 20 ml","description":"\u003ch3 data-start=\"1130\" data-end=\"1189\"\u003e\u003cstrong data-start=\"1133\" data-end=\"1187\"\u003eOverview: Histidine Buffered Saline (HBS)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1191\" data-end=\"1545\"\u003eHistidine Buffered Saline has become increasingly important in pharmaceutical and protein research and is one of the most commonly used solutions for peptide or small molecule reconstitution because of its effective buffering capacity in the slightly acidic to neutral range. Histidine’s imidazole side chain allows precise pH regulation, making HBS a preferred choice in studies where \u003cstrong data-start=\"1479\" data-end=\"1524\"\u003eprotein stability and biological activity\u003c\/strong\u003e must be preserved.\u003c\/p\u003e\n\u003cp data-start=\"1547\" data-end=\"1861\"\u003eIn \u003cstrong data-start=\"1550\" data-end=\"1583\"\u003epeptide and antibody research\u003c\/strong\u003e, HBS helps maintain molecular integrity by reducing denaturation and aggregation, which can occur in less stable buffers. It has also been applied in \u003cstrong data-start=\"1734\" data-end=\"1757\"\u003eformulation studies\u003c\/strong\u003e, where maintaining consistent conditions is crucial for reproducibility and accurate data collection.\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eComparative research has shown that histidine buffers may outperform phosphate buffers in scenarios involving \u003cstrong data-start=\"1973\" data-end=\"1999\"\u003esensitive biomolecules\u003c\/strong\u003e, particularly when phosphate interference could alter experimental outcomes. For this reason, HBS is widely used in \u003cstrong data-start=\"2116\" data-end=\"2175\"\u003ebiotechnology, immunology, and biochemical laboratories\u003c\/strong\u003e as a reliable, research-grade buffer solution.\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eSee other bufferes saline solution products: \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/phosphate-buffer-pbs-20-ml\"\u003ePhosphate Buffered Saline (PBS) - 20 ml\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"1863\" data-end=\"2224\"\u003eFor guidance on peptide reconstitution and buffer selection, see our detailed comparison of \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/pbs-vs-hbs-vs-bacteriostatic-water\"\u003e\u003cstrong data-end=\"1092\" data-start=\"1054\"\u003ePBS vs HBS vs bacteriostatic water\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":51730117722378,"sku":null,"price":18.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/histide5.png?v=1760888775"},{"product_id":"thymosin-alpha-1-10mg","title":"Thymosin Alpha-1 – High Purity Research Peptide (10mg per vial)","description":"\u003ch3 data-start=\"385\" data-end=\"402\"\u003e\u003cstrong data-start=\"388\" data-end=\"400\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Thymosin Alpha-1 is commonly studied in research models examining immune signaling, inflammatory balance, and cellular resilience under physiological stress, including contexts related to tissue recovery and regeneration-supportive processes.\u003cstrong data-start=\"388\" data-end=\"400\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"403\" data-end=\"853\"\u003eThymosin Alpha-1 is a synthetic version of a naturally occurring thymic peptide that plays a critical role in immune regulation. It works by stimulating T-cell production and activity, enhancing the body’s ability to respond to pathogens and modulate inflammatory processes. Preclinical and clinical research has investigated its potential in managing immune deficiencies, chronic infections, cancer immunotherapy, and vaccine response enhancement.\u003c\/p\u003e\n\u003cp data-start=\"855\" data-end=\"1019\"\u003eBeyond its immune functions, emerging research suggests Tα1 may also impact neurodevelopment and cognitive performance through immune–nervous system interactions.\u003c\/p\u003e\n\u003ch3 data-start=\"268\" data-end=\"296\"\u003ePrimary research pairing\u003c\/h3\u003e\n\u003cp data-start=\"298\" data-end=\"506\"\u003eIn experimental and laboratory research settings, \u003cstrong data-start=\"348\" data-end=\"368\"\u003eThymosin Alpha 1\u003c\/strong\u003e is frequently examined alongside peptides involved in \u003cstrong data-start=\"423\" data-end=\"505\"\u003eimmune signaling, cellular regulation, and tissue-associated response pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"508\" data-end=\"676\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-10mg-per-vial\"\u003e\u003cstrong data-start=\"510\" data-end=\"528\"\u003eBPC-157 (vial)\u003c\/strong\u003e – peptide-mediated cellular signaling and tissue-related research\u003c\/a\u003e\u003cbr data-start=\"594\" data-end=\"597\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"599\" data-end=\"616\"\u003eTB-500 (vial)\u003c\/strong\u003e – cytoskeletal regulation and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"683\" data-end=\"740\"\u003eNeuroimmune and regulatory signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"742\" data-end=\"920\"\u003eSome experimental models explore \u003cstrong data-start=\"775\" data-end=\"795\"\u003eThymosin Alpha 1\u003c\/strong\u003e in parallel with compounds studied for \u003cstrong data-start=\"835\" data-end=\"919\"\u003eneuroimmune signaling, stress-response pathways, and regulatory peptide activity\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"922\" data-end=\"994\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/selank-peptide-25-mg\"\u003e\u003cstrong data-start=\"924\" data-end=\"934\"\u003eSelank\u003c\/strong\u003e – regulatory peptide and neurochemical signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1001\" data-end=\"1048\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1050\" data-end=\"1225\"\u003eCertain research discussions reference \u003cstrong data-start=\"1089\" data-end=\"1109\"\u003eThymosin Alpha 1\u003c\/strong\u003e alongside alternative peptide formats when evaluating \u003cstrong data-start=\"1164\" data-end=\"1224\"\u003edelivery considerations and experimental exposure models\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1227\" data-end=\"1291\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1229\" data-end=\"1251\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1026\" data-end=\"1043\"\u003e\u003cstrong data-start=\"1029\" data-end=\"1041\"\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1044\" data-end=\"1209\"\u003eAnimal studies have demonstrated that peripheral administration of Thymosin Alpha-1 can improve cognitive abilities early in life. In neonatal mice, Tα1 treatment:\u003c\/p\u003e\n\u003cul data-start=\"1211\" data-end=\"1865\"\u003e\n\u003cli data-start=\"1211\" data-end=\"1387\"\u003e\n\u003cp data-start=\"1213\" data-end=\"1387\"\u003e\u003cstrong data-start=\"1213\" data-end=\"1239\"\u003ePromoted Neurogenesis:\u003c\/strong\u003e Increased populations of hippocampal neural progenitors and differentiated neurons (BrdU+, nestin+, Tbr2+, BrdU+\/DCX+, BrdU+\/Iba1+, BrdU+\/NeuN+).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1388\" data-end=\"1545\"\u003e\n\u003cp data-start=\"1390\" data-end=\"1545\"\u003e\u003cstrong data-start=\"1390\" data-end=\"1423\"\u003eBoosted Neurotrophic Factors:\u003c\/strong\u003e Elevated brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and insulin-like growth factor-1 (IGF-1).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1546\" data-end=\"1643\"\u003e\n\u003cp data-start=\"1548\" data-end=\"1643\"\u003e\u003cstrong data-start=\"1548\" data-end=\"1573\"\u003eReduced Inflammation:\u003c\/strong\u003e Lowered IL-6 and TNF-α, while increasing IL-4 and interferon-gamma.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1644\" data-end=\"1748\"\u003e\n\u003cp data-start=\"1646\" data-end=\"1748\"\u003e\u003cstrong data-start=\"1646\" data-end=\"1674\"\u003eInduced Th1 Immune Bias:\u003c\/strong\u003e Positive link between neurotrophic factor expression and Th1\/Th2 ratio.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1749\" data-end=\"1865\"\u003e\n\u003cp data-start=\"1751\" data-end=\"1865\"\u003e\u003cstrong data-start=\"1751\" data-end=\"1780\"\u003eProvided Neuroprotection:\u003c\/strong\u003e Prevented lipopolysaccharide (LPS)-induced disruption of hippocampal neurogenesis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003eThese findings indicate that Tα1 may exert neuroprotective and cognitive benefits by modulating systemic immunity and enhancing neuronal growth factors.\u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e\u003cem data-start=\"269\" data-end=\"380\"\u003eLearn more about the scientific background and research applications of Thymosin Alpha-1 in our full article. \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/thymosin-alpha-1-mechanisms\" title=\"thymosin alpha1 benefits\"\u003e➜ \u003c\/a\u003e\u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/thymosin-alpha-1-mechanisms\" title=\"thymosin alpha1 benefits\"\u003e\u003cstrong data-start=\"400\" data-end=\"478\"\u003eThymosin Alpha-1: Mechanisms, Immune Modulation, and Research Applications\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on immune signaling, cellular balance, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRecent research explores how Thymosin α1 may influence iron regulation pathways, including hepcidin signaling and dopamine-related mechanisms in neurodevelopmental conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/adhd-iron-dysregulation-hepcidin-dopamine\"\u003e\u003cstrong\u003eRead the ADHD iron dysregulation research article\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eThymosin Alpha-1 in Immune and Gut Signaling Research\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThymosin Alpha-1 is studied in research models focused on immune signaling, cytokine regulation, and system-level coordination. Within gut-associated environments, it is examined in relation to how immune responses align with local cellular conditions.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo explore how TA1 is positioned alongside KPV and BPC-157 in gut and inflammation research:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1867\" data-end=\"2021\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"97\" data-end=\"149\"\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003eThymosin Alpha-1 10mg – Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"150\" data-end=\"336\"\u003e\u003cstrong data-start=\"150\" data-end=\"163\"\u003eSynonyms:\u003c\/strong\u003e Thymalfasin\u003cbr data-start=\"175\" data-end=\"178\"\u003e\u003cstrong data-start=\"178\" data-end=\"193\"\u003eMolar Mass:\u003c\/strong\u003e 3108.28 g\/mol\u003cbr data-start=\"207\" data-end=\"210\"\u003e\u003cstrong data-start=\"210\" data-end=\"225\"\u003eCAS Number:\u003c\/strong\u003e 62304-98-7\u003cbr data-start=\"236\" data-end=\"239\"\u003e\u003cstrong data-start=\"239\" data-end=\"251\"\u003ePubChem:\u003c\/strong\u003e 16130571\u003cbr data-start=\"260\" data-end=\"263\"\u003e\u003cstrong data-start=\"263\" data-end=\"291\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-start=\"306\" data-end=\"309\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"97\" data-end=\"149\"\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003eThymosin Alpha-1 \u003cspan\u003eStructures:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"100\" data-end=\"147\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Thymalfasin.png?v=1755185016\" alt=\"Thymosin Alpha-1 Structures\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/16130571\" title=\"PubChem_Thymosin Alpha 1\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52192218677514,"sku":"thymosinalpha1_10mg-1","price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52192218710282,"sku":"thymosinalpha1_10mg-2","price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/thymosinalpha-1_10mg.png?v=1764412645"},{"product_id":"ss-31-50mg-per-vial","title":"SS-31 50mg – Research Peptide","description":"\u003ch2 data-start=\"338\" data-end=\"354\"\u003e\u003cstrong data-start=\"342\" data-end=\"354\"\u003eOverview\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. SS-31 is studied in experimental systems focused on mitochondrial stability, oxidative stress modulation, and cellular energy preservation. Research models examine its role in maintaining mitochondrial efficiency under stress conditions.\u003cstrong data-start=\"342\" data-end=\"354\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"442\" data-start=\"400\"\u003ePrimary mitochondrial research pairing\u003c\/h3\u003e\n\u003cp data-end=\"649\" data-start=\"444\"\u003eIn experimental and laboratory research settings, SS-31 (Elamipretide) is examined either as a standalone mitochondrial-targeting compound or within specific growth hormone–related research models.\u003c\/p\u003e\n\u003ch3 data-end=\"711\" data-start=\"656\"\u003eGrowth hormone–related research context\u003c\/h3\u003e\n\u003cp data-end=\"848\" data-start=\"713\"\u003eSome experimental frameworks explore SS-31 alongside compounds involved in GHRH-mediated metabolic and mitochondrial signaling.\u003c\/p\u003e\n\u003cp data-end=\"935\" data-start=\"850\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-end=\"871\" data-start=\"852\"\u003eCJC-1295\u003c\/strong\u003e – GHRH-related metabolic and mitochondrial signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"999\" data-start=\"942\"\u003eAlternative GH-axis research context \u003c\/h3\u003e\n\u003cp data-end=\"1142\" data-start=\"1001\"\u003eOther experimental models reference SS-31 in parallel with compounds studied for GH-axis modulation without long-acting GHRH analogs.\u003c\/p\u003e\n\u003cp data-end=\"1271\" data-start=\"1144\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-end=\"1161\" data-start=\"1146\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-end=\"1208\" data-start=\"1205\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-end=\"1224\" data-start=\"1210\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1349\" data-start=\"1278\"\u003eMitochondrial and cellular energy research context \u003c\/h3\u003e\n\u003cp data-end=\"1559\" data-start=\"1351\"\u003eIn research frameworks not centered on growth hormone signaling, SS-31 is commonly examined alongside compounds involved in mitochondrial efficiency, cellular energy balance, and metabolic regulation.\u003c\/p\u003e\n\u003cp data-end=\"1726\" data-start=\"1561\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/slu-pp-332-200mg\"\u003e\u003cstrong data-end=\"1577\" data-start=\"1563\"\u003eSLU-PP-332\u003c\/strong\u003e – mitochondrial energy signaling and metabolic efficiency research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1790\" data-start=\"1733\"\u003eRedox balance and metabolic cofactor research context\u003c\/h3\u003e\n\u003cp data-end=\"1943\" data-start=\"1792\"\u003eSome experimental discussions reference SS-31 alongside compounds examined for oxidative stress regulation and intracellular redox homeostasis.\u003c\/p\u003e\n\u003cp data-end=\"2080\" data-start=\"1945\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"1964\" data-start=\"1947\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003cbr data-end=\"2010\" data-start=\"2007\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/5-amino-1mq-50mg\"\u003e\u003cstrong data-end=\"2027\" data-start=\"2012\"\u003e5-Amino-1MQ\u003c\/strong\u003e – NNMT-related metabolic and NAD⁺ pathway research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2146\" data-start=\"2087\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-end=\"2293\" data-start=\"2148\"\u003eIn specialized experimental models, SS-31 may be referenced alongside compounds studied for neurotrophic signaling and synaptic function.\u003c\/p\u003e\n\u003cp data-end=\"2356\" data-start=\"2295\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-end=\"2307\" data-start=\"2297\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2410\" data-start=\"2363\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-end=\"2576\" data-start=\"2412\"\u003eCertain research discussions reference SS-31 alongside alternative peptide formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-end=\"2642\" data-start=\"2578\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-end=\"2602\" data-start=\"2580\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"356\" data-end=\"715\"\u003eSS-31 peptide has been FDA-approved in 2025 for treating Barth syndrome, a rare mitochondrial disorder, by improving cardiac function and exercise tolerance in affected patients.\u003cbr data-start=\"526\" data-end=\"529\"\u003eIn clinical trials, SS-31 peptide demonstrates potential to alleviate symptoms of primary mitochondrial diseases, including fatigue and muscle weakness, by enhancing mitochondrial bioenergetics.\u003c\/p\u003e\n\u003ch3 data-start=\"722\" data-end=\"769\"\u003e\u003cstrong data-start=\"726\" data-end=\"769\"\u003eClinical Research Settings and Benefits\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"771\" data-end=\"947\"\u003eFor patients with heart failure, SS-31 shows promise in reducing cardiac ischemia-reperfusion injury and improving overall heart function through mitochondrial stabilization.\u003c\/p\u003e\n\u003cp data-start=\"949\" data-end=\"1117\"\u003eSS-31 may benefit individuals with renal diseases by protecting against kidney ischemia-reperfusion damage, potentially slowing progression of chronic kidney disease.\u003c\/p\u003e\n\u003cp data-start=\"1119\" data-end=\"1313\"\u003eIn neurodegenerative conditions like Alzheimer’s and Parkinson’s, preclinical and early clinical data suggest SS-31 could mitigate neuronal damage by reducing oxidative stress in mitochondria.\u003c\/p\u003e\n\u003cp data-start=\"1315\" data-end=\"1466\"\u003eAging-related frailty may be addressed by SS-31, as studies indicate it improves skeletal muscle function and reduces inflammation in elderly models.\u003c\/p\u003e\n\u003cp data-start=\"1468\" data-end=\"1777\"\u003eSS-31 holds potential for treating orphan cardiomyopathies, where it supports mitochondrial integrity to enhance cardiac output and patient quality of life. Clinical trials have demonstrated that elamipretide can improve myocardial ischemia-reperfusion injury and reduce complications after cardiac surgery.\u003c\/p\u003e\n\u003cp data-start=\"1779\" data-end=\"2355\"\u003eFor cognitive decline associated with aging, SS-31’s ability to restore mitochondrial health may improve brain function and memory in clinical settings.\u003cbr data-start=\"1931\" data-end=\"1934\"\u003eSS-31 not only protects mitochondrial function but also plays a role in regulating the apoptotic process. It promotes cell survival by inhibiting endogenous apoptotic signals and delaying cell apoptosis. This property makes Elamipretide show potential in the study of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease because these diseases are often accompanied by abnormal cell apoptosis.\u003c\/p\u003e\n\u003cp data-start=\"2357\" data-end=\"2903\"\u003eIn models of dry age-related macular degeneration, SS-31 has shown efficacy in preserving retinal function by targeting mitochondrial dysfunction in ocular cells.\u003cbr data-start=\"2519\" data-end=\"2522\"\u003eSlow photoreceptor degeneration by preserving EZ (Ellipsoid Zone) integrity. Improve low-luminance vision and reduce GA (Geographic Atrophy) progression (though not statistically significant in Phase 2 primaries). Mitigate oxidative stress and apoptosis in RPE cells (Retinal Pigment Epithelium Cell), potentially delaying vision loss. Offer neuroprotection without cytotoxicity.\u003c\/p\u003e\n\u003cp data-start=\"2905\" data-end=\"3086\"\u003eOverall, SS-31’s broad therapeutic potential extends to metabolic disorders, where it could enhance energy production and insulin sensitivity by optimizing mitochondrial efficiency.\u003c\/p\u003e\n\u003ch3 data-start=\"3093\" data-end=\"3130\"\u003e\u003cstrong data-start=\"3097\" data-end=\"3130\"\u003eMolecular Mechanism of Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3132\" data-end=\"3527\"\u003eSS-31 peptide, a synthetic tetrapeptide, selectively targets mitochondria by binding to cardiolipin in the inner mitochondrial membrane through hydrophobic interactions with acyl chains and electrostatic interactions with phosphate head groups.\u003cbr data-start=\"3368\" data-end=\"3371\"\u003eThis binding concentrates SS-31 in the inner membrane, stabilizing cristae morphology and optimizing the organization of respiratory chain supercomplexes.\u003c\/p\u003e\n\u003cp data-start=\"3529\" data-end=\"3840\"\u003eSS-31 peptide interacts with subunits of oxidative phosphorylation complexes, such as complex III (QCR2 and QCR6), complex IV (NDUA4), and complex V (ATPA and ATPB), near their cardiolipin-binding sites. These interactions enhance electron transport efficiency and reduce hydrogen peroxide production in mitochondria.\u003c\/p\u003e\n\u003cp data-start=\"3842\" data-end=\"4010\"\u003eBy binding to ADP\/ATP translocase (ADT1) in its matrix-open state, SS-31 prevents proton leak through charge repulsion while improving ADP sensitivity and ATP export.\u003c\/p\u003e\n\u003cp data-start=\"4012\" data-end=\"4175\"\u003eSS-31 also binds to creatine kinase S-type near cardiolipin-binding residues, supporting mitochondrial structural integrity and phosphocreatine energy buffering.\u003c\/p\u003e\n\u003cp data-start=\"4177\" data-end=\"4340\"\u003eIn fatty acid β-oxidation, SS-31 interacts with the trifunctional enzyme subunit ECHA near its active site, potentially rescuing proton leak in deficient models.\u003c\/p\u003e\n\u003cp data-start=\"4342\" data-end=\"4678\"\u003eFor 2-oxoglutarate metabolism, SS-31 binds to isocitrate dehydrogenase at sites that may regulate enzymatic activity and NADPH production via electrostatic effects.\u003cbr data-start=\"4506\" data-end=\"4509\"\u003eAdditional interactions with 2-oxoglutarate dehydrogenase complex subunits and aspartate aminotransferase suggest SS-31 modulates TCA cycle flux and redox homeostasis.\u003c\/p\u003e\n\u003cp data-start=\"4680\" data-end=\"4846\"\u003eOverall, these molecular interactions reduce reactive oxygen species, improve bioenergetics, and mitigate mitochondrial dysfunction at the protein and membrane level.\u003c\/p\u003e\n\u003ch3 data-start=\"1976\" data-end=\"2004\"\u003e\u003cstrong data-start=\"1979\" data-end=\"2002\"\u003eSS-31 Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"2005\" data-end=\"2315\"\u003e\n\u003cli data-start=\"2005\" data-end=\"2050\"\u003e\n\u003cp data-start=\"2007\" data-end=\"2050\"\u003e\u003cstrong data-start=\"2007\" data-end=\"2020\"\u003eSequence:\u003c\/strong\u003e D-Arg-Tyr(2,6-diMe)-Lys-Phe\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2051\" data-end=\"2088\"\u003e\n\u003cp data-start=\"2053\" data-end=\"2088\"\u003e\u003cstrong data-start=\"2053\" data-end=\"2075\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₄₉N₉O₅\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2089\" data-end=\"2126\"\u003e\n\u003cp data-start=\"2091\" data-end=\"2126\"\u003e\u003cstrong data-start=\"2091\" data-end=\"2112\"\u003eMolecular Weight:\u003c\/strong\u003e 639.8 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2127\" data-end=\"2156\"\u003e\n\u003cp data-start=\"2129\" data-end=\"2156\"\u003e\u003cstrong data-start=\"2129\" data-end=\"2145\"\u003ePubChem CID:\u003c\/strong\u003e 11764719\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2157\" data-end=\"2188\"\u003e\n\u003cp data-start=\"2159\" data-end=\"2188\"\u003e\u003cstrong data-start=\"2159\" data-end=\"2174\"\u003eCAS Number:\u003c\/strong\u003e 736992-21-5\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2189\" data-end=\"2238\"\u003e\n\u003cp data-start=\"2191\" data-end=\"2238\"\u003e\u003cstrong data-start=\"2191\" data-end=\"2204\"\u003eSynonyms:\u003c\/strong\u003e elamipretide, MTP-131, Bendavia\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2239\" data-end=\"2285\"\u003e\n\u003cp data-start=\"2241\" data-end=\"2285\"\u003e\u003cstrong data-start=\"2241\" data-end=\"2269\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 50 mg per vial\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eResearch background \u0026amp; scientific overview:\u003c\/strong\u003e\u003cbr data-start=\"749\" data-end=\"752\"\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ss-31-peptide\" title=\"ss 31 research article\"\u003eSS-31 (Elamipretide): Mitochondrial research mechanisms and study background\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eSS-31 Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"ss-31 50 mg strucutre\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Elamipretide.png?v=1755186474\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11764719\" title=\"PubChem_SS-31\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1754\" data-end=\"2029\"\u003e\u003cstrong data-start=\"104\" data-end=\"174\"\u003e \u003c\/strong\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":51972266721546,"sku":"ss31_50mg-1","price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ss-31_50mg_7_pen.png?v=1760890668"},{"product_id":"epithalon-50mg","title":"Epithalon 50mg – High Purity Longevity Research Peptide","description":"\u003ch3 data-start=\"408\" data-end=\"892\"\u003e\u003cstrong data-start=\"408\" data-end=\"420\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"408\" data-end=\"892\"\u003e\u003cbr data-start=\"420\" data-end=\"423\"\u003eEpithalon (Ala-Glu-Asp-Gly) is a laboratory-synthesized analogue of epithalamin, a naturally occurring peptide secreted by the pineal gland. It has been studied for its unique ability to stimulate telomerase activity, an enzyme that rebuilds telomeres — protective caps at the ends of chromosomes that naturally shorten with age. By supporting telomere maintenance, Epithalon may help delay cellular senescence, contributing to healthier aging at the molecular level.\u003c\/p\u003e\n\u003cp data-start=\"894\" data-end=\"1203\"\u003eBeyond telomere regulation, research suggests Epithalon can enhance antioxidant activity, normalize circadian rhythm regulation, and promote optimal immune and endocrine function. These combined effects make it a compound of interest in the fields of anti-aging, regenerative medicine, and metabolic health.\u003c\/p\u003e\n\u003ch3 data-start=\"1210\" data-end=\"1695\"\u003e\u003cstrong data-start=\"1210\" data-end=\"1222\"\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1210\" data-end=\"1695\"\u003e\u003cbr data-start=\"1222\" data-end=\"1225\"\u003eOver several decades, both preclinical and limited clinical studies have investigated Epithalon’s biological effects. Laboratory research has demonstrated that it can activate telomerase and maintain telomere length in cultured cells, potentially reversing some age-related cellular changes. In animal models, Epithalon administration has been associated with increased lifespan, improved immune system responsiveness, and normalization of hormonal secretion patterns.\u003c\/p\u003e\n\u003cp data-start=\"1697\" data-end=\"2250\"\u003eStudies also indicate its antioxidant properties, including the ability to reduce lipid peroxidation and oxidative stress markers. These benefits may result from improved mitochondrial efficiency and gene expression modulation linked to stress resistance and longevity. Furthermore, Epithalon has been explored for its potential role in restoring circadian rhythms and regulating melatonin secretion, both of which decline with age. While these results are promising, larger-scale human trials are needed to fully confirm its therapeutic applications.\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2257\" data-end=\"2280\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2257\" data-end=\"2577\"\u003e\u003cstrong data-start=\"2283\" data-end=\"2296\"\u003eSynonyms:\u003c\/strong\u003e 307297-39-8, Epithalon, Epithalone, UNII-O65P17785G, alanyl-glutamyl-aspartyl-glycine\u003cbr data-start=\"2382\" data-end=\"2385\"\u003e\u003cstrong data-start=\"2385\" data-end=\"2407\"\u003eMolecular Formula:\u003c\/strong\u003e C14H22N4O9\u003cbr data-start=\"2418\" data-end=\"2421\"\u003e\u003cstrong data-start=\"2421\" data-end=\"2436\"\u003eMolar Mass:\u003c\/strong\u003e 390.35 g\/mol\u003cbr data-start=\"2449\" data-end=\"2452\"\u003e\u003cstrong data-start=\"2452\" data-end=\"2467\"\u003eCAS Number:\u003c\/strong\u003e 307297-40-1\u003cbr data-start=\"2479\" data-end=\"2482\"\u003e\u003cstrong data-start=\"2482\" data-end=\"2494\"\u003ePubChem:\u003c\/strong\u003e 219042\u003cbr data-start=\"2501\" data-end=\"2504\"\u003e\u003cstrong data-start=\"2504\" data-end=\"2532\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 50 mg (1 vial)\u003cbr data-start=\"2547\" data-end=\"2550\"\u003e\u003cstrong data-start=\"2550\" data-end=\"2565\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-start=\"2257\" data-end=\"2577\"\u003eEpithalon \u003cspan\u003eStructures:\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Epitalon.png?v=1755244759\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSource \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/219042\" title=\"PubChem_Epithalon\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000856568074,"sku":"epithalon50mg-1","price":215.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000856600842,"sku":"epithalon50mg-2","price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/epithalon_50mg_4.png?v=1778072674"},{"product_id":"bpc-157-tb-500-blend","title":"BPC-157 + TB-500  – Blend ( 10mg + 10mg )","description":"\u003ch3\u003e\u003cstrong\u003eGlow Blend Overview: \u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The BPC-157 and TB-500 combination is studied in experimental systems exploring complementary tissue signaling, cellular migration, and recovery-adjacent pathways. Research models often examine how these peptides interact within broader regeneration frameworks.\u003cstrong\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157 (10mg)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA synthetic pentadecapeptide with 15 amino acids, derived from a naturally occurring protein in gastric juice. Known in research for its potential to accelerate healing, promote angiogenesis, and support gastrointestinal and musculoskeletal recovery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500 (10mg)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA synthetic fragment of the naturally occurring thymosin beta-4 protein. Studied for its role in promoting tissue repair, reducing inflammation, and aiding recovery from injuries by enhancing cell migration and blood vessel formation.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eResearch\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e has demonstrated healing benefits in animal studies by modulating VEGFR2 activity, activating FAK–paxillin signaling, and enhancing nitric oxide pathways, leading to improved angiogenesis, fibroblast migration, and epithelial repair. Preclinical results show accelerated recovery in muscle, tendon, ligament, and intestinal injuries.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e acts as a potent regulator of cell movement by binding to actin, facilitating tissue regeneration through VEGF upregulation and reduced inflammatory cytokines. It has been investigated for applications ranging from cardiac repair to dermal wound closure, particularly in chronic or slow-healing injuries.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eLearn more about combined peptide recovery mechanisms - \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of why these peptides are often studied together, see:\u003cstrong\u003e\u003cbr data-end=\"886\" data-start=\"883\"\u003e\u003ca title=\"bpc-157-tb-500-together\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\"\u003e\u003cstrong data-end=\"956\" data-start=\"888\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eProduct Description: \u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3\u003e\n\u003cstrong\u003eName:\u003c\/strong\u003e \u003cstrong\u003eBPC-157 + TB-500  Blend (10mg + 10mg)\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e:\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 137525-51-0\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolar Mass:\u003c\/strong\u003e 1419.556 g\/mol\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C62H98N16O22\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e:\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 77591-33-4\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolar Mass:\u003c\/strong\u003e 4963.44 g\/mol\u003c\/li\u003e\n\u003cli class=\"ql-indent-1\"\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C212H350N56O78S\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251892941066,"sku":"bpc157_tb500_10mg-1","price":170.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251892973834,"sku":"bpc157_tb500_10mg-2","price":195.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/bpc157_tb500_10_10_1.png?v=1765457237"},{"product_id":"bpc-157-10mg-per-vial","title":"BPC-157 10mg – High Purity Research Peptide","description":"\u003ch3 data-end=\"806\" data-start=\"789\"\u003e\u003cstrong data-end=\"804\" data-start=\"792\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. BPC-157 is widely studied in experimental models focused on tissue signaling, structural integrity, and recovery-related cellular pathways. It is commonly examined in research exploring how biological systems respond to injury and regeneration signals.\u003cstrong data-end=\"804\" data-start=\"792\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"176\" data-end=\"221\"\u003ePrimary tissue-signaling research pairing\u003c\/h3\u003e\n\u003cp data-start=\"223\" data-end=\"440\"\u003eIn experimental and laboratory research settings, BPC-157 is frequently examined alongside peptides involved in cellular signaling, extracellular matrix interactions, and tissue-associated regulatory pathways.\u003c\/p\u003e\n\u003cp data-start=\"442\" data-end=\"616\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ghk-cu-50-mg\"\u003e\u003cstrong data-start=\"444\" data-end=\"454\"\u003eGHK-Cu\u003c\/strong\u003e – copper peptide research focused on cellular communication and matrix-related signaling\u003c\/a\u003e\u003cbr data-start=\"543\" data-end=\"546\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"548\" data-end=\"558\"\u003eTB-500\u003c\/strong\u003e – cytoskeletal dynamics and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"623\" data-end=\"674\"\u003eImmune and cellular regulation research context\u003c\/h3\u003e\n\u003cp data-start=\"676\" data-end=\"837\"\u003eSome experimental models explore BPC-157 in parallel with compounds studied for immune modulation, cellular resilience, and regulatory peptide signaling.\u003c\/p\u003e\n\u003cp data-start=\"839\" data-end=\"914\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/thymosin-alpha-1-10mg\"\u003e\u003cstrong data-start=\"841\" data-end=\"861\"\u003eThymosin Alpha 1\u003c\/strong\u003e – immune-related and regulatory signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"921\" data-end=\"980\"\u003eRedox balance and cellular environment research context\u003c\/h3\u003e\n\u003cp data-start=\"982\" data-end=\"1132\"\u003eAdditional research frameworks reference BPC-157 alongside compounds examined for oxidative stress regulation and intracellular redox balance.\u003c\/p\u003e\n\u003cp data-start=\"1134\" data-end=\"1198\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"1136\" data-end=\"1153\"\u003eL-Glutathione\u003c\/strong\u003e – antioxidant and redox signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1205\" data-end=\"1264\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"1266\" data-end=\"1446\"\u003eIn specialized experimental discussions, BPC-157 may be referenced alongside compounds studied for neurotrophic signaling and higher-order molecular communication pathways.\u003c\/p\u003e\n\u003cp data-start=\"1448\" data-end=\"1509\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"1450\" data-end=\"1460\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1516\" data-end=\"1563\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1565\" data-end=\"1723\"\u003eCertain research discussions reference BPC-157 alongside alternative formats when evaluating delivery considerations and experimental exposure models.\u003c\/p\u003e\n\u003cp data-start=\"1725\" data-end=\"1789\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1727\" data-end=\"1749\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"390\" data-start=\"50\"\u003eBPC-157, short for Body Protection Compound-157, is a peptide fragment derived from a naturally occurring body protection compound (BPC) found in human gastric juice. This protein plays an important role in safeguarding the gastrointestinal lining from damage, supporting tissue repair, and stimulating the formation of new blood vessels.\u003c\/p\u003e\n\u003cp data-end=\"634\" data-start=\"392\"\u003eSynthetic BPC-157 is a pentadecapeptide made up of 15 amino acids, isolated from the larger parent BPC protein. Research indicates that it retains many of the parent compound’s regenerative properties. Studies suggest BPC-157 may influence:\u003c\/p\u003e\n\u003cul data-end=\"905\" data-start=\"636\"\u003e\n\u003cli data-end=\"677\" data-start=\"636\"\u003e\n\u003cp data-end=\"677\" data-start=\"638\"\u003eWound healing and tissue regeneration\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"719\" data-start=\"678\"\u003e\n\u003cp data-end=\"719\" data-start=\"680\"\u003eAngiogenesis (blood vessel formation)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"747\" data-start=\"720\"\u003e\n\u003cp data-end=\"747\" data-start=\"722\"\u003eThe coagulation process\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"775\" data-start=\"748\"\u003e\n\u003cp data-end=\"775\" data-start=\"750\"\u003eNitric oxide production\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"804\" data-start=\"776\"\u003e\n\u003cp data-end=\"804\" data-start=\"778\"\u003eImmune system modulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"824\" data-start=\"805\"\u003e\n\u003cp data-end=\"824\" data-start=\"807\"\u003eGene expression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"905\" data-start=\"825\"\u003e\n\u003cp data-end=\"905\" data-start=\"827\"\u003eHormonal regulation, particularly within the gastrointestinal nervous system\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"1479\" data-start=\"1462\"\u003e\u003cstrong data-end=\"1477\" data-start=\"1465\"\u003eBPC-157 Peptide Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1531\" data-start=\"1480\"\u003ePreclinical animal studies on BPC-157 have shown:\u003c\/p\u003e\n\u003cul data-end=\"2446\" data-start=\"1532\"\u003e\n\u003cli data-end=\"1692\" data-start=\"1532\"\u003e\n\u003cp data-end=\"1692\" data-start=\"1534\"\u003e\u003cstrong data-end=\"1558\" data-start=\"1534\"\u003eAccelerated Healing:\u003c\/strong\u003e Enhanced repair of muscle, tendon, ligament, bone, and skin injuries, including burns, via increased blood flow to damaged tissues.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1910\" data-start=\"1693\"\u003e\n\u003cp data-end=\"1910\" data-start=\"1695\"\u003e\u003cstrong data-end=\"1727\" data-start=\"1695\"\u003eGastrointestinal Protection:\u003c\/strong\u003e Prevention and reversal of gastric ulcers, protection against NSAID-induced damage, and improvement in inflammatory bowel conditions such as Crohn’s disease and ulcerative colitis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2085\" data-start=\"1911\"\u003e\n\u003cp data-end=\"2085\" data-start=\"1913\"\u003e\u003cstrong data-end=\"1951\" data-start=\"1913\"\u003eAngiogenesis \u0026amp; Collagen Synthesis:\u003c\/strong\u003e Significant upregulation of angiogenic factors and stimulation of fibroblasts and macrophages, leading to robust tissue remodeling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2252\" data-start=\"2086\"\u003e\n\u003cp data-end=\"2252\" data-start=\"2088\"\u003e\u003cstrong data-end=\"2108\" data-start=\"2088\"\u003eNeuroprotection:\u003c\/strong\u003e Evidence of protective effects against certain types of nervous system injury, including potential benefits in traumatic brain injury models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2446\" data-start=\"2253\"\u003e\n\u003cp data-end=\"2446\" data-start=\"2255\"\u003e\u003cstrong data-end=\"2275\" data-start=\"2255\"\u003eSystemic Action:\u003c\/strong\u003e Unlike many peptides, BPC-157 appears to exert benefits both locally and systemically, including the modulation of nitric oxide pathways and oxidative stress responses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003eThese findings highlight BPC-157’s potential as a versatile regenerative peptide with wide-ranging applications in injury recovery and organ protection. Further human studies are needed to confirm its efficacy and safety in clinical settings.\u003c\/p\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"418\" data-end=\"447\"\u003eFurther research reading:\u003c\/h3\u003e\n\u003cp data-start=\"449\" data-end=\"677\"\u003eCurious to explore the research background of BPC-157 beyond the product specifications?\u003cbr data-start=\"537\" data-end=\"540\"\u003eOur \u003cstrong data-start=\"544\" data-end=\"566\"\u003e“What Is BPC-157?”\u003c\/strong\u003e article provides an overview of its origin, molecular characteristics, and commonly studied research contexts.\u003c\/p\u003e\n\u003cp data-start=\"679\" data-end=\"721\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-bpc-157\"\u003e\u003cstrong data-start=\"681\" data-end=\"721\"\u003eWhat Is BPC-157? – Research Overview\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"723\" data-end=\"933\"\u003eResearchers comparing different laboratory formats may also find value in our analysis of \u003cstrong data-start=\"813\" data-end=\"863\"\u003eoral versus injectable BPC-157 research models\u003c\/strong\u003e, outlining how these formats are referenced in experimental settings.\u003c\/p\u003e\n\u003cp data-start=\"935\" data-end=\"991\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-oral-versus-injection-best-method\"\u003e\u003cstrong data-start=\"937\" data-end=\"991\"\u003eBPC-157: Oral vs Injection – Research Perspectives\u003c\/strong\u003e\u003c\/a\u003e\u003cstrong data-start=\"937\" data-end=\"991\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"935\" data-end=\"991\"\u003eLearn more about how BPC-157 is studied alongside other peptides in \u003cstrong\u003emuscle and tendon recovery research\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"2692\" data-start=\"2448\"\u003e➝ \u003ca title=\"peptides for muscle recovery\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle and Tendon Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"1001\" data-start=\"809\"\u003eResearchers interested in how BPC-157 is evaluated in comparative peptide research may also find value in our overview of its relationship with other regenerative peptides, including TB-500.\u003c\/p\u003e\n\u003cp data-end=\"1078\" data-start=\"1008\"\u003e→ \u003ca title=\"bpc 157 peptide and tb 500\" href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\"\u003e\u003cstrong data-end=\"1078\" data-start=\"1010\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBPC-157 is commonly studied in experimental models involving angiogenesis, vascular signaling, and soft tissue repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo understand how it compares with matrix-focused peptides, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-vs-bpc-157\"\u003eGHK-Cu vs BPC-157: Tissue Repair, Angiogenesis, and Peptide Signaling\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eExplore BPC-157 in Gut Research Context\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eBPC-157 is frequently referenced in experimental research exploring tissue response, structural signaling, and epithelial integrity. In gut-associated models, it is studied in relation to cellular organization and how tissues adapt within dynamic signaling environments.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo understand how BPC-157 fits into broader gut and immune-related research systems:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"222\" data-start=\"178\"\u003e\u003cstrong data-end=\"220\" data-start=\"181\"\u003eBPC-157 10 mg – Product Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cstrong data-end=\"236\" data-start=\"223\"\u003eSynonyms:\u003c\/strong\u003e PL 14736\u003cbr data-end=\"248\" data-start=\"245\"\u003e\u003cstrong data-end=\"263\" data-start=\"248\"\u003eMolar Mass:\u003c\/strong\u003e 1419.5 g\/mol\u003cbr data-end=\"279\" data-start=\"276\"\u003e\u003cstrong data-end=\"294\" data-start=\"279\"\u003eCAS Number:\u003c\/strong\u003e 137525-51-0\u003cbr data-end=\"309\" data-start=\"306\"\u003e\u003cstrong data-end=\"321\" data-start=\"309\"\u003ePubChem:\u003c\/strong\u003e 9941957\u003cbr data-end=\"332\" data-start=\"329\"\u003e\u003cstrong data-end=\"370\" data-start=\"332\"\u003eTotal Amount of Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-end=\"388\" data-start=\"385\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"415\" data-start=\"223\"\u003e\u003cstrong\u003eBPC-157 Structures:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cspan\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Bpc-157_5dcbe81f-689b-4577-a465-7f1a0d14f9f2.png?v=1755183632\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Chemical structure diagram of bpc-157 peptide\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Bpc-157.png?v=1755163863\"\u003e\u003c\/div\u003e\n\u003cp data-end=\"415\" data-start=\"223\"\u003e\u003cspan\u003eSource \u003ca title=\"PubChem_BPC-157\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\"\u003e\u003c\/a\u003e\u003ca title=\"bpc 157 structure\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9941957\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251950022922,"sku":"bpc157_10mg-1","price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251950055690,"sku":"bpc157_10mg-2","price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/bpc-157_10mg_2.png?v=1765457082"},{"product_id":"tb-500-10-mg","title":"TB-500 10 mg - Peptide for Regeneration \u0026 Healing","description":"\u003ch3 data-end=\"108\" data-start=\"91\"\u003eOverview\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. TB-500 is studied in laboratory models examining cellular migration, actin regulation, and tissue remodeling processes. Research interest often relates to how cells coordinate movement and repair signaling after structural stress.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eIntroduction to TB-500 (Thymosin Beta-4) TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found in most eukaryotic cells. It is primarily known for sequestering G-actin (monomeric actin) and preventing its polymerization into F-actin filaments, thereby regulating cytoskeletal dynamics. At the molecular level, Tβ4 influences cell migration, proliferation, differentiation, and survival through pathways including PI3K\/Akt and HIF-1α, and through interactions with proteins such as PINCH-1 and ILK. It promotes tissue repair, angiogenesis, and anti-inflammatory\u003cbr\u003eeffects; however, it is not FDA-approved for human use and is primarily studied in research contexts.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003eNF-κB Modulation\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 acts as an NF-κB modulator by inhibiting its activation. It interferes with TNF-α-mediated NF-κB signaling, thereby reducing downstream IL-8 gene transcription and inflammation. This occurs via suppression of NF-κB nuclear translocation and phosphorylation, as shown in corneal and endothelial cell studies. In pathogen-induced inflammation, this modulation enhances resolution by activating pro-resolving pathways.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003eCytoskeleton Movement and Mitochondrial Shape\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 binds G-actin, thereby buffering the G-actin pool and regulating F-actin assembly, facilitating cytoskeletal reorganization, cell motility, and lamellipodia formation. It influences mitochondrial shape by promoting mitochondrial transfer via tunneling nanotubes (TNTs) via Rac\/F-actin pathways, maintaining the mitochondrial membrane potential (Δψm) under oxidative stress, and preventing cristae disruption in damaged cells.\u003c\/p\u003e\n\u003ch3 data-end=\"1416\" data-start=\"1263\"\u003e\n\u003cbr\u003eCell Differentiation and Neonatal Gene Activation\u003c\/h3\u003e\n\u003cp data-end=\"1416\" data-start=\"1263\"\u003eTβ4 promotes stem cell differentiation, particularly in cardiac and endothelial lineages, by upregulating embryonic genes like those in the epicardium. This is considered a primary effect, as it reactivates neonatal-like regenerative programs in adult tissues, enhancing organ repair via Wnt and Notch signaling. In thymocytes, it aids differentiation through cytoskeletal rearrangement and mitochondrial transfer in thymic epithelial cells.\u003c\/p\u003e\n\u003ch3\u003eStroke Effect Reduction\u003c\/h3\u003e\n\u003cp\u003eTβ4 reduces stroke effects by providing neuroprotection and neurorestoration. It decreases infarct volume, promotes oligodendrogenesis, and enhances axonal remodeling in embolic stroke models. Mechanisms include stabilizing hypoxia-induced brain microvascular barriers and improving neurological outcomes via actin sequestration and vascular repair, though effects vary in aged models.\u003c\/p\u003e\n\u003ch3\u003eEnhancement of Antibiotics\u003c\/h3\u003e\n\u003cp\u003eTβ4 synergistically enhances antibiotic effects, such as ciprofloxacin against Pseudomonas aeruginosa in keratitis models, by promoting bacterial clearance, wound healing, and inflammation resolution without direct antibacterial action at neutral pH. It boosts host defense via pro-resolving mediators.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eActin Level Increase\u003c\/h3\u003e\n\u003cp\u003eTβ4 increases actin levels indirectly by sequestering G-actin, regulating its availability for polymerization into F-actin. This elevates overall actin dynamics, supporting cell structure, migration, and repair processes.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eCell Migration to Injured Areas\u003c\/h3\u003e\n\u003cp\u003eTβ4 facilitates cell migration to injured sites by binding actin and promoting the mobilization of stem\/progenitor cells. It enhances endothelial and epithelial migration via integrin-linked kinase (ILK) activation and cytoskeletal remodeling, which are crucial for wound healing and tissue remodeling.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eAngiogenesis\u003c\/h3\u003e\n\u003cp\u003eTβ4 induces angiogenesis by upregulating angiogenic factors like angiopoietin-1 and von Willebrand factor. It promotes endothelial cell proliferation and vascular growth via PI3K\/Akt\/eNOS signaling, thereby improving blood flow in ischemic tissues, such as the sciatic nerve, in diabetic models.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eAnti-Inflammatory Effects\u003c\/h3\u003e\n\u003cp\u003eTβ4 is anti-inflammatory, suppressing NF-κB and Toll-like receptor pathways to reduce cytokine production (e.g., IL-8, TNF-α). It limits inflammation in models like keratitis and liver fibrosis by activating autophagy and pro-resolving mediators.\u003c\/p\u003e\n\u003ch3\u003eDAPK1 Pathway Activation; Apoptosis and Autophagy Regulation\u003c\/h3\u003e\n\u003cp\u003eTβ4 activates the DAPK1 pathway, promoting LC3-associated phagocytosis (LAP) for inflammation resolution. It regulates apoptosis by inhibiting TGF-β\/Smad signaling and autophagy via HIF-1α stabilization, protecting cells from stress-induced death while enhancing repair in tissues like the cornea and colon.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eEffects in Pathogen-Caused Inflammation: Direct Anti-Microbial Effect\u003c\/h3\u003e\n\u003cp\u003eTβ4 excels in pathogen-induced inflammation (e.g., bacterial keratitis) by enhancing host defense and resolution without strong direct anti-microbial activity at neutral pH. Its antimicrobial effects are pH-dependent, increasing at alkaline conditions (pH\u0026gt;7.0), where it inhibits bacteria such as S. aureus and E. coli, likely due to structural changes that enhance efficacy.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eTransforming Growth Factor Beta (TGF-β) Activation\u003c\/h3\u003e\n\u003cp\u003eTβ4 activates TGF-β signaling pathways in certain contexts, such as tumor progression via TGF-β\/MMP-2 signaling during metastasis. However, it often inhibits TGF-β activity, thereby suppressing Smad activation and reducing fibrosis and apoptosis in models such as renal injury and hepatic stellate cells.\u003c\/p\u003e\n\u003ch3\u003ePTEN Suppression for Muscle Repair in Diabetes\u003c\/h3\u003e\n\u003cp\u003eTβ4 suppresses PTEN activity, thereby enhancing PI3K\/Akt signaling and improving endothelial cell viability, proliferation, and senescence in diabetic models. This enhances reparative capacity, vascular density, and muscle repair, thereby alleviating hyperglycemia and insulin resistance in type II diabetes. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003eTB-500 is frequently referenced in \u003cstrong data-start=\"2640\" data-end=\"2680\"\u003etendon and soft tissue repair models\u003c\/strong\u003e, including comparative peptide research.\u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-recovery\" title=\"peptides for muscle recovery\"\u003e\u003cstrong\u003eBest Peptides for Muscle and Tendon Recovery\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"2448\" data-end=\"2692\"\u003e\u003cem data-start=\"586\" data-end=\"693\"\u003eFor a research-focused explanation of how TB-500 is evaluated alongside other regenerative peptides, see:\u003c\/em\u003e\u003cbr data-start=\"693\" data-end=\"696\"\u003e\u003cstrong data-start=\"698\" data-end=\"766\"\u003e➝ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/bpc-157-tb-500-how-these-peptides-work-together\" title=\"tb 500 peptide and bpc 157\"\u003eBPC-157 and TB-500: How These Peptides Work Together in Research\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong data-end=\"147\" data-start=\"124\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"543\" data-start=\"151\"\u003e\n\u003cli data-end=\"197\" data-start=\"151\"\u003e\n\u003cp data-end=\"197\" data-start=\"153\"\u003e\u003cstrong data-end=\"169\" data-start=\"153\"\u003eProduct Name\u003c\/strong\u003e: TB-500 (Thymosin Beta-4)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"228\" data-start=\"198\"\u003e\n\u003cp data-end=\"228\" data-start=\"200\"\u003e\u003cstrong data-end=\"214\" data-start=\"200\"\u003eCAS Number\u003c\/strong\u003e: 77591-33-4\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"274\" data-start=\"229\"\u003e\n\u003cp data-end=\"274\" data-start=\"231\"\u003e\u003cstrong data-end=\"243\" data-start=\"231\"\u003eSynonyms\u003c\/strong\u003e: Thymosin Beta-4, Tβ4, TB500\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"321\" data-start=\"275\"\u003e\n\u003cp data-end=\"321\" data-start=\"277\"\u003e\u003cstrong data-end=\"298\" data-start=\"277\"\u003eMolecular Formula\u003c\/strong\u003e: \u003cstrong data-end=\"319\" data-start=\"300\"\u003eC₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"354\" data-start=\"322\"\u003e\n\u003cp data-end=\"354\" data-start=\"324\"\u003e\u003cstrong data-end=\"338\" data-start=\"324\"\u003eMolar Mass\u003c\/strong\u003e: 4963.5 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"383\" data-start=\"355\"\u003e\n\u003cp data-end=\"383\" data-start=\"357\"\u003e\u003cstrong data-end=\"371\" data-start=\"357\"\u003ePubChem ID\u003c\/strong\u003e: 16132397\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"485\" data-start=\"423\"\u003e\n\u003cp data-end=\"485\" data-start=\"425\"\u003e\u003cstrong data-end=\"466\" data-start=\"425\"\u003eTotal Amount of the Active Ingredient\u003c\/strong\u003e: 10 mg (per vial)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\n\u003cspan class=\"flex-1\"\u003eStructures\u003c\/span\u003e\u003cstrong\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Timbetasin.png?v=1757427968\"\u003e\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eSource \u003ca title=\"TB-500 structures\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/16132341\"\u003ePubChem\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251953070346,"sku":null,"price":125.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251953103114,"sku":null,"price":150.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tb-500_10mg_2_1.png?v=1765456935"},{"product_id":"ghk-cu-50-mg","title":"GHK-Cu 50 mg – High-Purity Copper Peptide","description":"\u003ch3\u003eResearch context overview\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. GHK-Cu is studied in laboratory models focusing on tissue remodeling, cellular communication, and extracellular matrix–related repair mechanisms.\u003c\/p\u003e\n\u003ch3 data-start=\"213\" data-end=\"241\"\u003ePrimary research pairing\u003c\/h3\u003e\n\u003cp data-start=\"243\" data-end=\"451\"\u003eIn experimental and laboratory research settings, \u003cstrong data-start=\"293\" data-end=\"303\"\u003eGHK-Cu\u003c\/strong\u003e is frequently examined alongside peptides involved in \u003cstrong data-start=\"358\" data-end=\"450\"\u003etissue-associated signaling, extracellular matrix dynamics, and cellular repair pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"453\" data-end=\"589\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-10mg-per-vial\"\u003e\u003cstrong data-start=\"455\" data-end=\"473\"\u003eBPC-157 (vial)\u003c\/strong\u003e – peptide-mediated tissue signaling research\u003c\/a\u003e\u003cbr data-start=\"518\" data-end=\"521\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tb-500-10-mg\"\u003e\u003cstrong data-start=\"523\" data-end=\"540\"\u003eTB-500 (vial)\u003c\/strong\u003e – cytoskeletal and cellular migration research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"596\" data-end=\"643\"\u003eRedox and cellular balance research context\u003c\/h3\u003e\n\u003cp data-start=\"645\" data-end=\"818\"\u003eSome experimental frameworks explore \u003cstrong data-start=\"682\" data-end=\"692\"\u003eGHK-Cu\u003c\/strong\u003e in parallel with compounds studied for \u003cstrong data-start=\"732\" data-end=\"817\"\u003eredox regulation, oxidative stress balance, and intracellular signaling stability\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"820\" data-end=\"882\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-start=\"822\" data-end=\"839\"\u003eL-Glutathione\u003c\/strong\u003e – redox balance and antioxidant research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"889\" data-end=\"948\"\u003eNeurobiological and advanced signaling research context\u003c\/h3\u003e\n\u003cp data-start=\"950\" data-end=\"1130\"\u003eIn more specialized experimental models, \u003cstrong data-start=\"991\" data-end=\"1001\"\u003eGHK-Cu\u003c\/strong\u003e may be referenced alongside compounds examined for \u003cstrong data-start=\"1053\" data-end=\"1129\"\u003eneurotrophic signaling and higher-order molecular communication pathways\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1132\" data-end=\"1193\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/dihexa-20mg\"\u003e\u003cstrong data-start=\"1134\" data-end=\"1144\"\u003eDihexa\u003c\/strong\u003e – neurotrophic and synaptic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1200\" data-end=\"1247\"\u003eAlternative formulation and exposure models\u003c\/h3\u003e\n\u003cp data-start=\"1249\" data-end=\"1414\"\u003eCertain research discussions reference \u003cstrong data-start=\"1288\" data-end=\"1298\"\u003eGHK-Cu\u003c\/strong\u003e alongside alternative peptide formats when evaluating \u003cstrong data-start=\"1353\" data-end=\"1413\"\u003edelivery considerations and experimental exposure models\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"1416\" data-end=\"1480\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/bpc-157-500mcg\"\u003e\u003cstrong data-start=\"1418\" data-end=\"1440\"\u003eBPC-157 (capsules)\u003c\/strong\u003e – comparative peptide format research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"148\" data-end=\"165\"\u003e\n\u003cspan class=\"s2\"\u003eGHK-Cu\u003c\/span\u003e Overview\u003c\/h3\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex)\u003c\/span\u003e\u003cspan\u003e is \u003c\/span\u003e\u003cspan\u003ean endogenous peptide found in human plasma, saliva, and urine. \u003c\/span\u003e\u003cspan\u003eGHK-Cu\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003estructures \u003c\/span\u003e\u003cspan\u003eenable safe copper transport into cells, modulating regenerative, antioxidant, and anti-inflammatory processes at nanomolar to micromolar concentrations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eFibroblast Stimulation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu activates dermal fibroblasts (connective tissue cells that produce extracellular matrix), enhancing extracellular matrix (ECM) remodeling. It upregulates mRNA (messenger RNA) for collagen type I, elastin, and glycosaminoglycans (GAGs; e.g., dermatan sulfate, chondroitin sulfate, decorin) via the TGF-β (transforming growth factor beta) signaling pathway, increasing integrin β1 expression and restoring fibroblast function in damaged tissues (e.g., COPD (chronic obstructive pulmonary disease) lungs). \u003c\/span\u003e\u003cspan\u003eIt \u003c\/span\u003e\u003cspan\u003eboosts collagen synthesis by 70–230% in wound models and elevates matrix metalloproteinases (MMPs; MMP1, MMP2) while balancing their tissue inhibitors (TIMPs; TIMP1, TIMP2) to prevent excessive ECM degradation. Evidence: In vitro fibroblast studies and rat wound models show up to 9-fold collagen increase; gene profiling confirms TGF-β pathway activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eAntioxidant and Anti-Inflammatory Effects\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu mimics superoxide dismutase (SOD) by supplying bioavailable Cu²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e for Cu,Zn-SOD1 (copper-zinc superoxide dismutase 1), reducing reactive oxygen species (ROS) such as superoxide and hydroxyl radicals. It blocks Fe²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e (iron(II) ion) release from ferritin (87% inhibition), \u003c\/span\u003e\u003cspan\u003edecreases\u003c\/span\u003e\u003cspan\u003e lipid peroxidation byproducts (e.g., 4-hydroxynonenal, acrolein), and inhibits Cu²\u003c\/span\u003e\u003cspan class=\"s6\"\u003e⁺\u003c\/span\u003e\u003cspan\u003e-dependent LDL oxidation (full protection vs. 20% for SOD1 alone). Anti-inflammatory actions involve suppression of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) p65 and p38 MAPK (mitogen-activated protein \u003c\/span\u003e\u003cspan\u003ekinase), lowering TNF-α\u003c\/span\u003e\u003cspan\u003e, I\u003c\/span\u003e\u003cspan\u003eL-6\u003c\/span\u003e\u003cspan\u003e,\u003c\/span\u003e\u003cspan\u003e and fibrinogen. In lung injury models, it elevates SOD activity and curbs ROS-induced inflammation. Evidence: Keratinocyte UV protection assays and fibroblast cultures show cytokine reduction; animal models confirm ROS scavenging and anti-inflammatory gene modulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eEnhancement of Angiogenesis\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu promotes new blood vessel formation (angiogenesis) by upregulating vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF, also known as FGF2) secretion from mesenchymal stem cells (MSCs) and fibroblasts. Released from SPARC (secreted protein acidic and rich in cysteine) protein during tissue injury, it stimulates endothelial cell proliferation and vessel growth in early wound phases, while inhibiting excess later via SPARC restoration. Gene data show +487% expression of ANGPT1 (angiopoietin 1). Evidence: Rabbit wound studies demonstrate enhanced granulation tissue and vessels; in vitro MSC assays confirm VEGF\/bFGF increases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s3\"\u003e\u003cstrong\u003e\u003cspan class=\"s2\"\u003eGene Expression Modulation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eGHK-Cu alters \u003c\/span\u003e\u003cspan\u003ethe \u003c\/span\u003e\u003cspan\u003eexpression of over 1,000 genes (e.g., 1,569 upregulated, 583 downregulated at ≥50% change), acting as an epigenetic modifier by inhibiting histone deacetylases (HDACs) to reverse gene silencing. It activates regenerative pathways (e.g., TGF-β, integrins, p63 (tumor protein p63)) and suppresses cancer-related genes (70% of 54 metastatic colon cancer genes). In neurons, it upregulates 408 genes (e.g., OPRM1 (opioid receptor mu 1) +1,294%) for development and pain relief. Evidence: Microarray analyses (e.g., Connectivity Map database) show broad impacts; COPD gene reversal (127 genes) and ubiquitin-proteasome system (UPS) pathway activation (41 genes upregulated) support tissue repair roles. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompound background and research mechanisms\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of GHK-Cu, including its role in cellular communication, extracellular matrix remodeling, and antioxidant regulation, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-ghk-cu\"\u003eWhat is GHK-Cu? – Research overview\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo explore GHK-Cu in hair loss–related research, including hair follicle signaling and extracellular matrix remodeling, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-hair-loss-research\"\u003e\u003cstrong\u003eGHK-Cu and Hair Follicle Research: Copper Peptides and Tissue Remodeling\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eGHK-Cu is frequently examined in research related to extracellular matrix signaling and dermal remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a broader comparison with repair-focused peptides, see:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghk-cu-vs-bpc-157\"\u003eGHK-Cu vs BPC-157: Tissue Repair, Angiogenesis, and Peptide Signaling\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how this compound fits into broader experimental frameworks focused on cellular homeostasis, metabolic balance, antioxidant regulation, and long-term functional maintenance, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/cellular-homeostasis-research\"\u003e\u003cstrong\u003eCellular Homeostasis \u0026amp; Health Maintenance Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"1567\" data-end=\"1595\"\u003e\u003cstrong data-start=\"1570\" data-end=\"1593\"\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli data-start=\"1599\" data-end=\"1645\"\u003eProduct Name: GHK-Cu (Copper Tripeptide)\u003c\/li\u003e\n\u003cli data-start=\"1599\" data-end=\"1645\"\u003eMolecular Formula: C₁₄H₂₃CuN₆O₄\u003c\/li\u003e\n\u003cli\u003eSynonyms : \u003cspan class=\"value\"\u003ePrezatide \u003c\/span\u003e\u003cspan class=\"value\"\u003ecopper, Copper peptide, BCP32687, SY253680, GHK copper; CG-copper peptide; [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003eMolar Mass : \u003cspan class=\"value\"\u003e401.91 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003eCAS Number : \u003cspan class=\"value\"\u003e89030-95-5\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003ePubChem : \u003cspan class=\"value\"\u003e78122578\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1895\" data-end=\"1990\"\u003eTotal Amount of the Active Ingredient: 50 mg \/ vial \u003c\/li\u003e\n\u003c\/ul\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52417639153930,"sku":null,"price":160.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52417639186698,"sku":null,"price":185.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/GHK-Cu_50mg_4.png?v=1768894375"},{"product_id":"ipamorelin-5-mg","title":"Ipamorelin 5 mg – Selective GH Secretagogue Peptide","description":"\u003ch3 data-start=\"163\" data-end=\"178\"\u003e\u003cstrong data-start=\"166\" data-end=\"178\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Ipamorelin is examined in experimental systems focused on growth hormone secretagogue signaling and metabolic adaptation. Research models often explore its role in pulsatile hormonal communication pathways.\u003c\/p\u003e\n\u003cp\u003eIpamorelin is a synthetic pentapeptide (C₃₈H₄₉N₉O₅; MW 711.9 Da) developed in the 1990s as the first selective growth hormone secretagogue (GHS). It mimics ghrelin to stimulate pulsatile growth hormone (GH) release with high specificity, without affecting other hormones. Studies show its potency in vitro (EC₅₀ 1.3 nmol\/L) and in vivo (ED₅₀ 80 nmol\/kg in rats, 2 nmol\/kg in swine). It has a 2-hour half-life, with peak GH effects at 0.67 hours post-dose, suitable for IV, SC, or intranasal administration. Blends with CJC-1295 or tesamorelin enhance synergistic GH pulses for recovery and optimization.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003eAs a GHS-R1a agonist, ipamorelin binds ghrelin receptors in the pituitary and hypothalamus, activating phospholipase C to raise intracellular calcium and trigger GH secretion from somatotrophs. It inhibits somatostatin, which limits GH release, while boosting IGF-1 levels. Unlike non-selective GHSs, it spares ACTH, cortisol, PRL, FSH, LH, TSH, aldosterone, and acetylcholine, even at high doses. It mimics ghrelin to increase hunger but maintains selectivity. Administration before sleep can induce GH secretion within 20 minutes.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003ePotential Applications\u003c\/h3\u003e\n\u003cp\u003eIpamorelin supports hormonal balance, particularly in women, by restoring fertility, menstrual cycles, and alleviating menopausal symptoms like fatigue, low libido, and weight gain. It increases uterine size and pregnancy rates in infertility cases, and improves thyroid\/adrenal function for better energy and mood. For body composition, it reduces fat storage, promotes lean muscle via protein synthesis and satellite cell activation, and enhances strength in aging populations. Anti-aging benefits include collagen production (up to 860% increase), cell repair for skin issues (wrinkles, sagging), and wound healing.\u003cbr\u003eIt bolsters bone and joint health by elevating bone mineral content and velocity, countering glucocorticoid-induced loss (e.g., restoring periosteal formation four-fold in rat models). Injury recovery accelerates through tissue repair and reduced inflammation. Metabolic applications involve fat loss via lipolysis, improved insulin sensitivity for blood sugar control, and energy metabolism. It enhances sleep quality (slow-wave sleep), immune function (thymus\/T-cell development), brain health (dopamine for Parkinson's), heart function (cardiac output), gastrointestinal motility (for ileus), and sexual health (nitric oxide, testosterone\/estrogen boost). In fitness and performance, it's ranked highly among GH peptides for muscle building and recovery, often cycled with other agents such as MK-677 or HGH. \u003c\/p\u003e\n\u003cp\u003e\u003cem data-start=\"516\" data-end=\"657\"\u003eFor a deeper scientific overview of how GHRP peptides like Ipamorelin differ from GHRH compounds, see our GHRH vs GHRP research comparison. - \u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong data-start=\"675\" data-end=\"711\"\u003eGHRH vs GHRP research comparison\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eOur research article on \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003emuscle preservation\u003c\/a\u003e\u003c\/strong\u003e during GLP-1\/GIP therapy provides additional context on how growth hormone signaling pathways are studied in relation to lean muscle maintenance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Description – Ipamorelin 5 mg\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"1610\" data-end=\"1623\"\u003eSynonyms:\u003c\/strong\u003e Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr data-start=\"1689\" data-end=\"1692\"\u003e\u003cstrong data-start=\"1692\" data-end=\"1714\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₈H₄₉N₉O₅\u003cbr data-start=\"1725\" data-end=\"1728\"\u003e\u003cstrong data-start=\"1728\" data-end=\"1743\"\u003eMolar Mass:\u003c\/strong\u003e ~711.87 g\/mol\u003cbr data-start=\"1757\" data-end=\"1760\"\u003e\u003cstrong data-start=\"1760\" data-end=\"1775\"\u003eCAS Number:\u003c\/strong\u003e 170851-70-4\u003cbr\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e: 9831659\u003cbr\u003e\u003cstrong data-start=\"1790\" data-end=\"1818\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Ipamorelin_1.png?v=1757839513\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9831659\" title=\"Ipamorelin stuctures\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251945566474,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251945599242,"sku":null,"price":115.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ipamorelin_3_1.png?v=1765456716"},{"product_id":"tesamorelin-10-mg","title":"Tesamorelin 10 mg – High-Purity GHRH Analog Peptide","description":"\u003ch3 data-end=\"161\" data-start=\"146\"\u003e\u003cstrong data-end=\"161\" data-start=\"149\"\u003eOverview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Tesamorelin is studied in experimental models investigating growth hormone axis modulation and body composition–related signaling. Research interest includes how endocrine signaling influences metabolic and structural adaptation.\u003cstrong data-end=\"161\" data-start=\"149\"\u003e\u003cbr\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoyl group for enhanced stability and potency. Originally developed as an orphan drug (branded as Egrifta), it received FDA approval in 2010 for reducing excess visceral adipose tissue (VAT) in HIV-infected adults with lipodystrophy associated with antiretroviral therapy. It has since gained attention in anti-aging, body composition optimization, metabolic health, performance enhancement, and cognitive support.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003eTesamorelin selectively binds to GHRH receptors on pituitary somatotroph cells, stimulating pulsatile release of endogenous growth hormone (GH) while preserving natural feedback regulation and avoiding receptor desensitization. The resulting GH surge prompts hepatic production of insulin-like growth factor-1 (IGF-1), which promotes lipolysis, protein synthesis, and metabolic efficiency. With a short half-life (8–120 minutes), it mimics physiological GH pulses without significantly affecting cortisol, prolactin, TSH, LH, FSH, or ACTH. It enhances mitochondrial biogenesis, fatty acid beta-oxidation, autophagy, and key signaling pathways including PI3K\/AKT\/mTOR and AMPK, supporting cellular energy efficiency, myogenesis, and preferential fat utilization. It synergizes effectively with testosterone and other GH secretagogues to amplify anabolism, improve glucose disposal, promote deep sleep, and reduce triglycerides without promoting insulin resistance.\u003c\/p\u003e\n\u003ch3\u003e\n\u003cbr\u003eBenefits and Potential Applications\u003c\/h3\u003e\n\u003cp\u003eClinical data demonstrate 12–20% reductions in visceral adipose tissue, 1.3–1.8 cm decreases in waist circumference, and improvements in liver enzymes (reduced ALT\/AST) in non-alcoholic fatty liver disease. Lipid profiles improve with significant drops in triglycerides (up to ~150 mg\/dL), total cholesterol, and LDL, alongside cardiovascular benefits such as reduced carotid intima-media thickness. Cognitive effects include enhanced executive function, verbal memory, and visual recall, particularly in aging populations or those with mild impairment after 20 weeks of use. For physique and performance, it supports indirect muscle gains through elevated GH, accelerated recovery, increased stamina, and fat loss—most pronounced in caloric surplus (12–20% above maintenance) with optimized testosterone levels. It aids nerve repair, activates satellite cells for myogenesis and angiogenesis, reduces fibrosis during training stress, and improves sleep architecture. Off-label applications include general obesity management, menopausal hormone optimization, immune modulation, sexual function, sleep quality, and athletic performance. Exploratory studies examine its role in age-related abdominal fat accumulation, though long-term safety data remain limited outside the approved indication.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eTo better understand how Tesamorelin functions within growth hormone research, explore our detailed guide on the differences between GHRH and GHRP peptides - \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong\u003eDifferences Between GHRH and GHRP peptides\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how growth hormone–related peptide research is examined in the context of muscle preservation during GLP-1\/GIP–associated weight loss, see our related research article on \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003e\u003cstrong\u003emuscle preservation mechanisms.\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eProduct Description – Tesamorelin 10 mg\u003c\/h3\u003e\n\u003cp data-end=\"418\" data-start=\"266\"\u003e\u003cstrong data-end=\"288\" data-start=\"266\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003csub\u003e223\u003c\/sub\u003eH\u003csub\u003e370\u003c\/sub\u003eN\u003csub\u003e72\u003c\/sub\u003eO\u003csub\u003e69\u003c\/sub\u003eS\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"418\" data-start=\"266\"\u003e\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-end=\"360\" data-start=\"345\"\u003eMolar Mass:\u003c\/strong\u003e ~ 5196 g\/mol\u003c\/p\u003e\n\u003cp data-end=\"487\" data-start=\"420\"\u003e\u003cstrong data-end=\"435\" data-start=\"420\"\u003eCAS Number:\u003c\/strong\u003e 901758-09-6\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"553\" data-start=\"489\"\u003e\u003cstrong data-end=\"504\" data-start=\"489\"\u003ePubChem ID:\u003c\/strong\u003e 44147413\u003cspan data-state=\"closed\" class=\"\"\u003e\u003cspan data-testid=\"webpage-citation-pill\" class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[9px] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" alt=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" rel=\"noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tesamorelin?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between\"\u003e\u003cspan class=\"max-w-[15ch] grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003e\u003cstrong data-end=\"583\" data-start=\"555\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Tesamorelin.png?v=1757839048\"\u003e\u003c\/p\u003e\n\u003cp data-end=\"647\" data-start=\"555\"\u003eSource: \u003ca title=\"Tesamorelin structures\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/44147413\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251944190218,"sku":null,"price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251944222986,"sku":null,"price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tesamorelin_10mg_3.png?v=1765456463"},{"product_id":"cjc-1295-10mg","title":"CJC-1295 ( No DAC ) 10 mg – High-Purity GHRH Analog Peptide","description":"\u003ch2 data-start=\"122\" data-end=\"137\"\u003eCJC- 1295 Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. CJC-1295 is studied in experimental models examining growth hormone–related signaling and anabolic regulation pathways. Research interest includes its role in long-term hormonal signaling dynamics.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eCJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous growth hormone (GH) production from the pituitary gland. It is available in two main forms: with Drug Affinity Complex (DAC), which significantly extends its half-life, and without DAC, which provides shorter, more pulsatile effects. It is frequently combined with other peptides, such as Ipamorelin, to enhance GH release, improve body composition, support recovery, and promote overall vitality.\u003c\/p\u003e\n\u003ch3 data-start=\"1487\" data-end=\"1711\"\u003e\n\u003cbr\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eCJC-1295 acts as a GHRH receptor agonist, binding to somatotroph cells in the anterior pituitary. This activates G-protein-coupled signaling that elevates intracellular cyclic AMP (cAMP), leading to calcium influx, GH vesicle exocytosis, and increased GH synthesis through transcription factors such as CREB. The result is amplified pulsatile or sustained GH secretion, followed by hepatic production of insulin-like growth factor-1 (IGF-1).\u003cbr\u003eThe DAC-conjugated version binds reversibly to albumin, prolonging plasma half-life to approximately 6–8 days. This produces sustained GH elevations (2–10-fold) and IGF-1 increases (1.5–3-fold) that can persist for up to 11 days after a single dose. In contrast, non-DAC CJC-1295 has a shorter half-life (~30 minutes), generating more physiological, pulsatile GH release patterns similar to those seen in younger individuals. Both forms stimulate the GH\/IGF-1 axis without introducing exogenous hormones, promoting protein synthesis, lipolysis, collagen production, and cellular repair while preserving natural feedback regulation when dosed appropriately.\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003ePotential Applications\u003cbr\u003eCJC-1295 is primarily used in research and optimization protocols for:\u003cbr\u003eBody composition improvement: Increased lean muscle mass, accelerated fat loss (particularly visceral fat), and enhanced metabolic rate. Recovery and performance: Faster healing from training or injury, improved sleep quality, and greater exercise capacity. Anti-aging and longevity: Counteracting age-related GH decline, supporting connective tissue integrity, reducing inflammation, improving insulin sensitivity, and promoting cardiovascular health. Regenerative therapy: Applications in musculoskeletal repair, metabolic optimization, and addressing conditions associated with low GH\/IGF-1, such as sarcopenia or chronic fatigue.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003e\u003cem data-end=\"898\" data-start=\"773\"\u003eLearn more about the role of GHRH analogs such as CJC-1295 in growth hormone research by reading our GHRH vs GHRP overview. - \u003c\/em\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/ghrh-vs-ghrp-key-differences-in-growth-hormone-research\"\u003e\u003cstrong data-end=\"941\" data-start=\"916\"\u003eGHRH vs GHRP overview\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"1487\" data-end=\"1711\"\u003eFor a broader research discussion on muscle loss during GLP-1\/GIP therapy and the role of growth hormone signaling pathways, refer to our detailed\u003cstrong data-end=\"941\" data-start=\"916\"\u003e \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003eresearch article on muscle preservation.\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader research overview of muscle growth, anabolic signaling, and adaptive recovery pathways, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Description:\u003cstrong\u003e \u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cdiv class=\"p-2 sm:table-row pc-gray-border-t sm:border-0\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 pb-1 pl-2 sm:align-middle\"\u003e\n\u003cp\u003e\u003cstrong data-start=\"284\" data-end=\"306\"\u003eMolecular Formula:\u003c\/strong\u003e C₁₅₂H₂₅₂N₄₄O₄₂\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"364\" data-end=\"412\"\u003e\u003cstrong data-start=\"364\" data-end=\"379\"\u003eMolar Mass:\u003c\/strong\u003e ~ 3367.9 g\/mol\u003c\/p\u003e\n\u003cp data-start=\"414\" data-end=\"443\"\u003e\u003cstrong data-start=\"414\" data-end=\"429\"\u003eCAS Number:\u003c\/strong\u003e 863288-34-0\u003c\/p\u003e\n\u003cp data-start=\"445\" data-end=\"470\"\u003e\u003cstrong data-start=\"445\" data-end=\"460\"\u003ePubChem ID:\u003c\/strong\u003e 56841945\u003c\/p\u003e\n\u003cp data-start=\"472\" data-end=\"553\"\u003e\u003cstrong data-start=\"472\" data-end=\"500\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/CJC1295_Without_DAC.png?v=1757838270\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/CJC1295-Without-DAC?utm_source=chatgpt.com\" title=\"CJC-1295 structures\"\u003ePubChem\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52251942093066,"sku":null,"price":110.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52251942125834,"sku":null,"price":135.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/CJC-1295_4.png?v=1765456298"},{"product_id":"cjc-1295-ipamorelin-10mg-5mg","title":"CJC-1295 No DAC (10 mg) + Ipamorelin (5 mg) Research Peptide Blend","description":"\u003ch2 data-start=\"468\" data-end=\"492\"\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The CJC-1295 and Ipamorelin combination is studied in experimental models focused on coordinated growth hormone release and anabolic signaling dynamics. Research interest includes how multiple secretagogue pathways influence long-term endocrine communication.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"494\" data-end=\"1024\"\u003e\u003cstrong data-start=\"494\" data-end=\"519\"\u003eCJC-1295 + Ipamorelin\u003c\/strong\u003e is a dual-peptide blend commonly utilized in controlled experimental settings to investigate coordinated interactions within growth hormone–related signaling pathways. CJC-1295 is a synthetic tetrasubstituted peptide analog of GHRH, designed to support prolonged receptor engagement through increased stability. Ipamorelin is a selective GHSR (growth hormone secretagogue receptor) agonist frequently explored for its high receptor specificity and minimal off-target binding profile in laboratory assays.\u003c\/p\u003e\n\u003cp data-start=\"1026\" data-end=\"1384\"\u003eCombined in a 10 mg (CJC-1295) + 5 mg (Ipamorelin) format, the blend enables researchers to examine multi-pathway activation dynamics involving both GHRH-mediated and ghrelin-mimetic mechanisms, offering a complementary model for studying pulsatile GH release patterns, receptor synergy, and peptide pharmacokinetics under controlled experimental conditions.\u003c\/p\u003e\n\u003ch3 data-start=\"1446\" data-end=\"1476\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"1446\" data-end=\"1476\"\u003eScientific Description\u003c\/h3\u003e\n\u003cp data-start=\"1478\" data-end=\"1853\"\u003eCJC-1295 is a modified peptide incorporating Drug Affinity Complex (DAC) technology in some research variants, enhancing its plasma stability and receptor interaction time frame. It engages GHRH receptors (GHRH-R), influencing intracellular signaling cascades such as cAMP–PKA, CREB activation, and downstream transcriptional pathways related to somatotropic axis modulation.\u003c\/p\u003e\n\u003cp data-start=\"1855\" data-end=\"2323\"\u003eIpamorelin, a pentapeptide secretagogue, selectively binds GHSR-1a and exhibits high specificity for this receptor compared to earlier GHRP-class compounds. In vitro studies frequently evaluate its selective suppression of off-target hormones while maintaining preserved ghrelin-receptor binding kinetics. The combined blend allows investigation of synchronized receptor activation events, GH pulse frequency modulation, and comparative potency across peptide classes.\u003c\/p\u003e\n\u003ch3 data-start=\"2381\" data-end=\"2408\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"2381\" data-end=\"2408\"\u003eResearch Background\u003c\/h3\u003e\n\u003cp data-start=\"2410\" data-end=\"2488\"\u003eExperimental literature involving CJC-1295 and Ipamorelin commonly focuses on:\u003c\/p\u003e\n\u003cul data-start=\"2490\" data-end=\"3069\"\u003e\n\u003cli data-start=\"2490\" data-end=\"2592\"\u003e\n\u003cp data-start=\"2492\" data-end=\"2592\"\u003e\u003cstrong data-start=\"2492\" data-end=\"2521\"\u003eReceptor pathway synergy:\u003c\/strong\u003e GHRH-R and GHSR-1a co-activation and downstream signaling interplay.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2593\" data-end=\"2722\"\u003e\n\u003cp data-start=\"2595\" data-end=\"2722\"\u003e\u003cstrong data-start=\"2595\" data-end=\"2624\"\u003ePharmacokinetic modeling:\u003c\/strong\u003e comparative half-life, stability, and degradation kinetics of individual and combined peptides.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2723\" data-end=\"2840\"\u003e\n\u003cp data-start=\"2725\" data-end=\"2840\"\u003e\u003cstrong data-start=\"2725\" data-end=\"2763\"\u003ePeptide–receptor binding profiles:\u003c\/strong\u003e selectivity, receptor affinity, and influence on intracellular messengers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2841\" data-end=\"2951\"\u003e\n\u003cp data-start=\"2843\" data-end=\"2951\"\u003e\u003cstrong data-start=\"2843\" data-end=\"2878\"\u003ePulsatile secretion patterning:\u003c\/strong\u003e simulation and mapping of growth-hormone–related pulsatility in vitro.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2952\" data-end=\"3069\"\u003e\n\u003cp data-start=\"2954\" data-end=\"3069\"\u003e\u003cstrong data-start=\"2954\" data-end=\"2997\"\u003eStructure–activity relationships (SAR):\u003c\/strong\u003e how substitutions and sequence motifs influence stability and function.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3071\" data-end=\"3240\"\u003eThe blend format (10 mg + 5 mg) provides a practical ratio for comparative and combination-model research, enabling consistent experimental conditions across replicates.\u003c\/p\u003e\n\u003cp data-start=\"3242\" data-end=\"3350\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"3357\" data-end=\"3393\"\u003eSpecifications \u0026amp; Identifiers\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCJC-1295 - 10 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂\u003cbr\u003eMolar Mass: ~ 3367.9 g\/mol\u003cbr\u003eCAS Number: 863288-34-0\u003cbr\u003ePubChem ID: 56841945\u003cbr\u003eTotal Active Ingredient: 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin 5 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSynonyms: Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr\u003eMolecular Formula: C₃₈H₄₉N₉O₅\u003cbr\u003eMolar Mass: ~711.87 g\/mol\u003cbr\u003eCAS Number: 170851-70-4\u003cbr\u003ePubChem CID: 9831659\u003cbr\u003eTotal Active Ingredient: 5 mg lyophilised peptide per vial\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52252210233610,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52252210266378,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/cjc_ipa_10_5_1.png?v=1765456033"},{"product_id":"tesamorelin-10-mg-ipamorelin-5-mg-research-peptide-blend","title":"Tesamorelin (10 mg) + Ipamorelin (5 mg) Research Peptide Blend","description":"\u003ch2 data-start=\"492\" data-end=\"517\"\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThis research-grade peptide combination is supplied exclusively for laboratory and experimental use. The Ipamorelin and Tesamorelin combination is studied in experimental systems examining complementary growth hormone–related signaling pathways. Research models explore how pulsatile and regulatory endocrine signals interact within metabolic and structural adaptation frameworks.\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-start=\"519\" data-end=\"1084\"\u003eThe \u003cstrong data-start=\"523\" data-end=\"589\"\u003eTesamorelin (10 mg) + Ipamorelin (5 mg) Research Peptide Blend\u003c\/strong\u003e is a dual-component formulation designed for controlled laboratory investigations into growth hormone–related signaling pathways. Tesamorelin is a stabilized growth hormone–releasing hormone (GHRH) analog featuring enhanced structural resistance to enzymatic degradation, allowing extended receptor interaction in vitro. Ipamorelin is a selective agonist of the ghrelin receptor (GHSR-1a), known for its high receptor specificity and minimal off-target binding profile in experimental settings.\u003c\/p\u003e\n\u003cp data-start=\"1086\" data-end=\"1395\"\u003eIn combined format, this blend enables researchers to explore synergistic or comparative activation patterns involving \u003cstrong data-start=\"1205\" data-end=\"1215\"\u003eGHRH-R\u003c\/strong\u003e and \u003cstrong data-start=\"1220\" data-end=\"1231\"\u003eGHSR-1a\u003c\/strong\u003e pathways, providing a versatile model for studying intracellular signaling events, pulsatile GH modulation, peptide pharmacokinetics, and receptor-ligand dynamics.\u003c\/p\u003e\n\u003cp data-start=\"1397\" data-end=\"1461\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"1468\" data-end=\"1499\"\u003eScientific Description\u003c\/h3\u003e\n\u003cp data-start=\"1501\" data-end=\"1845\"\u003eTesamorelin is a synthetic, stabilized peptide analog of human GHRH incorporating modifications that increase half-life and promote sustained interaction with its receptor. Experimental models often assess its ability to modulate cAMP-dependent intracellular pathways, CREB-associated transcription factors, and somatotropic signaling cascades.\u003c\/p\u003e\n\u003cp data-start=\"1847\" data-end=\"2139\"\u003eIpamorelin, a pentapeptide secretagogue, selectively targets the GHSR-1a receptor without engaging secondary hormonal pathways. Its binding profile allows for the evaluation of ghrelin-mimetic receptor dynamics with minimized confounding cross-interactions seen in older GHRP-class compounds.\u003c\/p\u003e\n\u003cp data-start=\"2141\" data-end=\"2378\"\u003eTogether, Tesamorelin and Ipamorelin form a complementary dual-peptide system that supports advanced studies on coordinated receptor activation, downstream signal propagation, and peptide stability under controlled laboratory conditions.\u003c\/p\u003e\n\u003cp data-start=\"2380\" data-end=\"2457\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"2464\" data-end=\"2492\"\u003eResearch Background\u003c\/h3\u003e\n\u003cp data-start=\"2494\" data-end=\"2575\"\u003eScientific literature examining Tesamorelin and Ipamorelin frequently focuses on:\u003c\/p\u003e\n\u003cul data-start=\"2577\" data-end=\"3128\"\u003e\n\u003cli data-start=\"2577\" data-end=\"2676\"\u003e\n\u003cp data-start=\"2579\" data-end=\"2676\"\u003e\u003cstrong data-start=\"2579\" data-end=\"2607\"\u003eReceptor synergy models:\u003c\/strong\u003e comparative and combined activation of GHRH-R and GHSR-1a pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2677\" data-end=\"2784\"\u003e\n\u003cp data-start=\"2679\" data-end=\"2784\"\u003e\u003cstrong data-start=\"2679\" data-end=\"2708\"\u003ePharmacokinetic analysis:\u003c\/strong\u003e stability, degradation kinetics, and extended plasma interaction modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2785\" data-end=\"2884\"\u003e\n\u003cp data-start=\"2787\" data-end=\"2884\"\u003e\u003cstrong data-start=\"2787\" data-end=\"2820\"\u003eIntracellular signal mapping:\u003c\/strong\u003e cAMP-PKA, CREB, PLC, and calcium-dependent messenger pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2885\" data-end=\"2993\"\u003e\n\u003cp data-start=\"2887\" data-end=\"2993\"\u003e\u003cstrong data-start=\"2887\" data-end=\"2930\"\u003eGrowth hormone pulsatility simulations:\u003c\/strong\u003e rhythm modulation and receptor-driven pulse-pattern modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2994\" data-end=\"3128\"\u003e\n\u003cp data-start=\"2996\" data-end=\"3128\"\u003e\u003cstrong data-start=\"2996\" data-end=\"3039\"\u003eStructure–activity relationships (SAR):\u003c\/strong\u003e amino acid modifications and their impact on receptor affinity and functional behavior\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3130\" data-end=\"3283\"\u003eThe 10 mg + 5 mg ratio is widely utilized in experimental settings due to its consistency and suitability for parallel or synergistic pathway evaluation.\u003c\/p\u003e\n\u003ch3 data-start=\"3366\" data-end=\"3403\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"3366\" data-end=\"3403\"\u003eSpecifications \u0026amp; Identifiers\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin 10 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C223H370N72O69S\u003cbr\u003eMolar Mass: ~ 5196 g\/mol\u003cbr\u003eCAS Number: 901758-09-6\u003cbr\u003ePubChem ID: 44147413\u003cbr\u003eTotal Active Ingredient: 10 mg lyophilised peptide per vial\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin 5 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSynonyms: Ipamorelin, NNC-26-0161, Growth Hormone Secretagogue Pentapeptide\u003cbr\u003eMolecular Formula: C₃₈H₄₉N₉O₅\u003cbr\u003eMolar Mass: ~711.87 g\/mol\u003cbr\u003eCAS Number: 170851-70-4\u003cbr\u003ePubChem CID: 9831659\u003cbr\u003eTotal Active Ingredient: 5 mg lyophilised peptide per vial\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52252227272970,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52252227305738,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tesa_ipa_10_5_1.png?v=1765455838"},{"product_id":"motsc-10mg-research-grade","title":"MOTS-c 10 mg - Mitochondrial Peptide (Research Grade)","description":"\u003ch3\u003eIntroduction to MOTS-c\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. MOTS-C is examined in experimental models investigating mitochondrial signaling, cellular energy regulation, and metabolic adaptation. Research interest centers on how cells respond to energetic stress and efficiency-related signals.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded by the mitochondrial genome (mtDNA). Discovered in 2015, it functions as a mitochondrial-derived peptide (MDP) with systemic regulatory roles. Unlike traditional mitochondrial proteins, MOTS-c translocates from mitochondria to the nucleus, influencing gene expression and metabolic pathways. Its molecular-level mechanism of action (MoA) centers on modulating cellular energy homeostasis, primarily through AMPK activation and purine metabolism interference. Recent studies (2025-2026) highlight its potential in metabolic disorders, aging, and neurodegeneration, with applications as an exercise mimetic. Structurally distinct from other MDPs like Humanin (a 24-amino acid peptide), MOTS-c shares cytoprotective effects but targets different pathways, making it promising for neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/mots_c_product_480x480.png?v=1768894662\" alt=\"mots-c peptide mechanism\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eCore Molecular Mechanism\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, MOTS-c regulates metabolism by inhibiting the folate\/methionine cycle in the nucleus. It binds to nuclear factors, reducing de novo purine biosynthesis, which leads to accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR is a potent activator of AMP-activated protein kinase (AMPK), mimicking energy stress and triggering catabolic pathways.\u003cbr\u003e\u003cbr\u003e - \u003cstrong\u003eGlycolysis Enhancement and AICAR Buildup:\u003c\/strong\u003e MOTS-c promotes glycolysis by shifting cellular reliance from oxidative phosphorylation (OXPHOS) to glycolytic flux under stress. This is achieved via AICAR-mediated AMPK activation, which phosphorylates targets like ACC (acetyl-CoA carboxylase), inhibiting fatty acid synthesis and favoring glucose uptake.\u003cbr\u003eRecent studies (e.g., 2025 Nature article) confirm MOTS-c's role in pancreatic islets, where it boosts glycolytic enzymes like PFK1, preventing senescence.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eNAD+ Improvement and AMPK Synergy:\u003c\/strong\u003e MOTS-c elevates NAD+ levels by enhancing NAD+ salvage pathways and mitochondrial biogenesis via PGC-1α upregulation. Although AMPK activation typically depletes NAD+ in acute states, MOTS-c's chronic effects parallel NAD+ boosting (e.g., via SIRT1 activation), resolving the apparent paradox. This dual action supports mitochondrial repair and energy efficiency, as seen in 2025 NIH studies\u003cbr\u003eshowing restored OXPHOS and reduced ATP hydrolysis in damaged mitochondria.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003ep53 Upregulation and NF-κB Downregulation:\u003c\/strong\u003e MOTS-c translocates to the nucleus, interacting with transcription factors to increase p53 expression, promoting DNA repair and apoptosis in stressed cells. Conversely, it suppresses NF-κB signaling, reducing pro-inflammatory cytokines like TNF-α and CRP. This anti-inflammatory profile is key for metabolic health, without elevating homocysteine or other markers, despite increased methylation (via methionine cycle modulation).\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMitochondrial Damage Repair:\u003c\/strong\u003e MOTS-c improves mitochondrial function by increasing ROS in a controlled manner ( hormesis), enhancing OXPHOS capacity, and mitigating damage from aging or diabetes. 2025 Springer studies on diabetic cardiomyopathy show MOTS-c restores membrane potential and biogenesis, acting as a mitohormetic agent.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMetabolic and Physiological Benefits\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c's MoA extends to systemic effects, positioning it as a therapeutic for obesity, insulin resistance, and muscle health.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eObesity Prevention and Body Recomposition:\u003c\/strong\u003e By activating AMPK, MOTS-c inhibits lipogenesis and promotes fat oxidation, preventing weight gain and liver fat accumulation (2025 Taylor \u0026amp; Francis study). It aids body recomposition by enhancing lean mass through myostatin inhibition, reducing muscle atrophy signals. This is particularly beneficial for age-related sarcopenia, where MOTS-c mimics exercise-induced muscle adaptations.\u003cbr\u003e\u003cbr\u003e-\u003cstrong\u003e Insulin Resistance Improvement: \u003c\/strong\u003eMOTS-c enhances insulin sensitivity via GLUT4 translocation and IRS-1 phosphorylation, countering resistance in type 2 diabetes models. In 2025 Nature research, it protected pancreatic islets in nonobese diabetic mice, improving glucose tolerance.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eExercise Mimetic Properties:\u003c\/strong\u003e As an \"exercise in a pill\", MOTS-c replicates endurance training effects by boosting AMPK and PGC-1α, increasing mitochondrial density and aerobic capacity. 2025-2026 studies link exercise intensity to circulating MOTS-c levels, correlating with metabolic improvements.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMethylation Effects Without Inflammatory Drawbacks:\u003c\/strong\u003e MOTS-c increases global DNA methylation by altering one-carbon metabolism, supporting epigenetic stability. However, it does not elevate inflammatory markers (CRP,TNF-α) or homocysteine, avoiding risks associated with hypermethylation therapies.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSimilarities to Humanin and Applications in Neurodegeneration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c exhibits Humanin-like effects, including neuroprotection and anti-apoptotic actions, but with a distinct structure (no shared sequence motifs) and administration routes (e.g., injectable vs. oral potential). In neurodegenerative diseases, MOTS-c modulates AMPK in neurons, reducing amyloid aggregation and tau phosphorylation. 2025 studies suggest applications in Alzheimer\u0026amp;#39;s, where it preserves synaptic function and mitochondrial integrity, differing from Humanin's IGFBP-3 binding. \u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e101\u003c\/sub\u003eH\u003csub\u003e152\u003c\/sub\u003eN\u003csub\u003e28\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003e Mitochondria-derived peptide, mots-c, EX-A626, Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e2174.6 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e1627580-64-6\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e146675088\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e \u003cspan class=\"value\"\u003e10 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Mots-c.png?v=1768051802\" alt=\"Mots-c peptide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/146675088#section=2D-Structure\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52417743290634,"sku":null,"price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52417743323402,"sku":null,"price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/motsc_10mg.png?v=1768895729"},{"product_id":"mots-c-20-mg-research-grade","title":"MOTS-c 20 mg Mitochondrial Peptide (Research Grade)","description":"\u003ch3\u003eMOTS-c Peptide Introduction and Overview\u003cbr\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. MOTS-C is examined in experimental models investigating mitochondrial signaling, cellular energy regulation, and metabolic adaptation. Research interest centers on how cells respond to energetic stress and efficiency-related signals.\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003eMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded by the mitochondrial genome (mtDNA). Discovered in 2015, it functions as a mitochondrial-derived peptide (MDP) with systemic regulatory roles. Unlike traditional mitochondrial proteins, MOTS-c translocates from mitochondria to the nucleus, influencing gene expression and metabolic pathways. Its molecular-level mechanism of action (MoA) centers on modulating cellular energy homeostasis, primarily through AMPK activation and purine metabolism interference. Recent studies (2025-2026) highlight its potential in metabolic disorders, aging, and neurodegeneration, with applications as an exercise mimetic. Structurally distinct from other MDPs like Humanin (a 24-amino acid peptide), MOTS-c shares cytoprotective effects but targets different pathways, making it promising for neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCore Molecular Mechanism\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, MOTS-c regulates metabolism by inhibiting the folate\/methionine cycle in the nucleus. It binds to nuclear factors, reducing de novo purine biosynthesis, which leads to accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR is a potent activator of AMP-activated protein kinase (AMPK), mimicking energy stress and triggering catabolic pathways.\u003cbr\u003e\u003cbr\u003e - \u003cstrong\u003eGlycolysis Enhancement and AICAR Buildup:\u003c\/strong\u003e MOTS-c promotes glycolysis by shifting cellular reliance from oxidative phosphorylation (OXPHOS) to glycolytic flux under stress. This is achieved via AICAR-mediated AMPK activation, which phosphorylates targets like ACC (acetyl-CoA carboxylase), inhibiting fatty acid synthesis and favoring glucose uptake.\u003cbr\u003eRecent studies (e.g., 2025 Nature article) confirm MOTS-c's role in pancreatic islets, where it boosts glycolytic enzymes like PFK1, preventing senescence.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eNAD+ Improvement and AMPK Synergy:\u003c\/strong\u003e MOTS-c elevates NAD+ levels by enhancing NAD+ salvage pathways and mitochondrial biogenesis via PGC-1α upregulation. Although AMPK activation typically depletes NAD+ in acute states, MOTS-c's chronic effects parallel NAD+ boosting (e.g., via SIRT1 activation), resolving the apparent paradox. This dual action supports mitochondrial repair and energy efficiency, as seen in 2025 NIH studies\u003cbr\u003eshowing restored OXPHOS and reduced ATP hydrolysis in damaged mitochondria.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003ep53 Upregulation and NF-κB Downregulation:\u003c\/strong\u003e MOTS-c translocates to the nucleus, interacting with transcription factors to increase p53 expression, promoting DNA repair and apoptosis in stressed cells. Conversely, it suppresses NF-κB signaling, reducing pro-inflammatory cytokines like TNF-α and CRP. This anti-inflammatory profile is key for metabolic health, without elevating homocysteine or other markers, despite increased methylation (via methionine cycle modulation).\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMitochondrial Damage Repair:\u003c\/strong\u003e MOTS-c improves mitochondrial function by increasing ROS in a controlled manner ( hormesis), enhancing OXPHOS capacity, and mitigating damage from aging or diabetes. 2025 Springer studies on diabetic cardiomyopathy show MOTS-c restores membrane potential and biogenesis, acting as a mitohormetic agent.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMetabolic and Physiological Benefits\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c's MoA extends to systemic effects, positioning it as a therapeutic for obesity, insulin resistance, and muscle health.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eObesity Prevention and Body Recomposition:\u003c\/strong\u003e By activating AMPK, MOTS-c inhibits lipogenesis and promotes fat oxidation, preventing weight gain and liver fat accumulation (2025 Taylor \u0026amp; Francis study). It aids body recomposition by enhancing lean mass through myostatin inhibition, reducing muscle atrophy signals. This is particularly beneficial for age-related sarcopenia, where MOTS-c mimics exercise-induced muscle adaptations.\u003cbr\u003e\u003cbr\u003e-\u003cstrong\u003e Insulin Resistance Improvement: \u003c\/strong\u003eMOTS-c enhances insulin sensitivity via GLUT4 translocation and IRS-1 phosphorylation, countering resistance in type 2 diabetes models. In 2025 Nature research, it protected pancreatic islets in nonobese diabetic mice, improving glucose tolerance.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eExercise Mimetic Properties:\u003c\/strong\u003e As an \u0026amp;quot;exercise in a pill,\u0026amp;quot; MOTS-c replicates endurance training effects by boosting AMPK and PGC-1α, increasing mitochondrial density and aerobic capacity. 2025-2026 studies link exercise intensity to circulating MOTS-c levels, correlating with metabolic improvements.\u003cbr\u003e\u003cbr\u003e- \u003cstrong\u003eMethylation Effects Without Inflammatory Drawbacks:\u003c\/strong\u003e MOTS-c increases global DNA methylation by altering one-carbon metabolism, supporting epigenetic stability. However, it does not elevate inflammatory markers (CRP,TNF-α) or homocysteine, avoiding risks associated with hypermethylation therapies.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSimilarities to Humanin and Applications in Neurodegeneration\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eMOTS-c exhibits Humanin-like effects, including neuroprotection and anti-apoptotic actions, but with a distinct structure (no shared sequence motifs) and administration routes (e.g., injectable vs. oral potential). In neurodegenerative diseases, MOTS-c modulates AMPK in neurons, reducing amyloid aggregation and tau phosphorylation. 2025 studies suggest applications in Alzheimer\u0026amp;#39;s, where it preserves synaptic function and mitochondrial integrity, differing from Humanin's IGFBP-3 binding. \u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRelated research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo explore how mitochondrial efficiency and metabolic signaling intersect with muscle performance and recovery research, see:\u003cbr\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-kerning: none;\"\u003eRead more about mitochondrial peptides, exercise adaptation, and cellular energy signaling in our mitochondrial health deep dive.\u003cbr\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"s4\"\u003e\u003cspan\u003e \u003cstrong\u003eProduct Description: \u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e101\u003c\/sub\u003eH\u003csub\u003e152\u003c\/sub\u003eN\u003csub\u003e28\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003e Mitochondria-derived peptide, mots-c, EX-A626, Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e2174.6 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e1627580-64-6\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e146675088\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e2\u003cspan class=\"value\"\u003e0 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Mots-c_1.png?v=1768052342\" alt=\"Mots-c structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/146675088#section=2D-Structure\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52398804631818,"sku":null,"price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen (1 )","offer_id":52398804664586,"sku":null,"price":205.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/motsc_20mg.png?v=1768896003"},{"product_id":"selank-50mg","title":"Selank 50mg – Research Peptide","description":"\u003ch3\u003eIntroduction\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Selank is studied in research models exploring stress regulation, cognitive signaling, and neuroimmune communication. It is commonly examined in experimental systems focused on emotional balance, attention-related pathways, and adaptive neural responses.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of tuftsin, a natural immunomodulatory tetrapeptide derived from the heavy chain of human immunoglobulin G. Selank was created to combine anxiolytic (anti-anxiety), nootropic (cognitive-enhancing), and immunomodulatory properties. It is primarily used in Russia and Ukraine for treating generalized anxiety disorders, neurasthenia, and cognitive impairments. Unlike traditional anxiolytics like benzodiazepines, Selank reportedly lacks sedative effects, addiction potential, or withdrawal symptoms. It is administered intranasally or intravenously, subcutaneously often as a lyophilized powder reconstituted in sterile water, requiring refrigeration for stability.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eChemical Structure\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), a seven-amino-acid chain. The first four residues (Thr-Lys-Pro-Arg) mimic tuftsin, extended by Pro-Gly-Pro to enhance metabolic stability and prolong action.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMechanism of Action (Molecular Level)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, Selank acts as a positive allosteric modulator of GABA_A receptors, enhancing their affinity for gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter. This modulation inhibits central nervous system excitability, contributing to anxiolytic effects without the side effects of benzodiazepines.\u003cbr\u003e\u003cbr\u003eSelank alters gene expression in brain regions like the frontal cortex. In rat models, intranasal administration (300 μg\/kg) changes expression of 45 neurotransmission-related genes, with overlaps to GABA's effects. Key alterations include:\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA receptor subunits like Gabre (ε, ~20-fold at 1 hour) and Gabrq (θ, ~20-fold at 1 hour), reducing inhibitory tone.\u003cbr\u003e\u003cbr\u003e- Upregulation of others like Gabrb3 (β3, 1.58-fold) and Gabrg3 (γ3, 1.29-fold), enhancing receptor function.\u003cbr\u003e\u003cbr\u003e Modulation of dopamine receptors (Drd1a, Drd2, Drd3) was upregulated at 1 hour, and serotonin receptors (Htr3a, Htr1b).\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA transporters (Slc32a1, Slc6a1, Slc6a11), prolonging GABA availability.\u003cbr\u003e\u003cbr\u003e- Dramatic changes in orexin precursor (Hcrt, ~25-fold downregulation at 1 hour, 128-fold upregulation at 3 hours), aiding sleep-wake regulation.\u003cbr\u003e\u003cbr\u003e- Selank elevates brain-derived neurotrophic factor (BDNF) in the hippocampus, promoting neurogenesis, synaptic plasticity, and cognitive function. It modulates monoamine neurotransmitters: enhancing serotonin metabolism (influencing mood, sleep, and appetite) and dopamine release (improving focus and reward).\u003cbr\u003e\u003cbr\u003e- As a tuftsin analog, it stimulates interleukin-6 (IL-6) and interferon production, balancing T helper cell cytokines for immunomodulation. Enhance the phagocytic function of macrophages.\u003cbr\u003e\u003cbr\u003e- Selank inhibits enkephalin-degrading enzymes, such as carboxypeptidase H, thereby extending the effects of endogenous peptides. It maintains cortisol levels, reducing stress responses.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003ePharmacological Effects and Uses\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank exhibits anxiolytic, antidepressant, and nootropic effects in animal and human studies. It reduces anxiety and asthenia in patients with generalized anxiety disorders, improving emotional stability and cognitive performance.\u003cbr\u003e\u003cbr\u003eNootropic benefits include enhanced memory, concentration, learning, and mental endurance via BDNF upregulation and neural plasticity. It protects against alcohol-induced cognitive deficits by regulating BDNF in the hippocampus and frontal cortex.\u003cbr\u003e\u003cbr\u003eSelank, as a tuftsin analog, has neuroprotective and immunomodulatory properties that could theoretically benefit neurodegenerative conditions like ALS, Parkinson’s Disease, and Multiple Sclerosis, which involve motor neuron degeneration, inflammation, and oxidative stress.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparative research context:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader comparison of neuropeptide research compounds, including Selank, Semax, and Dihexa, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003eSemax vs Selank vs Dihexa – Key research differences\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFurther research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of Selank, including its molecular structure, neuroregulatory signaling mechanisms, and role in experimental neuroimmune models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-selank\"\u003e\u003cstrong\u003eWhat is Selank? – A Regulatory Neuropeptide in Experimental Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003e\u003cstrong\u003eOCD Circuit-Level Neurobiology Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eChemical Formula : \u003c\/span\u003e \u003cspan\u003eC\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003eThr-Lys-Pro-Arg-Pro-Gly-Pro, L-Proline, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-, Selanc, UNII-TS9JR8EP1G\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e751.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e129954-34-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e11765600\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e \u003cspan class=\"value\"\u003e50 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Selank.png?v=1768053286\" alt=\"Selank structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11765600\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52423539523850,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52423539556618,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/selank_50mg.png?v=1768901930"},{"product_id":"selank-25mg","title":"Selank 25mg – Research Peptide","description":"\u003ch3\u003eSelank Introduction\u003c\/h3\u003e\n\u003cp\u003eThis research-grade peptide is supplied exclusively for laboratory and experimental use. Selank is studied in research models exploring stress regulation, cognitive signaling, and neuroimmune communication. It is commonly examined in experimental systems focused on emotional balance, attention-related pathways, and adaptive neural responses.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analog of tuftsin, a natural immunomodulatory tetrapeptide derived from the heavy chain of human immunoglobulin G. Selank was created to combine anxiolytic (anti-anxiety), nootropic (cognitive-enhancing), and immunomodulatory properties. It is primarily used in Russia and Ukraine for treating generalized anxiety disorders, neurasthenia, and cognitive impairments. Unlike traditional anxiolytics like benzodiazepines, Selank reportedly lacks sedative effects, addiction potential, or withdrawal symptoms. It is administered intranasally or intravenously, subcutaneously often as a lyophilized powder reconstituted in sterile water, requiring refrigeration for stability.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eChemical Structure\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), a seven-amino-acid chain. The first four residues (Thr-Lys-Pro-Arg) mimic tuftsin, extended by Pro-Gly-Pro to enhance metabolic stability and prolong action.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMechanism of Action (Molecular Level)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eAt the molecular level, Selank acts as a positive allosteric modulator of GABA_A receptors, enhancing their affinity for gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter. This modulation inhibits central nervous system excitability, contributing to anxiolytic effects without the side effects of benzodiazepines.\u003cbr\u003e\u003cbr\u003eSelank alters gene expression in brain regions like the frontal cortex. In rat models, intranasal administration (300 μg\/kg) changes expression of 45 neurotransmission-related genes, with overlaps to GABA's effects. Key alterations include:\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA receptor subunits like Gabre (ε, ~20-fold at 1 hour) and Gabrq (θ, ~20-fold at 1 hour), reducing inhibitory tone.\u003cbr\u003e\u003cbr\u003e- Upregulation of others like Gabrb3 (β3, 1.58-fold) and Gabrg3 (γ3, 1.29-fold), enhancing receptor function.\u003cbr\u003e\u003cbr\u003e Modulation of dopamine receptors (Drd1a, Drd2, Drd3) was upregulated at 1 hour, and serotonin receptors (Htr3a, Htr1b).\u003cbr\u003e\u003cbr\u003e- Downregulation of GABA transporters (Slc32a1, Slc6a1, Slc6a11), prolonging GABA availability.\u003cbr\u003e\u003cbr\u003e- Dramatic changes in orexin precursor (Hcrt, ~25-fold downregulation at 1 hour, 128-fold upregulation at 3 hours), aiding sleep-wake regulation.\u003cbr\u003e\u003cbr\u003e- Selank elevates brain-derived neurotrophic factor (BDNF) in the hippocampus, promoting neurogenesis, synaptic plasticity, and cognitive function. It modulates monoamine neurotransmitters: enhancing serotonin metabolism (influencing mood, sleep, and appetite) and dopamine release (improving focus and reward).\u003cbr\u003e\u003cbr\u003e- As a tuftsin analog, it stimulates interleukin-6 (IL-6) and interferon production, balancing T helper cell cytokines for immunomodulation. Enhance the phagocytic function of macrophages.\u003cbr\u003e\u003cbr\u003e- Selank inhibits enkephalin-degrading enzymes, such as carboxypeptidase H, thereby extending the effects of endogenous peptides. It maintains cortisol levels, reducing stress responses.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003ePharmacological Effects and Uses\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eSelank exhibits anxiolytic, antidepressant, and nootropic effects in animal and human studies. It reduces anxiety and asthenia in patients with generalized anxiety disorders, improving emotional stability and cognitive performance.\u003cbr\u003e\u003cbr\u003eNootropic benefits include enhanced memory, concentration, learning, and mental endurance via BDNF upregulation and neural plasticity. It protects against alcohol-induced cognitive deficits by regulating BDNF in the hippocampus and frontal cortex.\u003cbr\u003e\u003cbr\u003eSelank, as a tuftsin analog, has neuroprotective and immunomodulatory properties that could theoretically benefit neurodegenerative conditions like ALS, Parkinson’s Disease, and Multiple Sclerosis, which involve motor neuron degeneration, inflammation, and oxidative stress.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComparative research context:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a broader comparative overview of Selank in relation to other neuropeptide research compounds, including Semax and Dihexa, see:\u003cbr\u003e→ \u003cstrong\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003eSemax vs Selank vs Dihexa – Key research differences\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFurther research context\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor a detailed research-focused overview of Selank, including its molecular structure, neuroregulatory signaling mechanisms, and role in experimental neuroimmune models, see:\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-selank\"\u003e\u003cstrong\u003eWhat is Selank? – A Regulatory Neuropeptide in Experimental Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003e\u003cstrong\u003eOCD Circuit-Level Neurobiology Research\u003c\/strong\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"even\"\u003e\u003cspan\u003eChemical Formula : C\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eSynonyms : \u003c\/span\u003e \u003cspan class=\"value\"\u003eThr-Lys-Pro-Arg-Pro-Gly-Pro, L-Proline, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-, Selanc, UNII-TS9JR8EP1G\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003eMolar Mass : \u003c\/span\u003e \u003cspan class=\"value\"\u003e751.9 g\/mol\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eCAS Number : \u003c\/span\u003e \u003cspan class=\"value\"\u003e129954-34-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"even\"\u003e\n\u003cspan\u003ePubChem : \u003c\/span\u003e \u003cspan class=\"value\"\u003e11765600\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"odd\"\u003e\n\u003cspan\u003eTotal Amount of the Active Ingredient : \u003c\/span\u003e2\u003cspan class=\"value\"\u003e5 mg (1 vial)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Selank_1.png?v=1768053588\" alt=\"Selank peptide structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan class=\"value\"\u003eSource: \u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11765600\"\u003ePubChem\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52423541031178,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52423541063946,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/selank_25mg.png?v=1768901804"},{"product_id":"tirzepatide-20mg","title":"Tirzepatide 20mg – Research Peptide","description":"\u003cp\u003e\u003cstrong\u003eStructure, Molecular Mechanism of Action, Receptor Interactions:\u003c\/strong\u003e Tirzepatide is a first-in-class, unimolecular, long-acting dual GIP\/GLP-1 receptor agonist (39-amino acid syntheticlinear peptide.\u003c\/p\u003e\n\u003cp\u003eTirzepatide is a dual incretin receptor agonist studied for its effects on metabolic signaling and energy regulation pathways. In research models, it is examined for its interaction with glucose balance, appetite-related signaling, and hormonal coordination.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eMolecular Mechanism of Action :\u003c\/strong\u003e Tirzepatide is a dual agonist of the glucose-dependent\u003cbr\u003einsulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R),\u003cbr\u003eboth class B GPCRs. Tirzepatide exhibits imbalanced agonism (preferential GIPR engagement) and biased signaling at GLP-1R, driving its superior glycemic\/weight effects vs. GLP-1R mono-agonists.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGIPR: Unbiased; full mimicry of GIP (Gs → ↑cAMP → PKA; β-arrestin2;\u003cbr\u003einternalization).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGLP-1R: Biased partial agonist favoring Gs\/cAMP\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDownstream Molecular\/Physiologic Effects (Glucose-Dependent):\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePancreatic β-cells (both receptors): Gs–cAMP–PKA → voltage-gated Ca²⁺\u003cbr\u003einflux\/exocytosis → insulin secretion; improved β-cell function\/sensitivity.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eα-cells (GLP-1R dominant): Glucagon suppression.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eGI (GLP-1R): Delayed gastric emptying; satiety\/appetite reduction (central\u003cbr\u003ehypothalamic arcuate\/paraventricular neurons).\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdipose\/liver\/muscle (GIPR + GLP-1R): Enhanced insulin sensitivity, lipid buffering\u003cbr\u003e(↑adiponectin), reduced ectopic fat, improved metabolic flexibility.\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCNS: Reduced food intake\/energy intake; sustained signaling from bias may enhance weight loss durability. Net: Superior HbA1c reduction (1.6–2.4%), weight loss (15–21% at 72 wk), cardiometabolic benefits (lipids, BP) vs. GLP-1 mono-agonists.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWant to understand the receptor signaling behind this compound?\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-tirzepatide\"\u003eWhat is Tirzepatide? Dual GLP-1\/GIP Peptide Explained\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003eExplore how dual-receptor incretin signaling compares with next-generation triple agonists.\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/retatrutide-tirzepatide\"\u003eRetatrutide vs Tirzepatide: Mechanism Comparison\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cstrong\u003eTirzepatide is commonly examined in research involving incretin signaling and metabolic regulation. \u003c\/strong\u003e\u003cstrong\u003eFor a broader perspective on how injectable peptides compare with oral compounds:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/oral-vs-injectable-metabolic-peptides-research\"\u003eOral vs Injectable Compounds (Orforglipron, Tirzepatide, Retatrutide)\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3\u003eTo explore how incretin-based signaling pathways interact with muscle metabolism and adaptive physiology in research models, see:\u003c\/h3\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/muscle-preservation-during-glp-1-gip-therapy\"\u003eMuscle Preservation During GLP-1\/GIP Therapy\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct description:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong\u003eMolecular Formula: \u003c\/strong\u003e\u003cspan\u003eC\u003csub\u003e225\u003c\/sub\u003eH\u003csub\u003e348\u003c\/sub\u003eN\u003csub\u003e48\u003c\/sub\u003eO\u003csub\u003e68\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 4813\u003cspan\u003e \u003c\/span\u003eg\/m   \u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cspan\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e \u003c\/span\u003e2023788-19-2\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong data-end=\"875\" data-start=\"847\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 20 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStructures:\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"Tirzepatide structure\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/tirzepatide.png?v=1772702974\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/156588324\"\u003e\u003cstrong\u003eSource: Pubchem\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641769521418,"sku":null,"price":180.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641769554186,"sku":null,"price":205.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Tirzepatide_2.png?v=1772286816"},{"product_id":"cagrilintide-5mg","title":"Cagrilintide 5mg – Research Peptide","description":"\u003ch3 data-start=\"566\" data-end=\"600\"\u003eCagrilintide – Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"602\" data-end=\"927\"\u003eCagrilintide is a long-acting amylin analog studied in experimental research for its interaction with appetite-related neuroendocrine signaling and metabolic regulation pathways. Laboratory studies frequently examine its role in satiety signaling, peptide hormone receptor pharmacology, and central energy-balance mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"929\" data-end=\"1308\"\u003eCagrilintide (NNC0174-0833 \/ AM833) is a synthetic 37-amino-acid peptide derived from human amylin (islet amyloid polypeptide, IAPP). It has been engineered as a long-acting analog designed to interact with \u003cstrong data-start=\"1136\" data-end=\"1163\"\u003eamylin receptors (AMYR)\u003c\/strong\u003e and \u003cstrong data-start=\"1168\" data-end=\"1198\"\u003ecalcitonin receptors (CTR)\u003c\/strong\u003e, forming part of a class sometimes referred to as dual amylin receptor\/calcitonin receptor agonists (DACRAs).\u003c\/p\u003e\n\u003ch3 data-start=\"1315\" data-end=\"1345\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003ch3 data-start=\"1347\" data-end=\"1392\"\u003eAmylin and Calcitonin Receptor Interaction\u003c\/h3\u003e\n\u003cp data-start=\"1394\" data-end=\"1700\"\u003eAmylin receptors consist of a \u003cstrong data-start=\"1424\" data-end=\"1512\"\u003ecalcitonin receptor core complexed with receptor activity-modifying proteins (RAMPs)\u003c\/strong\u003e. Cagrilintide has been shown in experimental models to activate these receptor complexes, producing intracellular signaling events associated with satiety-related neuroendocrine pathways.\u003c\/p\u003e\n\u003cp data-start=\"1702\" data-end=\"1808\"\u003eThese receptor systems are highly expressed in several regions involved in metabolic signaling, including:\u003c\/p\u003e\n\u003cul data-start=\"1810\" data-end=\"1936\"\u003e\n\u003cli data-start=\"1810\" data-end=\"1835\"\u003e\n\u003cp data-start=\"1812\" data-end=\"1835\"\u003ethe \u003cstrong data-start=\"1816\" data-end=\"1833\"\u003earea postrema\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1836\" data-end=\"1880\"\u003e\n\u003cp data-start=\"1838\" data-end=\"1880\"\u003ethe \u003cstrong data-start=\"1842\" data-end=\"1878\"\u003enucleus tractus solitarius (NTS)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1881\" data-end=\"1936\"\u003e\n\u003cp data-start=\"1883\" data-end=\"1936\"\u003ehypothalamic nuclei associated with energy regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1938\" data-end=\"2118\"\u003eActivation of these receptors has been associated in experimental models with modulation of neural circuits involved in satiety signaling and nutrient-responsive feedback pathways.\u003c\/p\u003e\n\u003ch3 data-start=\"2125\" data-end=\"2159\"\u003eCentral Neuroendocrine Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2161\" data-end=\"2309\"\u003eIn preclinical research, cagrilintide has been examined for its influence on central nervous system signaling pathways that regulate energy balance.\u003c\/p\u003e\n\u003cp data-start=\"2311\" data-end=\"2421\"\u003eExperimental observations suggest receptor activation within brainstem and hypothalamic regions may influence:\u003c\/p\u003e\n\u003cul data-start=\"2423\" data-end=\"2548\"\u003e\n\u003cli data-start=\"2423\" data-end=\"2461\"\u003e\n\u003cp data-start=\"2425\" data-end=\"2461\"\u003esatiety-related neuronal signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2462\" data-end=\"2507\"\u003e\n\u003cp data-start=\"2464\" data-end=\"2507\"\u003ehypothalamic appetite regulation pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2508\" data-end=\"2548\"\u003e\n\u003cp data-start=\"2510\" data-end=\"2548\"\u003ereward-related food signaling circuits\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2550\" data-end=\"2681\"\u003eThese neuroendocrine pathways are often studied in research investigating peptide hormone signaling involved in energy homeostasis.\u003c\/p\u003e\n\u003ch3 data-start=\"2688\" data-end=\"2719\"\u003ePeripheral Signaling Pathways\u003c\/h3\u003e\n\u003cp data-start=\"2721\" data-end=\"2861\"\u003eBeyond central receptor activity, experimental studies have also reported additional signaling events associated with cagrilintide activity.\u003c\/p\u003e\n\u003cp data-start=\"2863\" data-end=\"2877\"\u003eThese include:\u003c\/p\u003e\n\u003cul data-start=\"2879\" data-end=\"3050\"\u003e\n\u003cli data-start=\"2879\" data-end=\"2910\"\u003e\n\u003cp data-start=\"2881\" data-end=\"2910\"\u003e\u003cstrong data-start=\"2881\" data-end=\"2908\"\u003ecAMP signaling pathways\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2911\" data-end=\"2979\"\u003e\n\u003cp data-start=\"2913\" data-end=\"2979\"\u003ephosphorylation events involving cellular ion transport proteins\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2980\" data-end=\"3050\"\u003e\n\u003cp data-start=\"2982\" data-end=\"3050\"\u003esignaling interactions observed in renal epithelial transport models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3052\" data-end=\"3186\"\u003eSuch observations are typically explored in preclinical studies examining peptide hormone signaling and metabolic regulatory pathways.\u003c\/p\u003e\n\u003ch3 data-start=\"3193\" data-end=\"3221\"\u003eStructural Characteristics\u003c\/h3\u003e\n\u003cp data-start=\"3223\" data-end=\"3451\"\u003eCagrilintide is a \u003cstrong data-start=\"3241\" data-end=\"3273\"\u003e37-amino-acid peptide analog\u003c\/strong\u003e derived from the endogenous amylin sequence. Structural modifications have been introduced to improve molecular stability and prolong receptor engagement in experimental models.\u003c\/p\u003e\n\u003cp data-start=\"3453\" data-end=\"3603\"\u003eThese modifications differentiate cagrilintide from earlier amylin analogs, which have also been used in research examining amylin receptor signaling.\u003c\/p\u003e\n\u003cp\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide.jpg?v=1770821612\"\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct description:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e \u003c\/span\u003e\u003cspan\u003eC\u003csub\u003e194\u003c\/sub\u003eH\u003csub\u003e312\u003c\/sub\u003eN\u003csub\u003e54\u003c\/sub\u003eO\u003csub\u003e59\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003e\u003cstrong\u003eMolecular Weight: \u003c\/strong\u003e4409 g\/mol\u003c\/span\u003e\u003cspan\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cspan\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e \u003c\/span\u003e \u003cspan\u003e1415456-99-3\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cdiv class=\"text-left sm:table-cell sm:p-2 sm:border-t sm:border-gray-300 dark:sm:border-gray-300\/20 font-medium pt-1 sm:align-top sm:w-1\/3 xl:w-1\/4\"\u003e\n\u003cstrong data-start=\"847\" data-end=\"875\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003cspan\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide.png?v=1772704738\" alt=\"Cagrilintide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/171397054#section=Structures\"\u003e\u003cspan\u003eSource: PubChem\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641876082954,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641876115722,"sku":null,"price":215.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide5mg_2.png?v=1772288882"},{"product_id":"dsip-5mg","title":"DSIP (Acetate) 5mg – Research Peptide","description":"\u003ch3 data-start=\"760\" data-end=\"817\"\u003eDSIP (Delta Sleep-Inducing Peptide) – Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"819\" data-end=\"1168\"\u003eDSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied in experimental research examining sleep-related neurophysiology, circadian signaling, and neuroendocrine regulation. Laboratory models frequently investigate its interaction with stress-associated pathways, neurotransmitter systems, and slow-wave sleep architecture.\u003c\/p\u003e\n\u003cp data-start=\"1170\" data-end=\"1254\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"1366\" data-end=\"1622\"\u003eThe peptide was originally isolated in the 1970s from cerebral venous blood of sleeping rabbits during electrophysiological studies of sleep states. Subsequent research identified similar peptide immunoreactivity in mammalian tissues, including human milk.\u003c\/p\u003e\n\u003cp data-start=\"1624\" data-end=\"1763\"\u003eExperimental observations suggest that DSIP levels follow a \u003cstrong data-start=\"1684\" data-end=\"1704\"\u003ecircadian rhythm\u003c\/strong\u003e, with measurable fluctuations across the sleep–wake cycle.\u003c\/p\u003e\n\u003ch3 data-start=\"1770\" data-end=\"1808\"\u003eDistribution and Endogenous Presence\u003c\/h3\u003e\n\u003cp data-start=\"1810\" data-end=\"1918\"\u003eDSIP-related peptide activity has been detected in several regions of the central nervous system, including:\u003c\/p\u003e\n\u003cul data-start=\"1920\" data-end=\"1998\"\u003e\n\u003cli data-start=\"1920\" data-end=\"1932\"\u003e\n\u003cp data-start=\"1922\" data-end=\"1932\"\u003ethalamus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1933\" data-end=\"1952\"\u003e\n\u003cp data-start=\"1935\" data-end=\"1952\"\u003ecerebral cortex\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1953\" data-end=\"1967\"\u003e\n\u003cp data-start=\"1955\" data-end=\"1967\"\u003ecerebellum\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1968\" data-end=\"1984\"\u003e\n\u003cp data-start=\"1970\" data-end=\"1984\"\u003ehypothalamus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1985\" data-end=\"1998\"\u003e\n\u003cp data-start=\"1987\" data-end=\"1998\"\u003ebrainstem\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2000\" data-end=\"2209\"\u003eAlthough the peptide has been studied for decades, \u003cstrong data-start=\"2051\" data-end=\"2136\"\u003eno dedicated precursor gene or specific receptor has been definitively identified\u003c\/strong\u003e, suggesting its activity may involve broader neuromodulatory mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"2211\" data-end=\"2361\"\u003eDSIP is also reported to \u003cstrong data-start=\"2236\" data-end=\"2269\"\u003ecross the blood–brain barrier\u003c\/strong\u003e, enabling investigation of central nervous system signaling effects in experimental models.\u003c\/p\u003e\n\u003ch3 data-start=\"2368\" data-end=\"2402\"\u003eMolecular and Cellular Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2404\" data-end=\"2529\"\u003eResearch suggests that DSIP acts through \u003cstrong data-start=\"2445\" data-end=\"2528\"\u003emulti-system neuromodulatory interactions rather than a single receptor pathway\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"2531\" data-end=\"2554\"\u003eGlutamatergic System\u003c\/h3\u003e\n\u003cp data-start=\"2556\" data-end=\"2917\"\u003eExperimental models indicate that DSIP may influence \u003cstrong data-start=\"2609\" data-end=\"2649\"\u003eNMDA-related glutamatergic signaling\u003c\/strong\u003e. Studies have reported reductions in NMDA-activated neuronal currents in several brain regions, including the cortex, hippocampus, thalamus, and hypothalamus. These observations are associated with changes in intracellular calcium signaling and neuronal excitability.\u003c\/p\u003e\n\u003ch3 data-start=\"2924\" data-end=\"2946\"\u003eGABAergic Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2948\" data-end=\"3155\"\u003eLaboratory studies have reported that DSIP can modulate \u003cstrong data-start=\"3004\" data-end=\"3049\"\u003eGABA-related inhibitory neurotransmission\u003c\/strong\u003e, including increased GABA-activated currents in neuronal models such as hippocampal and cerebellar cells.\u003c\/p\u003e\n\u003cp data-start=\"3157\" data-end=\"3291\"\u003eThese observations suggest a role for DSIP in research examining inhibitory–excitatory balance within central nervous system circuits.\u003c\/p\u003e\n\u003ch3 data-start=\"3298\" data-end=\"3331\"\u003eOpioid and Endorphin Signaling\u003c\/h3\u003e\n\u003cp data-start=\"3333\" data-end=\"3611\"\u003eSome experimental studies have reported interactions between DSIP signaling and \u003cstrong data-start=\"3413\" data-end=\"3442\"\u003eendogenous opioid systems\u003c\/strong\u003e, including changes in central endorphin activity. In certain models, opioid receptor antagonists have been observed to modify DSIP-related neurophysiological responses.\u003c\/p\u003e\n\u003ch3 data-start=\"3618\" data-end=\"3646\"\u003eNeuroendocrine Regulation\u003c\/h3\u003e\n\u003cp data-start=\"3648\" data-end=\"3747\"\u003eDSIP has also been examined in experimental models investigating neuroendocrine signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3749\" data-end=\"3854\"\u003eReported interactions include modulation of hypothalamic and pituitary signaling systems associated with:\u003c\/p\u003e\n\u003cul data-start=\"3856\" data-end=\"4078\"\u003e\n\u003cli data-start=\"3856\" data-end=\"3896\"\u003e\n\u003cp data-start=\"3858\" data-end=\"3896\"\u003ecorticotropin-releasing factor (CRF)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3897\" data-end=\"3935\"\u003e\n\u003cp data-start=\"3899\" data-end=\"3935\"\u003eadrenocorticotropic hormone (ACTH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3936\" data-end=\"3977\"\u003e\n\u003cp data-start=\"3938\" data-end=\"3977\"\u003egonadotropin-releasing hormone (GnRH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3978\" data-end=\"4006\"\u003e\n\u003cp data-start=\"3980\" data-end=\"4006\"\u003eluteinizing hormone (LH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4007\" data-end=\"4044\"\u003e\n\u003cp data-start=\"4009\" data-end=\"4044\"\u003ethyroid-stimulating hormone (TSH)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4045\" data-end=\"4078\"\u003e\n\u003cp data-start=\"4047\" data-end=\"4078\"\u003egrowth hormone–related pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4080\" data-end=\"4203\"\u003eThese pathways are frequently investigated in research exploring stress physiology and circadian neuroendocrine regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"4210\" data-end=\"4250\"\u003eNeurotransmitter and Monoamine Systems\u003c\/h3\u003e\n\u003cp data-start=\"4252\" data-end=\"4350\"\u003eExperimental observations suggest DSIP may influence multiple neurotransmitter systems, including:\u003c\/p\u003e\n\u003cul data-start=\"4352\" data-end=\"4465\"\u003e\n\u003cli data-start=\"4352\" data-end=\"4378\"\u003e\n\u003cp data-start=\"4354\" data-end=\"4378\"\u003edopaminergic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4379\" data-end=\"4402\"\u003e\n\u003cp data-start=\"4381\" data-end=\"4402\"\u003eadrenergic pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4403\" data-end=\"4429\"\u003e\n\u003cp data-start=\"4405\" data-end=\"4429\"\u003eserotonergic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4430\" data-end=\"4465\"\u003e\n\u003cp data-start=\"4432\" data-end=\"4465\"\u003ehistamine-related neural pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4467\" data-end=\"4591\"\u003eChanges in neuropeptides such as \u003cstrong data-start=\"4500\" data-end=\"4515\"\u003esubstance P\u003c\/strong\u003e and \u003cstrong data-start=\"4520\" data-end=\"4535\"\u003eβ-endorphin\u003c\/strong\u003e have also been reported in certain experimental models.\u003c\/p\u003e\n\u003ch3 data-start=\"4598\" data-end=\"4649\"\u003eOxidative Stress and Cellular Protection Pathways\u003c\/h3\u003e\n\u003cp data-start=\"4651\" data-end=\"4777\"\u003eSeveral studies examining neuronal stress models have reported that DSIP may influence antioxidant enzyme activity, including:\u003c\/p\u003e\n\u003cul data-start=\"4779\" data-end=\"4879\"\u003e\n\u003cli data-start=\"4779\" data-end=\"4811\"\u003e\n\u003cp data-start=\"4781\" data-end=\"4811\"\u003eglutathione peroxidase (GPx)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4812\" data-end=\"4842\"\u003e\n\u003cp data-start=\"4814\" data-end=\"4842\"\u003esuperoxide dismutase (SOD)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4843\" data-end=\"4855\"\u003e\n\u003cp data-start=\"4845\" data-end=\"4855\"\u003ecatalase\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4856\" data-end=\"4879\"\u003e\n\u003cp data-start=\"4858\" data-end=\"4879\"\u003eglutathione reductase\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4881\" data-end=\"5029\"\u003eThese mechanisms are often investigated in experimental models studying oxidative stress, mitochondrial function, and neuronal metabolic regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"5036\" data-end=\"5067\"\u003eBlood–Brain Barrier Transport\u003c\/h3\u003e\n\u003cp data-start=\"5069\" data-end=\"5262\"\u003eExperimental research suggests DSIP may utilize \u003cstrong data-start=\"5117\" data-end=\"5189\"\u003ecarrier-mediated transport mechanisms across the blood–brain barrier\u003c\/strong\u003e, including potential involvement of the choroid plexus transport system.\u003c\/p\u003e\n\u003cp data-start=\"5264\" data-end=\"5393\"\u003eSuch mechanisms are frequently studied in research examining neuropeptide transport and central nervous system peptide signaling.\u003c\/p\u003e\n\u003cp data-start=\"5264\" data-end=\"5393\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"5400\" data-end=\"5421\"\u003eProduct Information\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong data-start=\"5423\" data-end=\"5436\"\u003eSynonyms:\u003c\/strong\u003e Delta Sleep-Inducing Peptide, DSIP\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"5474\" data-end=\"5487\"\u003eSequence:\u003c\/strong\u003e Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu\u003c\/p\u003e\n\u003cp\u003e\u003cstrong data-start=\"5562\" data-end=\"5583\"\u003eMolecular Weight:\u003c\/strong\u003e ~848.8–849 Da\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e \u003c\/span\u003e\u003cspan\u003eC\u003csub\u003e35\u003c\/sub\u003eH\u003csub\u003e48\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e15\u003c\/sub\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e\u003cspan\u003e62568-57-4\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eTotal Active Ingredient:\u003c\/strong\u003e 5 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eResearch Areas Referenced in Scientific Literature\u003c\/h3\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003cp data-start=\"5683\" data-end=\"5750\"\u003eDSIP is commonly referenced in experimental research investigating:\u003c\/p\u003e\n\u003cul data-start=\"5752\" data-end=\"6009\"\u003e\n\u003cli data-start=\"5752\" data-end=\"5804\"\u003e\n\u003cp data-start=\"5754\" data-end=\"5804\"\u003esleep architecture and slow-wave sleep signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5805\" data-end=\"5836\"\u003e\n\u003cp data-start=\"5807\" data-end=\"5836\"\u003ecircadian rhythm regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5837\" data-end=\"5874\"\u003e\n\u003cp data-start=\"5839\" data-end=\"5874\"\u003eneuroendocrine signaling pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5875\" data-end=\"5925\"\u003e\n\u003cp data-start=\"5877\" data-end=\"5925\"\u003eexcitatory–inhibitory neurotransmitter balance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5926\" data-end=\"5963\"\u003e\n\u003cp data-start=\"5928\" data-end=\"5963\"\u003estress-associated neurophysiology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5964\" data-end=\"6009\"\u003e\n\u003cp data-start=\"5966\" data-end=\"6009\"\u003eoxidative stress and mitochondrial function\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStructures:\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Delta_Sleep-Inducing_Peptide.png?v=1772706239\" alt=\"DSIP structure\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/68816\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eFor a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/obsessive-compulsive-disorder-ocd-research\"\u003eOCD Circuit-Level Neurobiology Research\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4 data-start=\"206\" data-end=\"254\"\u003eNeurotrophic Peptides in Cognitive Research\u003c\/h4\u003e\n\u003cp data-start=\"256\" data-end=\"471\"\u003eDSIP is frequently discussed in research exploring sleep, recovery, and cognitive function. Learn more about related compounds in our article: \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/neurotrophic-peptides-cognitive-research\"\u003e\u003cstrong data-start=\"399\" data-end=\"470\"\u003eBest Neurotrophic Peptides for Cognitive Research and Brain Support\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641881882890,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641881915658,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/DSIP5mg_2.png?v=1772289664"},{"product_id":"semax-10mg","title":"Semax 10mg – Neuroactive Research Peptide","description":"\u003ch3 data-end=\"762\" data-start=\"735\" data-section-id=\"1lpkwfh\"\u003e\u003cstrong\u003eSemax – Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1084\" data-start=\"764\"\u003eSemax is a synthetic neuropeptide studied in experimental research models examining neurochemical signaling, neurotrophic pathway regulation, and central nervous system adaptive responses. It is frequently referenced in studies investigating BDNF expression, synaptic plasticity mechanisms, and neuroendocrine signaling.\u003c\/p\u003e\n\u003cp data-end=\"1084\" data-start=\"764\"\u003eThe peptide was originally developed as a modified analog of the \u003cstrong data-end=\"1355\" data-start=\"1332\"\u003eACTH(4-10) fragment\u003c\/strong\u003e derived from adrenocorticotropic hormone. Structural extension with the stabilizing tripeptide \u003cstrong data-end=\"1472\" data-start=\"1451\"\u003ePro-Gly-Pro (PGP)\u003c\/strong\u003e increases resistance to enzymatic degradation and improves stability in experimental delivery models.\u003c\/p\u003e\n\u003ch3 data-end=\"1611\" data-start=\"1581\" data-section-id=\"5fqgg6\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003ch3 data-end=\"1658\" data-start=\"1613\" data-section-id=\"1uxzxoy\"\u003eNeurotrophic Signaling and BDNF Regulation\u003c\/h3\u003e\n\u003cp data-end=\"1789\" data-start=\"1660\"\u003eOne of the most widely studied mechanisms of Semax involves modulation of \u003cstrong data-end=\"1778\" data-start=\"1734\"\u003ebrain-derived neurotrophic factor (BDNF)\u003c\/strong\u003e signaling.\u003c\/p\u003e\n\u003cp data-end=\"1851\" data-start=\"1791\"\u003eExperimental studies have reported that Semax can influence:\u003c\/p\u003e\n\u003cul data-end=\"1983\" data-start=\"1853\"\u003e\n\u003cli data-end=\"1880\" data-start=\"1853\" data-section-id=\"1x8ztfz\"\u003e\n\u003cp data-end=\"1880\" data-start=\"1855\"\u003eBDNF protein expression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1946\" data-start=\"1881\" data-section-id=\"1nlkjgk\"\u003e\n\u003cp data-end=\"1946\" data-start=\"1883\"\u003eBDNF mRNA transcription (including exon-specific transcripts)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1983\" data-start=\"1947\" data-section-id=\"1buidk5\"\u003e\n\u003cp data-end=\"1983\" data-start=\"1949\"\u003eTrkB receptor signaling activation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2054\" data-start=\"1985\"\u003eThese effects have been observed in several brain regions, including:\u003c\/p\u003e\n\u003cul data-end=\"2109\" data-start=\"2056\"\u003e\n\u003cli data-end=\"2071\" data-start=\"2056\" data-section-id=\"5ynrz3\"\u003e\n\u003cp data-end=\"2071\" data-start=\"2058\"\u003ehippocampus\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2091\" data-start=\"2072\" data-section-id=\"ujdhdp\"\u003e\n\u003cp data-end=\"2091\" data-start=\"2074\"\u003ebasal forebrain\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2109\" data-start=\"2092\" data-section-id=\"1khwccz\"\u003e\n\u003cp data-end=\"2109\" data-start=\"2094\"\u003ecerebral cortex\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2245\" data-start=\"2111\"\u003eActivation of \u003cstrong data-end=\"2143\" data-start=\"2125\"\u003eTrkB receptors\u003c\/strong\u003e can initiate multiple downstream signaling cascades associated with neuronal plasticity and survival.\u003c\/p\u003e\n\u003ch3 data-end=\"2296\" data-start=\"2247\" data-section-id=\"prw0u9\"\u003eKey downstream pathways investigated include:\u003c\/h3\u003e\n\u003cp data-end=\"2316\" data-start=\"2298\"\u003e\u003cstrong data-end=\"2316\" data-start=\"2298\"\u003ePLCγ signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2401\" data-start=\"2318\"\u003ePLCγ → IP3\/DAG → Ca²⁺ signaling → CaMK activation → CREB transcriptional regulation\u003c\/p\u003e\n\u003cp data-end=\"2425\" data-start=\"2403\"\u003e\u003cstrong data-end=\"2425\" data-start=\"2403\"\u003eMAPK \/ ERK pathway\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2538\" data-start=\"2427\"\u003eRas → Raf → MEK → ERK signaling, frequently associated with neuronal growth and synaptic plasticity mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"2564\" data-start=\"2540\"\u003e\u003cstrong data-end=\"2564\" data-start=\"2540\"\u003ePI3K \/ Akt signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2699\" data-start=\"2566\"\u003ePI3K\/Akt pathways are commonly investigated in research examining neuronal survival signaling and anti-apoptotic cellular mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"2827\" data-start=\"2701\"\u003eThese pathways are widely studied in experimental models exploring synaptic plasticity, neurogenesis, and neuronal adaptation.\u003c\/p\u003e\n\u003ch3 data-end=\"2870\" data-start=\"2834\" data-section-id=\"tvgtqv\"\u003eMonoamine Neurotransmitter Systems\u003c\/h3\u003e\n\u003cp data-end=\"2992\" data-start=\"2872\"\u003eSemax has also been examined in experimental research investigating \u003cstrong data-end=\"2991\" data-start=\"2940\"\u003edopaminergic and serotonergic neurotransmission\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"3039\" data-start=\"2994\"\u003ePreclinical studies have reported changes in:\u003c\/p\u003e\n\u003cul data-end=\"3209\" data-start=\"3041\"\u003e\n\u003cli data-end=\"3091\" data-start=\"3041\" data-section-id=\"1olrog\"\u003e\n\u003cp data-end=\"3091\" data-start=\"3043\"\u003edopamine release dynamics in striatal pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3139\" data-start=\"3092\" data-section-id=\"bxsajx\"\u003e\n\u003cp data-end=\"3139\" data-start=\"3094\"\u003eserotonin metabolism markers such as 5-HIAA\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3209\" data-start=\"3140\" data-section-id=\"1wtezax\"\u003e\n\u003cp data-end=\"3209\" data-start=\"3142\"\u003emonoamine signaling associated with motivation and reward circuitry\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3357\" data-start=\"3211\"\u003eThese neurotransmitter systems are frequently studied in research exploring attention, cognitive signaling pathways, and neurochemical regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"3397\" data-start=\"3364\" data-section-id=\"1wg5iy8\"\u003eMelanocortin System Interaction\u003c\/h3\u003e\n\u003cp data-end=\"3525\" data-start=\"3399\"\u003eBecause Semax is derived from an ACTH fragment, it has also been examined for its interaction with \u003cstrong data-end=\"3524\" data-start=\"3498\"\u003emelanocortin receptors\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"3781\" data-start=\"3527\"\u003eExperimental data suggest Semax may interact with \u003cstrong data-end=\"3602\" data-start=\"3577\"\u003eMC4 and MC5 receptors\u003c\/strong\u003e, influencing signaling pathways involved in stress physiology and inflammatory regulation. Many observed effects appear independent of classical melanocortin receptor activation.\u003c\/p\u003e\n\u003ch3 data-end=\"3833\" data-start=\"3788\" data-section-id=\"e76rl2\"\u003eEnkephalinase and Opioid System Interaction\u003c\/h3\u003e\n\u003cp data-end=\"3960\" data-start=\"3835\"\u003eSome experimental studies have reported that Semax may inhibit enzymes involved in the degradation of endogenous enkephalins.\u003c\/p\u003e\n\u003cp data-end=\"4106\" data-start=\"3962\"\u003eBy influencing these enzymatic pathways, Semax has been investigated in models studying endogenous opioid signaling and neuropeptide regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"4159\" data-start=\"4113\" data-section-id=\"16racw5\"\u003eGene Expression and Cellular Response Models\u003c\/h3\u003e\n\u003cp data-end=\"4298\" data-start=\"4161\"\u003eGenome-wide transcription studies in experimental models have reported that Semax may influence gene expression patterns associated with:\u003c\/p\u003e\n\u003cul data-end=\"4429\" data-start=\"4300\"\u003e\n\u003cli data-end=\"4326\" data-start=\"4300\" data-section-id=\"4k306m\"\u003e\n\u003cp data-end=\"4326\" data-start=\"4302\"\u003eneurotrophic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4357\" data-start=\"4327\" data-section-id=\"134grtj\"\u003e\n\u003cp data-end=\"4357\" data-start=\"4329\"\u003evascular response pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4395\" data-start=\"4358\" data-section-id=\"zolgl6\"\u003e\n\u003cp data-end=\"4395\" data-start=\"4360\"\u003eimmune-related gene transcription\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4429\" data-start=\"4396\" data-section-id=\"1rshgzp\"\u003e\n\u003cp data-end=\"4429\" data-start=\"4398\"\u003eneurotransmission-related genes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"4592\" data-start=\"4431\"\u003eAdditional experimental observations include modulation of oxidative stress markers, nitric-oxide signaling pathways, and calcium homeostasis in neuronal models.\u003c\/p\u003e\n\u003ch3 data-end=\"4652\" data-start=\"4599\" data-section-id=\"kh9l9u\"\u003eMetal Ion Interaction and Oxidative Stress Research\u003c\/h3\u003e\n\u003cp data-end=\"4848\" data-start=\"4654\"\u003eSome experimental studies have also reported that Semax can interact with \u003cstrong data-end=\"4755\" data-start=\"4728\"\u003emetal ions such as Cu²⁺\u003c\/strong\u003e, forming stable complexes that influence peptide stability and cellular oxidative signaling.\u003c\/p\u003e\n\u003cp data-end=\"4969\" data-start=\"4850\"\u003eThese mechanisms have been investigated in research examining oxidative stress pathways and protein aggregation models.\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eRelated Research\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eSemax is frequently examined in experimental neuroscience models exploring neurotrophic signaling, neurotransmitter regulation, and adaptive neuronal plasticity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor a deeper explanation of the peptide’s structure and signaling mechanisms, see our research overview:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-semax\"\u003e\u003cspan\u003eWhat Is Semax? Mechanism and Neurotrophic Signaling\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearchers also often compare Semax with related neuroactive peptides studied for central nervous system signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e→ \u003c\/span\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/semax-vs-selank-vs-dihexa\"\u003e\u003cspan\u003eSelank vs Semax vs Dihexa – Comparative Research Overview\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"4997\" data-start=\"4976\" data-section-id=\"15qw8x\"\u003e\n\u003cstrong\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/h3\u003e\n\u003ch3 data-end=\"4997\" data-start=\"4976\" data-section-id=\"15qw8x\"\u003e\u003cstrong\u003eProduct Information\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"5193\" data-start=\"4999\"\u003e\u003cstrong data-end=\"5012\" data-start=\"4999\"\u003eSynonyms:\u003c\/strong\u003e Semax peptide, MEHFPGP peptide\u003cbr data-end=\"5046\" data-start=\"5043\"\u003e\u003cstrong data-end=\"5059\" data-start=\"5046\"\u003eSequence:\u003c\/strong\u003e Met-Glu-His-Phe-Pro-Gly-Pro\u003cbr data-end=\"5090\" data-start=\"5087\"\u003e\u003cstrong data-end=\"5109\" data-start=\"5090\"\u003eCAS:\u003c\/strong\u003e 80714-61-0\u003cbr data-end=\"5126\" data-start=\"5123\"\u003e\u003cstrong data-end=\"5148\" data-start=\"5126\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₇H₅₁N₉O₁₀S\u003cbr data-end=\"5164\" data-start=\"5161\"\u003e\u003cstrong data-end=\"5185\" data-start=\"5164\"\u003eMolecular Weight:\u003c\/strong\u003e ~813.9 g\/mol\u003c\/p\u003e\n\u003ch3 data-end=\"5252\" data-start=\"5200\" data-section-id=\"orlbwh\"\u003eResearch Areas Referenced in Scientific Literature\u003c\/h3\u003e\n\u003cp data-end=\"5324\" data-start=\"5254\"\u003eSemax is frequently referenced in experimental research investigating:\u003c\/p\u003e\n\u003cul data-end=\"5536\" data-start=\"5326\"\u003e\n\u003cli data-end=\"5361\" data-start=\"5326\" data-section-id=\"sec8a3\"\u003e\n\u003cp data-end=\"5361\" data-start=\"5328\"\u003eBDNF and neurotrophic signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5408\" data-start=\"5362\" data-section-id=\"b1t26a\"\u003e\n\u003cp data-end=\"5408\" data-start=\"5364\"\u003esynaptic plasticity and neuronal signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5450\" data-start=\"5409\" data-section-id=\"s67sr\"\u003e\n\u003cp data-end=\"5450\" data-start=\"5411\"\u003emonoamine neurotransmitter regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5485\" data-start=\"5451\" data-section-id=\"1t90rwd\"\u003e\n\u003cp data-end=\"5485\" data-start=\"5453\"\u003emelanocortin pathway signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5536\" data-start=\"5486\" data-section-id=\"mb3sip\"\u003e\n\u003cp data-end=\"5536\" data-start=\"5488\"\u003eoxidative stress and neuronal metabolic pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\u003cspan class=\"flex-1\"\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg style=\"margin-bottom: 16px; float: none;\" alt=\"semax Structures\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/semax.png?v=1772792942\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9811102\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641701986570,"sku":null,"price":120.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641702019338,"sku":null,"price":145.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Semax10mg_2.png?v=1772290152"},{"product_id":"kpv-10mg","title":"KPV 10mg – Research Peptide","description":"\u003ch3 data-start=\"393\" data-end=\"426\"\u003e\u003cstrong\u003eKPV Peptide – Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"428\" data-end=\"723\"\u003eKPV is the C-terminal tripeptide fragment (amino acids 11–13) of the α-melanocyte-stimulating hormone (α-MSH) sequence. This short peptide retains key regulatory signaling characteristics associated with the parent hormone while lacking the melanotropic activity linked to pigmentation pathways.\u003c\/p\u003e\n\u003cp data-start=\"725\" data-end=\"916\"\u003eIn experimental literature, KPV is primarily examined for its interaction with inflammatory signaling networks, particularly pathways associated with NF-κB activation and cytokine regulation.\u003c\/p\u003e\n\u003ch3 data-start=\"923\" data-end=\"953\"\u003eMolecular Mechanism Research\u003c\/h3\u003e\n\u003cp data-start=\"955\" data-end=\"973\"\u003e\u003cstrong\u003eCellular Uptake\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"975\" data-end=\"1292\"\u003eIn experimental models involving intestinal epithelial and immune cells, KPV can be transported intracellularly via the \u003cstrong data-start=\"1095\" data-end=\"1138\"\u003ePepT1 (hPepT1) oligopeptide transporter\u003c\/strong\u003e. This transporter is often upregulated in inflamed intestinal tissues and facilitates the uptake of small di- and tripeptides across epithelial barriers.\u003c\/p\u003e\n\u003cp data-start=\"1294\" data-end=\"1447\"\u003eBecause of this transporter interaction, KPV is frequently investigated in research examining intestinal peptide absorption and mucosal immune signaling.\u003c\/p\u003e\n\u003cp data-start=\"1454\" data-end=\"1482\"\u003e\u003cstrong\u003eNF-κB Pathway Interaction\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1484\" data-end=\"1680\"\u003eOne of the most widely discussed mechanisms of KPV in experimental literature involves its interaction with the \u003cstrong data-start=\"1596\" data-end=\"1623\"\u003eNF-κB signaling pathway\u003c\/strong\u003e, a central regulator of inflammatory gene transcription.\u003c\/p\u003e\n\u003cp data-start=\"1682\" data-end=\"1743\"\u003eResearch observations suggest several molecular interactions:\u003c\/p\u003e\n\u003cp data-start=\"1745\" data-end=\"1916\"\u003e• \u003cstrong data-start=\"1747\" data-end=\"1769\"\u003eIκBα stabilization\u003c\/strong\u003e – KPV has been associated with delayed degradation and accelerated recovery of IκBα, the inhibitory protein that retains NF-κB in the cytoplasm.\u003c\/p\u003e\n\u003cp data-start=\"1918\" data-end=\"2184\"\u003e• \u003cstrong data-start=\"1920\" data-end=\"1956\"\u003eNuclear translocation modulation\u003c\/strong\u003e – experimental data indicate that KPV may interfere with the interaction between the p65RelA NF-κB subunit and nuclear transport proteins such as importin-α3. This interaction can influence NF-κB nuclear translocation dynamics.\u003c\/p\u003e\n\u003cp data-start=\"2186\" data-end=\"2333\"\u003e• \u003cstrong data-start=\"2188\" data-end=\"2224\"\u003eReduced NF-κB signaling duration\u003c\/strong\u003e – rather than fully suppressing the pathway, KPV is associated with modulation of NF-κB activation dynamics.\u003c\/p\u003e\n\u003cp data-start=\"2335\" data-end=\"2454\"\u003eDownstream effects reported in experimental studies include changes in transcription of cytokine-related genes such as:\u003c\/p\u003e\n\u003cul data-start=\"2456\" data-end=\"2503\"\u003e\n\u003cli data-start=\"2456\" data-end=\"2465\"\u003e\n\u003cp data-start=\"2458\" data-end=\"2465\"\u003eTNF-α\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2466\" data-end=\"2475\"\u003e\n\u003cp data-start=\"2468\" data-end=\"2475\"\u003eIL-1β\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2476\" data-end=\"2484\"\u003e\n\u003cp data-start=\"2478\" data-end=\"2484\"\u003eIL-6\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2485\" data-end=\"2493\"\u003e\n\u003cp data-start=\"2487\" data-end=\"2493\"\u003eIL-8\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2494\" data-end=\"2503\"\u003e\n\u003cp data-start=\"2496\" data-end=\"2503\"\u003eMCP-1\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2505\" data-end=\"2619\"\u003eThese observations have made KPV a subject of interest in research examining cytokine-mediated signaling networks.\u003c\/p\u003e\n\u003ch3 data-start=\"2626\" data-end=\"2658\"\u003eAdditional Signaling Pathways\u003c\/h3\u003e\n\u003cp data-start=\"2660\" data-end=\"2799\"\u003eBeyond NF-κB-related signaling, some experimental models have reported interactions between KPV and \u003cstrong data-start=\"2760\" data-end=\"2787\"\u003eMAPK signaling cascades\u003c\/strong\u003e, including:\u003c\/p\u003e\n\u003cul data-start=\"2801\" data-end=\"2827\"\u003e\n\u003cli data-start=\"2801\" data-end=\"2811\"\u003e\n\u003cp data-start=\"2803\" data-end=\"2811\"\u003eERK1\/2\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2812\" data-end=\"2819\"\u003e\n\u003cp data-start=\"2814\" data-end=\"2819\"\u003eJNK\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2820\" data-end=\"2827\"\u003e\n\u003cp data-start=\"2822\" data-end=\"2827\"\u003ep38\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2829\" data-end=\"2976\"\u003eThese pathways are frequently investigated in studies examining cellular stress responses, cytokine signaling, and inflammatory pathway regulation.\u003c\/p\u003e\n\u003cp data-start=\"2978\" data-end=\"3217\"\u003eIn certain cell systems, particularly airway or skin models, limited evidence suggests involvement of melanocortin receptors such as \u003cstrong data-start=\"3111\" data-end=\"3119\"\u003eMC3R\u003c\/strong\u003e, although many reported effects appear independent of classical melanocortin receptor activation.\u003c\/p\u003e\n\u003ch3 data-start=\"3224\" data-end=\"3255\"\u003eExperimental Research Context\u003c\/h3\u003e\n\u003cp data-start=\"3257\" data-end=\"3290\"\u003e\u003cstrong\u003eIntestinal Inflammation Models\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"3292\" data-end=\"3565\"\u003eKPV is frequently investigated in preclinical intestinal inflammation models, including DSS and TNBS-induced colitis systems. In these models, experimental observations have reported changes in cytokine signaling, neutrophil infiltration, and inflammatory pathway activity.\u003c\/p\u003e\n\u003cp data-start=\"3567\" data-end=\"3684\"\u003eBecause KPV interacts with the PepT1 transporter in intestinal tissue, it is commonly examined in research exploring:\u003c\/p\u003e\n\u003cul data-start=\"3686\" data-end=\"3812\"\u003e\n\u003cli data-start=\"3686\" data-end=\"3718\"\u003e\n\u003cp data-start=\"3688\" data-end=\"3718\"\u003eepithelial barrier signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3719\" data-end=\"3748\"\u003e\n\u003cp data-start=\"3721\" data-end=\"3748\"\u003emucosal immune regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3749\" data-end=\"3781\"\u003e\n\u003cp data-start=\"3751\" data-end=\"3781\"\u003eintestinal cytokine networks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3782\" data-end=\"3812\"\u003e\n\u003cp data-start=\"3784\" data-end=\"3812\"\u003epeptide transporter dynamics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3819\" data-end=\"3862\"\u003e\u003cstrong\u003eSkin and Cellular Inflammatory Signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"3864\" data-end=\"4013\"\u003eCell culture studies have reported that KPV can influence \u003cstrong data-start=\"3922\" data-end=\"3972\"\u003eTNF-α-mediated signaling and ICAM-1 expression\u003c\/strong\u003e in dermal fibroblasts and keratinocytes.\u003c\/p\u003e\n\u003cp data-start=\"4015\" data-end=\"4148\"\u003eThese mechanisms are typically examined in laboratory models studying inflammatory signaling pathways in skin and epithelial tissues.\u003c\/p\u003e\n\u003cp data-start=\"4155\" data-end=\"4197\"\u003e\u003cstrong\u003eNeuroimmune and Gut–Brain Axis Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"4199\" data-end=\"4328\"\u003eInteractions between intestinal immune signaling and the nervous system are increasingly investigated in gut–brain axis research.\u003c\/p\u003e\n\u003cp data-start=\"4330\" data-end=\"4645\"\u003eChanges in cytokine signaling and epithelial barrier dynamics may influence vagal nerve pathways and systemic inflammatory signaling. Within this framework, peptides derived from melanocortin signaling systems, including KPV, are occasionally examined in experimental models investigating neuroimmune communication.\u003c\/p\u003e\n\u003ch3 data-start=\"4652\" data-end=\"4685\"\u003eTransport and Delivery Research\u003c\/h3\u003e\n\u003cp data-start=\"4687\" data-end=\"4879\"\u003eDue to its small tripeptide structure, KPV is capable of interacting with peptide transport systems such as \u003cstrong data-start=\"4795\" data-end=\"4804\"\u003ePepT1\u003c\/strong\u003e, which mediates the uptake of small peptides in the intestinal epithelium.\u003c\/p\u003e\n\u003cp data-start=\"4881\" data-end=\"5034\"\u003eFor this reason, oral capsule formats are often used in experimental settings investigating intestinal peptide transport and localized mucosal signaling.\u003c\/p\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eUnderstand KPV in Gut and Inflammation Research\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eKPV is widely studied in research models focused on inflammation signaling and epithelial cellular environments, particularly within gut-associated systems. Its interaction with pathways such as NF-κB makes it relevant in studies exploring how localized inflammation and cellular communication are regulated.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eTo see how KPV is examined alongside other compounds in gut and immune signaling research:\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003cstrong\u003eGut Health and Inflammation Research: KPV, BPC-157, and Thymosin Alpha-1\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eFor a deeper scientific overview of its mechanism, pathways, and research applications:\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cstrong\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/gut-health-and-inflammation-kpv-bpc-157-thymosin-alpha-1\"\u003e\u003c\/a\u003e\u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-kpv\"\u003eWhat is KPV? - NF-κB Signaling and Inflammation Research Explained\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-start=\"5041\" data-end=\"5062\"\u003eProduct Information\u003c\/h3\u003e\n\u003cp data-start=\"5064\" data-end=\"5213\"\u003e\u003cstrong data-start=\"5064\" data-end=\"5077\"\u003eSynonyms:\u003c\/strong\u003e Lys-Pro-Val peptide, KPV peptide\u003cbr data-start=\"5138\" data-end=\"5141\"\u003e\u003cstrong data-start=\"5141\" data-end=\"5163\"\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003c\/span\u003e\u003csub\u003e16\u003c\/sub\u003e\u003cspan\u003eH\u003c\/span\u003e\u003csub\u003e30\u003c\/sub\u003e\u003cspan\u003eN\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003eO\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cbr data-start=\"5174\" data-end=\"5177\"\u003e\u003cstrong data-start=\"5177\" data-end=\"5198\"\u003eMolecular Weight:\u003c\/strong\u003e \u003cspan\u003e342.43\u003c\/span\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003eg\/mol\u003cbr\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e67727-97-3\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-start=\"5220\" data-end=\"5261\"\u003eResearch Areas Referenced in Literature\u003c\/h3\u003e\n\u003cp data-start=\"5263\" data-end=\"5318\"\u003eExperimental studies have discussed KPV in relation to:\u003c\/p\u003e\n\u003cul data-start=\"5320\" data-end=\"5525\"\u003e\n\u003cli data-start=\"5320\" data-end=\"5348\"\u003e\n\u003cp data-start=\"5322\" data-end=\"5348\"\u003eNF-κB signaling pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5349\" data-end=\"5381\"\u003e\n\u003cp data-start=\"5351\" data-end=\"5381\"\u003ecytokine regulation networks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5382\" data-end=\"5412\"\u003e\n\u003cp data-start=\"5384\" data-end=\"5412\"\u003eepithelial barrier biology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5413\" data-end=\"5455\"\u003e\n\u003cp data-start=\"5415\" data-end=\"5455\"\u003emelanocortin-related peptide signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5456\" data-end=\"5490\"\u003e\n\u003cp data-start=\"5458\" data-end=\"5490\"\u003eintestinal transporter systems\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5491\" data-end=\"5525\"\u003e\n\u003cp data-start=\"5493\" data-end=\"5525\"\u003eneuroimmune communication models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKPV Structures: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv style=\"text-align: left;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Kpv_structure.png?v=1772702715\" alt=\"KPV peptide Structures\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/125672\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641930707210,"sku":null,"price":130.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641930739978,"sku":null,"price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/KPV10mg_2.png?v=1772291130"},{"product_id":"larazotide-20mg","title":"Larazotide 20mg – Research Peptide","description":"\u003ch3 data-section-id=\"5phdk4\" data-start=\"354\" data-end=\"431\"\u003eLarazotide Acetate – Intestinal Barrier and Tight Junction Research Peptide\u003c\/h3\u003e\n\u003ch3 data-section-id=\"cibsat\" data-start=\"433\" data-end=\"445\"\u003eOverview\u003c\/h3\u003e\n\u003cp data-start=\"447\" data-end=\"672\"\u003eLarazotide acetate (AT-1001) is a synthetic 8-amino-acid peptide (sequence: Gly-Gly-Val-Leu-Val-Gln-Pro-Gly; GGVLVQPG) investigated in research models of intestinal barrier regulation and epithelial tight junction dynamics.\u003c\/p\u003e\n\u003cp data-start=\"674\" data-end=\"862\"\u003eIt is commonly referenced in studies examining zonulin-associated signaling pathways and the molecular mechanisms that influence paracellular permeability within the intestinal epithelium.\u003c\/p\u003e\n\u003cp data-start=\"864\" data-end=\"1046\"\u003eUnlike many systemically active peptides, larazotide is designed to act primarily within the intestinal lumen, where it interacts locally with epithelial barrier signaling processes.\u003c\/p\u003e\n\u003ch3 data-section-id=\"o4rtew\" data-start=\"1053\" data-end=\"1084\"\u003eMolecular Mechanism of Action\u003c\/h3\u003e\n\u003cp data-start=\"1086\" data-end=\"1263\"\u003eLarazotide is studied as a \u003cstrong data-start=\"1113\" data-end=\"1172\"\u003ecompetitive antagonist of the zonulin signaling pathway\u003c\/strong\u003e, a regulatory system involved in the modulation of epithelial tight junction permeability.\u003c\/p\u003e\n\u003ch3 data-section-id=\"vmv2z6\" data-start=\"1265\" data-end=\"1305\"\u003eZonulin-Associated Signaling Cascade\u003c\/h3\u003e\n\u003cp data-start=\"1307\" data-end=\"1526\"\u003eIn experimental models, intestinal permeability can increase when zonulin is released by enterocytes in response to environmental triggers such as microbial products, inflammatory cytokines, or certain dietary peptides.\u003c\/p\u003e\n\u003cp data-start=\"1528\" data-end=\"1571\"\u003eThe pathway proceeds through several steps:\u003c\/p\u003e\n\u003col data-start=\"1573\" data-end=\"1595\"\u003e\n\u003cli data-section-id=\"qd2dee\" data-start=\"1573\" data-end=\"1595\"\u003e\n\u003cp data-start=\"1576\" data-end=\"1595\"\u003e\u003cstrong data-start=\"1576\" data-end=\"1595\"\u003eZonulin release\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"1597\" data-end=\"1745\"\u003eCertain luminal stimuli activate CXCR3-MyD88 signaling in enterocytes, leading to secretion of zonulin (prehaptoglobin-2) into the intestinal lumen.\u003c\/p\u003e\n\u003col start=\"2\" data-start=\"1747\" data-end=\"1774\"\u003e\n\u003cli data-section-id=\"1lol22z\" data-start=\"1747\" data-end=\"1774\"\u003e\n\u003cp data-start=\"1750\" data-end=\"1774\"\u003e\u003cstrong data-start=\"1750\" data-end=\"1774\"\u003eReceptor interaction\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"1776\" data-end=\"1986\"\u003eZonulin binds to receptors on the \u003cstrong data-start=\"1810\" data-end=\"1844\"\u003eapical membrane of enterocytes\u003c\/strong\u003e, particularly \u003cstrong data-start=\"1859\" data-end=\"1899\"\u003eprotease-activated receptor-2 (PAR2)\u003c\/strong\u003e, which can subsequently transactivate the \u003cstrong data-start=\"1942\" data-end=\"1985\"\u003eepidermal growth factor receptor (EGFR)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003col start=\"3\" data-start=\"1988\" data-end=\"2029\"\u003e\n\u003cli data-section-id=\"19celmm\" data-start=\"1988\" data-end=\"2029\"\u003e\n\u003cp data-start=\"1991\" data-end=\"2029\"\u003e\u003cstrong data-start=\"1991\" data-end=\"2029\"\u003eIntracellular signaling activation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2031\" data-end=\"2092\"\u003eThis interaction activates phospholipase C (PLC), leading to:\u003c\/p\u003e\n\u003cul data-start=\"2094\" data-end=\"2196\"\u003e\n\u003cli data-section-id=\"47notx\" data-start=\"2094\" data-end=\"2119\"\u003e\n\u003cp data-start=\"2096\" data-end=\"2119\"\u003eIP3 and DAG signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"awcxnp\" data-start=\"2120\" data-end=\"2155\"\u003e\n\u003cp data-start=\"2122\" data-end=\"2155\"\u003eintracellular Ca²⁺ mobilization\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"16y0kun\" data-start=\"2156\" data-end=\"2196\"\u003e\n\u003cp data-start=\"2158\" data-end=\"2196\"\u003eactivation of protein kinase Cα (PKCα)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col start=\"4\" data-start=\"2198\" data-end=\"2228\"\u003e\n\u003cli data-section-id=\"1025c4r\" data-start=\"2198\" data-end=\"2228\"\u003e\n\u003cp data-start=\"2201\" data-end=\"2228\"\u003e\u003cstrong data-start=\"2201\" data-end=\"2228\"\u003eCytoskeletal remodeling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2230\" data-end=\"2260\"\u003eDownstream signaling promotes:\u003c\/p\u003e\n\u003cul data-start=\"2262\" data-end=\"2392\"\u003e\n\u003cli data-section-id=\"16ahnd7\" data-start=\"2262\" data-end=\"2336\"\u003e\n\u003cp data-start=\"2264\" data-end=\"2336\"\u003ephosphorylation of \u003cstrong data-start=\"2283\" data-end=\"2311\"\u003emyosin light chain (MLC)\u003c\/strong\u003e via MLCK\/ROCK pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1qsdsjv\" data-start=\"2337\" data-end=\"2392\"\u003e\n\u003cp data-start=\"2339\" data-end=\"2392\"\u003econtraction of the \u003cstrong data-start=\"2358\" data-end=\"2392\"\u003eperijunctional actomyosin ring\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col start=\"5\" data-start=\"2394\" data-end=\"2429\"\u003e\n\u003cli data-section-id=\"v9ze9r\" data-start=\"2394\" data-end=\"2429\"\u003e\n\u003cp data-start=\"2397\" data-end=\"2429\"\u003e\u003cstrong data-start=\"2397\" data-end=\"2429\"\u003eTight junction rearrangement\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-start=\"2431\" data-end=\"2514\"\u003eThis process can result in redistribution of key tight junction proteins including:\u003c\/p\u003e\n\u003cul data-start=\"2516\" data-end=\"2579\"\u003e\n\u003cli data-section-id=\"132jsld\" data-start=\"2516\" data-end=\"2528\"\u003e\n\u003cp data-start=\"2518\" data-end=\"2528\"\u003e\u003cstrong data-start=\"2518\" data-end=\"2526\"\u003eZO-1\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1ln1t31\" data-start=\"2529\" data-end=\"2545\"\u003e\n\u003cp data-start=\"2531\" data-end=\"2545\"\u003e\u003cstrong data-start=\"2531\" data-end=\"2543\"\u003eoccludin\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"yz2n4z\" data-start=\"2546\" data-end=\"2562\"\u003e\n\u003cp data-start=\"2548\" data-end=\"2562\"\u003e\u003cstrong data-start=\"2548\" data-end=\"2560\"\u003eclaudins\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"cj802m\" data-start=\"2563\" data-end=\"2579\"\u003e\n\u003cp data-start=\"2565\" data-end=\"2579\"\u003e\u003cstrong data-start=\"2565\" data-end=\"2579\"\u003eE-cadherin\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2581\" data-end=\"2740\"\u003eThe resulting structural changes may increase \u003cstrong data-start=\"2627\" data-end=\"2656\"\u003eparacellular permeability\u003c\/strong\u003e, allowing macromolecules or luminal antigens to pass across the epithelial barrier.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1m23dbz\" data-start=\"2747\" data-end=\"2801\"\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2928\" data-end=\"2977\"\u003e \u003c\/p\u003e\n\u003ch3 data-section-id=\"x0xfe9\" data-start=\"3706\" data-end=\"3754\"\u003eFindings from Cellular and Experimental Models\u003c\/h3\u003e\n\u003cp data-start=\"3756\" data-end=\"3954\"\u003eIn commonly used epithelial cell models (including \u003cstrong data-start=\"3807\" data-end=\"3856\"\u003eCaco-2, MDCK, IEC-6, and intestinal organoids\u003c\/strong\u003e), larazotide exposure has been associated with measurable changes in barrier function indicators:\u003c\/p\u003e\n\u003cp data-start=\"3956\" data-end=\"4186\"\u003e• Increased \u003cstrong data-start=\"3968\" data-end=\"4016\"\u003etransepithelial electrical resistance (TEER)\u003c\/strong\u003e\u003cbr data-start=\"4016\" data-end=\"4019\"\u003e• Reduced \u003cstrong data-start=\"4029\" data-end=\"4068\"\u003eparacellular flux of macromolecules\u003c\/strong\u003e (e.g., FITC-dextran)\u003cbr data-start=\"4089\" data-end=\"4092\"\u003e• Preservation of tight junction protein localization during inflammatory or stress conditions\u003c\/p\u003e\n\u003cp data-start=\"4188\" data-end=\"4292\"\u003eThese findings have positioned larazotide as a compound frequently used in laboratory studies exploring:\u003c\/p\u003e\n\u003cul data-start=\"4294\" data-end=\"4416\"\u003e\n\u003cli data-section-id=\"wf19nu\" data-start=\"4294\" data-end=\"4332\"\u003e\n\u003cp data-start=\"4296\" data-end=\"4332\"\u003eintestinal permeability regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"q1q9q\" data-start=\"4333\" data-end=\"4364\"\u003e\n\u003cp data-start=\"4335\" data-end=\"4364\"\u003eepithelial barrier dynamics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1a2efgc\" data-start=\"4365\" data-end=\"4416\"\u003e\n\u003cp data-start=\"4367\" data-end=\"4416\"\u003eimmune-epithelial interaction at mucosal surfaces\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-section-id=\"zlqbtv\" data-start=\"4423\" data-end=\"4475\"\u003eResearch Context: Gut Barrier and Immune Signaling\u003c\/h3\u003e\n\u003cp data-start=\"4477\" data-end=\"4655\"\u003eBarrier integrity of the intestinal epithelium is increasingly studied as an important interface between microbial exposure, immune signaling, and systemic inflammatory pathways.\u003c\/p\u003e\n\u003cp data-start=\"4657\" data-end=\"4754\"\u003eExperimental literature has explored whether modulation of epithelial permeability may influence:\u003c\/p\u003e\n\u003cul data-start=\"4756\" data-end=\"4872\"\u003e\n\u003cli data-section-id=\"16pt98t\" data-start=\"4756\" data-end=\"4791\"\u003e\n\u003cp data-start=\"4758\" data-end=\"4791\"\u003emicrobial antigen translocation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"u2819a\" data-start=\"4792\" data-end=\"4814\"\u003e\n\u003cp data-start=\"4794\" data-end=\"4814\"\u003ecytokine signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"1ainr7i\" data-start=\"4815\" data-end=\"4872\"\u003e\n\u003cp data-start=\"4817\" data-end=\"4872\"\u003eimmune cell trafficking from the intestinal environment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4874\" data-end=\"5121\"\u003eAnimal studies investigating autoimmune and inflammatory models have reported that restoration of epithelial barrier integrity can influence systemic immune responses, including modulation of T-cell populations and inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"5123\" data-end=\"5261\"\u003eLarazotide has therefore been examined in research settings focused on \u003cstrong data-start=\"5194\" data-end=\"5226\"\u003egut-immune axis interactions\u003c\/strong\u003e and epithelial barrier regulation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6tnc4l\" data-start=\"5268\" data-end=\"5298\"\u003eClinical Development Context\u003c\/h3\u003e\n\u003cp data-start=\"5300\" data-end=\"5425\"\u003eLarazotide acetate has been investigated in multiple clinical research programs examining intestinal permeability modulation.\u003c\/p\u003e\n\u003cp data-start=\"5427\" data-end=\"5500\"\u003eClinical trials have primarily explored larazotide in contexts involving:\u003c\/p\u003e\n\u003cul data-start=\"5502\" data-end=\"5619\"\u003e\n\u003cli data-section-id=\"1fbr3ro\" data-start=\"5502\" data-end=\"5536\"\u003e\n\u003cp data-start=\"5504\" data-end=\"5536\"\u003eepithelial barrier dysfunction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"b67wo0\" data-start=\"5537\" data-end=\"5580\"\u003e\n\u003cp data-start=\"5539\" data-end=\"5580\"\u003egluten-triggered permeability responses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"15p3k4o\" data-start=\"5581\" data-end=\"5619\"\u003e\n\u003cp data-start=\"5583\" data-end=\"5619\"\u003einflammatory intestinal environments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"5621\" data-end=\"5796\"\u003eAcross published studies, larazotide has demonstrated a \u003cstrong data-start=\"5677\" data-end=\"5739\"\u003efavorable safety profile and localized mechanism of action\u003c\/strong\u003e, consistent with its design as a gut-restricted peptide.\u003c\/p\u003e\n\u003cp data-start=\"5798\" data-end=\"5929\"\u003eThe compound remains \u003cstrong data-start=\"5819\" data-end=\"5862\"\u003einvestigational and under ongoing study\u003c\/strong\u003e in several research programs examining epithelial barrier biology.\u003c\/p\u003e\n\u003ch3 data-section-id=\"15vs70q\" data-start=\"5936\" data-end=\"5963\"\u003eMolecular Characteristics\u003c\/h3\u003e\n\u003cp data-start=\"5965\" data-end=\"6234\"\u003e\u003cstrong data-start=\"5965\" data-end=\"5978\"\u003eSynonyms:\u003c\/strong\u003e Larazotide acetate, AT-1001\u003cbr data-start=\"6006\" data-end=\"6009\"\u003e\u003cstrong data-start=\"6009\" data-end=\"6030\"\u003ePeptide Sequence:\u003c\/strong\u003e Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (GGVLVQPG)\u003cbr data-start=\"6073\" data-end=\"6076\"\u003e\u003cstrong data-start=\"6076\" data-end=\"6098\"\u003eMolecular Formula:\u003c\/strong\u003e C₃₂H₅₅N₉O₁₀\u003cbr data-start=\"6110\" data-end=\"6113\"\u003e\u003cstrong data-start=\"6113\" data-end=\"6146\"\u003eMolecular Weight:\u003c\/strong\u003e ~725.8 g\/mol\u003cbr\u003e\u003cstrong\u003eCAS: \u003c\/strong\u003e258818-34-7\u003c\/p\u003e\n\u003ch3 class=\"flex items-end font-medium leading-tight break-words text-2xl lg:text-3xl\"\u003e\u003cspan class=\"flex-1\"\u003eStructures:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Larazotide.png?v=1772793744\" alt=\"Larazotide structure\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003cdiv style=\"text-align: start;\"\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9810532\"\u003eSource: PubChem\u003c\/a\u003e\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641934672138,"sku":null,"price":240.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641934704906,"sku":null,"price":265.0,"currency_code":"EUR","in_stock":true},{"title":"Capsules","offer_id":53149016391946,"sku":null,"price":290.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Larazotide20mg_4_1.png?v=1780478333"},{"product_id":"thymulin-20mg","title":"Thymulin 20mg – Research Peptide","description":"\u003cdiv style=\"text-align: start;\"\u003e\n\u003ch3 data-end=\"355\" data-start=\"283\" data-section-id=\"1xsa5r5\"\u003eThymulin – Zinc-Dependent Thymic Peptide for Immune Signaling Research\u003c\/h3\u003e\n\u003ch3 data-end=\"368\" data-start=\"357\" data-section-id=\"rzkdgm\"\u003eOverview\u003c\/h3\u003e\n\u003cp data-end=\"709\" data-start=\"370\"\u003eThymulin, also known as serum thymic factor (FTS), is a naturally occurring zinc-dependent nonapeptide hormone produced by thymic epithelial cells. In research settings, thymulin is frequently studied as a regulatory signal involved in T-cell differentiation, immune signaling coordination, and immune–neuroendocrine communication.\u003c\/p\u003e\n\u003cp data-end=\"1039\" data-start=\"711\"\u003eUnlike broader thymic peptide extracts such as thymalin, which contain multiple short peptides, thymulin represents a single, well-defined regulatory molecule. Its activity depends on complex formation with zinc ions (Zn²⁺), which induces a structural conformation required for receptor interaction and biological signaling.\u003c\/p\u003e\n\u003cp data-end=\"1233\" data-start=\"1041\"\u003eBecause of its highly specific signaling profile, thymulin is commonly examined in laboratory models investigating immune maturation, cytokine balance, and immune–brain axis communication.\u003c\/p\u003e\n\u003cp data-end=\"1586\" data-start=\"1373\"\u003eThe peptide alone exists in an apo-form that is biologically inactive. Binding to equimolar zinc ions produces the active metallopeptide complex capable of interacting with thymocyte and immune cell receptors.\u003c\/p\u003e\n\u003cp data-end=\"1782\" data-start=\"1588\"\u003eThis zinc-dependent structural activation distinguishes thymulin from many other thymic peptides and contributes to its role as a precise regulatory signal within immune maturation pathways.\u003c\/p\u003e\n\u003ch3 data-end=\"1869\" data-start=\"1823\" data-section-id=\"6bd1ur\"\u003eInteraction with T-Cell Development Pathways\u003c\/h3\u003e\n\u003cp data-end=\"1976\" data-start=\"1871\"\u003eThymulin has been extensively studied in models of T-lymphocyte differentiation and thymic signaling.\u003c\/p\u003e\n\u003cp data-end=\"2085\" data-start=\"1978\"\u003eExperimental findings suggest that thymulin participates in several processes related to T-cell maturation:\u003c\/p\u003e\n\u003cp data-end=\"2356\" data-start=\"2087\"\u003e• differentiation of bone-marrow-derived prothymocytes into mature T-lymphocytes\u003cbr data-end=\"2174\" data-start=\"2171\"\u003e• regulation of T-cell surface markers including CD3, CD4, CD8, and CD90 (Thy-1)\u003cbr data-end=\"2261\" data-start=\"2258\"\u003e• modulation of functional activity in helper, cytotoxic, and regulatory T-cell populations\u003c\/p\u003e\n\u003cp data-end=\"2539\" data-start=\"2358\"\u003eResearch models have also examined thymulin’s potential influence on Foxp3-positive regulatory T-cell development, which plays an important role in maintaining immune tolerance.\u003c\/p\u003e\n\u003cp data-end=\"2682\" data-start=\"2541\"\u003eIn addition, thymulin signaling has been associated with modulation of natural killer (NK) cell activity in certain experimental systems.\u003c\/p\u003e\n\u003ch3 data-end=\"2731\" data-start=\"2689\" data-section-id=\"7kso8o\"\u003eCytokine Signaling and Immune Regulation\u003c\/h3\u003e\n\u003cp data-end=\"2870\" data-start=\"2733\"\u003eThymulin has been studied for its role in coordinating pro- and anti-inflammatory cytokine networks within immune signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"3019\" data-start=\"2872\"\u003eIn laboratory models, thymulin exposure has been associated with balanced expression of cytokines involved in adaptive immune responses, including:\u003c\/p\u003e\n\u003cp data-end=\"3049\" data-start=\"3021\"\u003e• IL-2\u003cbr data-end=\"3030\" data-start=\"3027\"\u003e• IFN-γ\u003cbr data-end=\"3040\" data-start=\"3037\"\u003e• IL-10\u003c\/p\u003e\n\u003cp data-end=\"3122\" data-start=\"3051\"\u003ewhile modulating excessive signaling of inflammatory mediators such as:\u003c\/p\u003e\n\u003cp data-end=\"3149\" data-start=\"3124\"\u003e• IL-1\u003cbr data-end=\"3133\" data-start=\"3130\"\u003e• IL-6\u003cbr data-end=\"3142\" data-start=\"3139\"\u003e• TNF-α\u003c\/p\u003e\n\u003cp data-end=\"3300\" data-start=\"3151\"\u003eThese findings have positioned thymulin as a compound of interest in research exploring immune system regulation and cytokine signaling dynamics.\u003c\/p\u003e\n\u003ch3 data-end=\"3354\" data-start=\"3307\" data-section-id=\"efvsnp\"\u003eNeuroendocrine and Immune–Brain Axis Research\u003c\/h3\u003e\n\u003cp data-end=\"3460\" data-start=\"3356\"\u003eThymulin is notable among thymic peptides for its interaction with neuroendocrine signaling systems.\u003c\/p\u003e\n\u003cp data-end=\"3661\" data-start=\"3462\"\u003eExperimental literature has described bidirectional communication between the thymus and the hypothalamic–pituitary axis, with thymulin participating in signaling pathways involving hormones such as:\u003c\/p\u003e\n\u003cp data-end=\"3722\" data-start=\"3663\"\u003e• growth hormone (GH)\u003cbr data-end=\"3687\" data-start=\"3684\"\u003e• prolactin\u003cbr data-end=\"3701\" data-start=\"3698\"\u003e• ACTH\u003cbr data-end=\"3710\" data-start=\"3707\"\u003e• TSH\u003cbr data-end=\"3718\" data-start=\"3715\"\u003e• LH\u003c\/p\u003e\n\u003cp data-end=\"3894\" data-start=\"3724\"\u003eStudies have also explored thymulin’s presence in central nervous system environments, including its interaction with glial cells and inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-end=\"4117\" data-start=\"3896\"\u003eIn neuroinflammatory research models, thymulin has been observed to influence pathways associated with NF-κB signaling in neural tissues, suggesting potential relevance in investigations of immune–brain communication.\u003c\/p\u003e\n\u003ch3 data-end=\"4154\" data-start=\"4124\" data-section-id=\"1hfvtej\"\u003eAge-Related Thymic Signaling\u003c\/h3\u003e\n\u003cp data-end=\"4321\" data-start=\"4156\"\u003eCirculating thymulin levels decline with age in parallel with thymic involution, a well-described biological process involving reduced thymic activity over time.\u003c\/p\u003e\n\u003cp data-end=\"4395\" data-start=\"4323\"\u003eFor this reason, thymulin is frequently referenced in studies examining:\u003c\/p\u003e\n\u003cp data-end=\"4510\" data-start=\"4397\"\u003e• immune aging mechanisms\u003cbr data-end=\"4425\" data-start=\"4422\"\u003e• thymic signaling decline\u003cbr data-end=\"4454\" data-start=\"4451\"\u003e• adaptive immune system development across the lifespan\u003c\/p\u003e\n\u003cp data-end=\"4662\" data-start=\"4512\"\u003eThese research contexts have contributed to growing interest in thymulin as a model peptide for studying age-related changes in immune regulation.\u003c\/p\u003e\n\u003ch3 data-end=\"4712\" data-start=\"4669\" data-section-id=\"s1sill\"\u003eZinc Dependence and Structural Activation\u003c\/h3\u003e\n\u003cp data-end=\"4779\" data-start=\"4714\"\u003eA defining feature of thymulin is its strict zinc dependence.\u003c\/p\u003e\n\u003cp data-end=\"5024\" data-start=\"4781\"\u003eWithout zinc binding, thymulin remains in an inactive conformation. When Zn²⁺ ions bind to the peptide, the resulting metallopeptide undergoes a structural transition that allows high-affinity receptor interaction and downstream signaling.\u003c\/p\u003e\n\u003cp data-end=\"5234\" data-start=\"5026\"\u003eBecause of this requirement, many experimental systems examining thymulin activity also investigate zinc availability and metallopeptide formation as critical factors influencing thymic hormone signaling.\u003c\/p\u003e\n\u003ch3 data-end=\"5268\" data-start=\"5241\" data-section-id=\"15vs70q\"\u003eMolecular Characteristics\u003c\/h3\u003e\n\u003cp data-end=\"5496\" data-start=\"5270\"\u003e\u003cstrong data-end=\"5283\" data-start=\"5270\"\u003eSynonyms:\u003c\/strong\u003e Thymulin, Serum Thymic Factor (FTS), Facteur Thymique Sérique\u003cbr data-end=\"5348\" data-start=\"5345\"\u003e\u003cstrong data-end=\"5369\" data-start=\"5348\"\u003ePeptide Sequence:\u003c\/strong\u003e pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH\u003cbr data-end=\"5412\" data-start=\"5409\"\u003e\u003cstrong data-end=\"5433\" data-start=\"5412\"\u003eMolecular Weight:\u003c\/strong\u003e ~858.86 Da\u003cbr data-end=\"5447\" data-start=\"5444\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eSummary Table of Key MOA Layers\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable style=\"width: 88.75%; height: 108px;\" height=\"142\" width=\"262\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eLevel\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003eMechanism\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003e Main Outcomes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eMolecular\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003eZn²⁺ binding → active conformation \u0026amp; receptor signaling\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eProper receptor activation, marker induction, NF-κB modulation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eCellular\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003e\n\u003cp\u003eProthymocyte → mature T-cell differentiation\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eBalanced CD4\/CD8\/Treg populations,↑ NK activity, cytokine balance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.5938px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.5938px;\"\u003eTissue\/Organ\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.5938px;\"\u003e\n\u003cp\u003eThymic hormonal microenvironment signal\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.5938px;\"\u003eT-cell maturation, immune tolerance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"height: 21.625px;\"\u003e\n\u003ctd style=\"width: 23.2179%; height: 21.625px;\"\u003eSystemic\/Neuro\u003c\/td\u003e\n\u003ctd style=\"width: 37.0672%; height: 21.625px;\"\u003e\n\u003cp\u003eNeuroendocrine-immune axis integration\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 38.9002%; height: 21.625px;\"\u003eAnti-inflammation, analgesia, circadian regulation, homeostasis \u0026amp; longevity\u003cbr\u003esupport\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":52641940504842,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen ( 1 )","offer_id":52641940537610,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Thymulin20mg_2.png?v=1772292079"},{"product_id":"slu-pp-332-10mg","title":"SLU-PP-332 10mg – Metabolic \u0026 Exercise Signaling Research Compound","description":"\u003ch2 data-end=\"604\" data-start=\"139\"\u003e\u003cstrong data-end=\"162\" data-start=\"139\"\u003eSLU-PP-332 sQ\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"421\" data-start=\"83\"\u003eThis research-grade small molecule is supplied exclusively for laboratory and experimental use. SLU-PP-332 is examined in experimental models focused on metabolic efficiency, mitochondrial activation, and exercise-mimetic signaling pathways. Research interest centers on how cells adapt to increased energy demand without physical stress.\u003c\/p\u003e\n\u003cp data-end=\"665\" data-start=\"423\"\u003eSLU-PP-332 is studied for its potential role in modulating metabolic processes and regulating cellular energy dynamics. This compound is used in research settings exploring metabolic signaling, mitochondrial function, and cellular adaptation.\u003c\/p\u003e\n\u003cp data-end=\"742\" data-start=\"667\"\u003eExperimental studies have indicated that SLU-PP-332 may be associated with:\u003c\/p\u003e\n\u003cul data-end=\"884\" data-start=\"744\"\u003e\n\u003cli data-end=\"781\" data-start=\"744\" data-section-id=\"1bjsqce\"\u003eregulation of metabolic processes\u003c\/li\u003e\n\u003cli data-end=\"832\" data-start=\"782\" data-section-id=\"km3mdj\"\u003ecellular adaptation to increased energy demand\u003c\/li\u003e\n\u003cli data-end=\"884\" data-start=\"833\" data-section-id=\"9oarl7\"\u003esignaling pathways related to physical activity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1201\" data-start=\"886\"\u003eTraditionally, the physiological benefits associated with physical exercise have been difficult to replicate in pharmacological models. With the introduction of SLU-PP-332, a new area of research has emerged focused on studying the mechanisms underlying exercise-related metabolic signaling and cellular adaptation.\u003c\/p\u003e\n\u003ch3 data-end=\"206\" data-start=\"168\"\u003ePrimary metabolic research pairing\u003c\/h3\u003e\n\u003cp data-end=\"424\" data-start=\"208\"\u003eIn experimental and laboratory research settings, SLU-PP-332 is commonly examined alongside compounds involved in mitochondrial energy signaling, metabolic efficiency, and systemic energy regulation pathways.\u003c\/p\u003e\n\u003cp data-end=\"624\" data-start=\"426\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/cjc-1295-10-mg\"\u003e\u003cstrong data-end=\"440\" data-start=\"428\"\u003eCJC-1295\u003c\/strong\u003e – growth hormone–related metabolic signaling research\u003c\/a\u003e\u003cbr data-end=\"497\" data-start=\"494\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/tesamorelin-10-mg\"\u003e\u003cstrong data-end=\"514\" data-start=\"499\"\u003eTesamorelin\u003c\/strong\u003e – GH-axis and metabolic regulation research\u003c\/a\u003e\u003cbr data-end=\"561\" data-start=\"558\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ipamorelin-5-mg\"\u003e\u003cstrong data-end=\"577\" data-start=\"563\"\u003eIpamorelin\u003c\/strong\u003e – GHRP-related energy and signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"685\" data-start=\"631\"\u003eMitochondrial and cellular energy research context\u003c\/h3\u003e\n\u003cp data-end=\"852\" data-start=\"687\"\u003eSome experimental frameworks explore SLU-PP-332 in parallel with compounds studied for mitochondrial function, bioenergetics, and cellular stress adaptation.\u003c\/p\u003e\n\u003cp data-end=\"1017\" data-start=\"854\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/ss-31-50mg-per-vial\"\u003e\u003cstrong data-end=\"880\" data-start=\"856\"\u003eSS-31 (Elamipretide)\u003c\/strong\u003e – mitochondrial stabilization and respiration research\u003c\/a\u003e\u003cbr data-end=\"938\" data-start=\"935\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/mots-c-peptide-10-mg-research-grade\"\u003e\u003cstrong data-end=\"950\" data-start=\"940\"\u003eMOTS-c\u003c\/strong\u003e – mitochondrial-derived peptide and metabolic signaling research\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1080\" data-start=\"1024\"\u003eRedox balance and metabolic support research context\u003c\/h3\u003e\n\u003cp data-end=\"1239\" data-start=\"1082\"\u003eAdditional research models reference SLU-PP-332 alongside compounds examined for redox balance, cellular resilience, and metabolic cofactor pathways.\u003c\/p\u003e\n\u003cp data-end=\"1384\" data-start=\"1241\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/nad-plus-1000-mg\"\u003e\u003cstrong data-end=\"1251\" data-start=\"1243\"\u003eNAD+\u003c\/strong\u003e – cellular energy metabolism and redox signaling research\u003c\/a\u003e\u003cbr data-end=\"1312\" data-start=\"1309\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/products\/l-glutathione-3000-mg\"\u003e\u003cstrong data-end=\"1331\" data-start=\"1314\"\u003eL-Glutathione\u003c\/strong\u003e – oxidative stress and antioxidant system research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"376\" data-start=\"101\"\u003eSLU-PP-332 represents a notable advancement in this research category. It is an estrogen-related receptor (ERR) agonist designed to selectively target ERR alpha and gamma subtypes. In laboratory research, SLU-PP-332 has been examined in relation to several areas of interest:\u003c\/p\u003e\n\u003cul data-end=\"578\" data-start=\"378\"\u003e\n\u003cli data-end=\"432\" data-start=\"378\" data-section-id=\"1ia0ibu\"\u003emuscular endurance in experimental exercise models\u003c\/li\u003e\n\u003cli data-end=\"485\" data-start=\"433\" data-section-id=\"x5wjn6\"\u003emetabolic regulation and weight-related pathways\u003c\/li\u003e\n\u003cli data-end=\"525\" data-start=\"486\" data-section-id=\"1i8xedd\"\u003ecardiovascular signaling mechanisms\u003c\/li\u003e\n\u003cli data-end=\"578\" data-start=\"526\" data-section-id=\"1yqydh7\"\u003eneurobiological research models related to aging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"897\" data-start=\"580\"\u003eBy engaging metabolic pathways similar to those activated during physical exercise, SLU-PP-332 has generated significant interest within the scientific community. Researchers focusing on longevity, energy metabolism, and cellular adaptation continue to investigate its role in these interconnected biological systems.\u003c\/p\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1060\" data-start=\"899\"\u003eThese research directions contribute to a broader understanding of how metabolic signaling and cellular responses may influence long-term physiological function.\u003c\/p\u003e\n\u003cp data-end=\"107\" data-start=\"64\"\u003e\u003cstrong data-end=\"107\" data-start=\"64\"\u003eFurther Research \u0026amp; Scientific Resources\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"322\" data-start=\"109\"\u003eTo explore the scientific background, molecular mechanisms, and research applications of \u003cstrong data-end=\"212\" data-start=\"198\"\u003eSLU-PP-332\u003c\/strong\u003e, read our detailed overview:\u003cbr data-end=\"244\" data-start=\"241\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-slu-pp-332\"\u003eWhat is SLU-PP-332? – Mechanism, metabolic signaling, and research context\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"457\" data-start=\"324\"\u003eSLU-PP-332 is investigated in experimental models focused on \u003cstrong data-end=\"456\" data-start=\"385\"\u003emitochondrial function, energy metabolism, and metabolic efficiency\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"638\" data-start=\"459\"\u003eFor a broader understanding of \u003cstrong data-end=\"552\" data-start=\"490\"\u003emetabolic energy pathways and performance-related research\u003c\/strong\u003e:\u003cbr data-end=\"556\" data-start=\"553\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/metabolic-energy-endurance-research\"\u003eMetabolic Energy Explained: Pathways, Fat Metabolism, and Performance Research\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"638\" data-start=\"459\"\u003e\u003cspan style=\"font-kerning: none;\"\u003eLearn how exercise-mimetic signaling and mitochondrial biogenesis pathways are connected in our detailed article on exercise and mitochondrial health.\u003cbr\u003e\u003cspan\u003e → \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/exercise-and-mitochondrial-health\"\u003e\u003cstrong\u003e\u003c\/strong\u003eExercise \u0026amp; Mitochondrial Health Blog\u003c\/a\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp data-end=\"672\" data-start=\"645\"\u003e\u003cstrong data-end=\"672\" data-start=\"645\"\u003eRelated Research Topics\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"858\" data-start=\"674\"\u003eTo understand how \u003cstrong data-end=\"744\" data-start=\"692\"\u003emitochondrial efficiency and metabolic signaling\u003c\/strong\u003e relate to \u003cstrong data-end=\"790\" data-start=\"755\"\u003emuscle performance and recovery\u003c\/strong\u003e, explore:\u003cbr data-end=\"803\" data-start=\"800\"\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/best-peptides-for-muscle-growth\"\u003eMuscle Growth \u0026amp; Regeneration: Research Perspectives\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"168\" data-start=\"130\"\u003eProduct Description – SLU-PP-332\u003c\/h3\u003e\n\u003cp data-end=\"434\" data-start=\"170\"\u003e\u003cstrong data-end=\"183\" data-start=\"170\"\u003eSynonyms:\u003c\/strong\u003e 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide\u003cbr data-end=\"240\" data-start=\"237\"\u003e\u003cstrong data-end=\"255\" data-start=\"240\"\u003eMolar Mass:\u003c\/strong\u003e 290.32 g\/mol\u003cbr data-end=\"271\" data-start=\"268\"\u003e\u003cstrong data-end=\"286\" data-start=\"271\"\u003eCAS Number:\u003c\/strong\u003e 303760-60-3\u003cbr data-end=\"301\" data-start=\"298\"\u003e\u003cstrong data-end=\"316\" data-start=\"301\"\u003ePubChem ID:\u003c\/strong\u003e 5338394\u003cbr data-end=\"327\" data-start=\"324\"\u003e\u003cstrong data-end=\"355\" data-start=\"327\"\u003eTotal Active Ingredient:\u003c\/strong\u003e 10 mg per vial\u003cbr data-end=\"407\" data-start=\"404\"\u003e\u003cstrong data-end=\"422\" data-start=\"407\"\u003eShelf Life:\u003c\/strong\u003e 36 months\u003c\/p\u003e\n\u003ch3 data-end=\"434\" data-start=\"170\"\u003e\u003cstrong\u003eSLU-PP-332 Structures\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg alt=\"Chemical structure diagram of SLU-PP-332\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Slu-PP-332.png?v=1755158769\"\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52711336182026,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52711336214794,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/slupp332_10mg_2.png?v=1773991050"},{"product_id":"ara-290-10mg","title":"ARA-290 10mg - Peptide for Inflammation \u0026 Tissue Signaling Research","description":"\u003ch3\u003eARA-290 (Cibinetide, CAS 1208243-50-8) – Molecular Mechanism of Action and Research Overview\u003c\/h3\u003e\n\u003cp\u003eARA-290, also known as cibinetide (CAS 1208243-50-8), is a synthetic 11-amino-acid linear peptide (sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH; molecular formula C₅₁H₈₄N₁₆O₂₁; molecular weight 1,257.31 Da). It was engineered from the three-dimensional structure of helix B of erythropoietin (EPO). Unlike full-length recombinant human EPO, ARA-290 is non-erythropoietic and does not bind the classical EPOR homodimer associated with hematopoietic activity.\u003c\/p\u003e\n\u003cp\u003eInstead, ARA-290 selectively activates the innate repair receptor (IRR), a tissue-protective heteromeric complex composed of one EPOR subunit and the β-common receptor (βcR, CD131). The IRR is minimally expressed under baseline conditions but becomes upregulated in response to cellular stress, injury, or inflammation across multiple cell types, including neurons, endothelial cells, macrophages, and glial cells. This inducible expression profile localizes signaling activity to affected tissues.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eMolecular Mechanism of Action (MOA)\u003c\/h3\u003e\n\u003cp\u003eLigand interaction with the IRR initiates several intracellular signaling cascades:\u003c\/p\u003e\n\u003cp\u003e• JAK2\/STAT3 and PI3K\/Akt pathways:\u003cbr\u003eAssociated with cellular survival signaling, anti-apoptotic regulation (e.g., Bcl-2\/Bax balance), and tissue-repair–related processes.\u003c\/p\u003e\n\u003cp\u003e• Anti-inflammatory signaling:\u003cbr\u003eARA-290 modulates NF-κB pathway activity, leading to reduced transcription of pro-inflammatory mediators such as TNF-α and IL-6. It also influences oxidative stress pathways by reducing reactive oxygen species (ROS), which contributes to suppression of inflammasome activation (e.g., NLRP3).\u003c\/p\u003e\n\u003cp\u003e• Immune modulation:\u003cbr\u003eResearch models indicate a shift in macrophage and microglial signaling profiles toward regulatory (M2-like) states.\u003c\/p\u003e\n\u003cp\u003e• Neurosensory signaling pathways:\u003cbr\u003ePreclinical data suggest modulation of TRPV1-related pathways and chemokine signaling (e.g., CCL2), which are associated with nociceptive and neuroimmune interactions.\u003c\/p\u003e\n\u003cp\u003eAlthough the peptide exhibits a short plasma half-life, downstream signaling effects may persist due to activation of intracellular regulatory pathways.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003ePreclinical and Clinical Research Context\u003c\/h3\u003e\n\u003cp\u003eARA-290 has been investigated primarily in experimental and early-phase clinical research models related to small-fiber neuropathy (SFN), metabolic signaling, and inflammatory conditions.\u003c\/p\u003e\n\u003cp\u003eAcross these research settings, observations include:\u003c\/p\u003e\n\u003cp\u003e• Modulation of neuropathic symptom-related endpoints\u003cbr\u003e• Changes in markers associated with nerve fiber structure and regeneration\u003cbr\u003e• Alterations in inflammatory and metabolic signaling parameters\u003cbr\u003e• Improvements in functional and quality-of-life–associated measurements in controlled study environments\u003c\/p\u003e\n\u003cp\u003eImportantly, available data originate from controlled research settings, including in vitro systems, animal models, and early-phase human studies. No completed Phase 3 trials have been reported as of 2026.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eMetabolic and Inflammatory Research Observations\u003c\/h3\u003e\n\u003cp\u003eIn experimental models examining metabolic signaling:\u003c\/p\u003e\n\u003cp\u003e• Changes in glucose-related biomarkers have been reported\u003cbr\u003e• Modulation of inflammatory cytokine profiles has been observed\u003cbr\u003e• Endothelial and microvascular signaling pathways have been explored\u003c\/p\u003e\n\u003cp\u003eThese findings are generally interpreted within the broader context of inflammation-linked metabolic regulation rather than as direct therapeutic outcomes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eNeuroprotective and Cognitive Research Context\u003c\/h3\u003e\n\u003cp\u003eBeyond peripheral systems, ARA-290 has been studied in central nervous system (CNS) models due to its interaction with the innate repair receptor.\u003c\/p\u003e\n\u003cp\u003ePreclinical research includes:\u003c\/p\u003e\n\u003cp\u003e• Neuroinflammation modulation in neurodegenerative models\u003cbr\u003e• Effects on amyloid-related pathways in transgenic systems\u003cbr\u003e• Regulation of tau-associated signaling in experimental models\u003cbr\u003e• Reduced markers of neuronal stress and apoptosis in ischemic and injury models\u003c\/p\u003e\n\u003cp\u003eAdditional experimental observations:\u003c\/p\u003e\n\u003cp\u003e• Modulation of monocyte and microglial signaling\u003cbr\u003e• Changes in neuroimmune communication pathways\u003cbr\u003e• Effects on behavioral and cognitive test outcomes in controlled models\u003c\/p\u003e\n\u003cp\u003eLimited exploratory human research has examined cognitive and emotional processing, indicating subtle modulation of affective processing pathways without broad systemic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eSafety and Research Status\u003c\/h3\u003e\n\u003cp\u003eARA-290 is currently classified as an experimental research peptide.\u003c\/p\u003e\n\u003cp\u003eAvailable data from early-phase investigations suggest:\u003c\/p\u003e\n\u003cp\u003e• No activation of erythropoietic pathways\u003cbr\u003e• No consistent signals related to hematologic or cardiovascular parameters\u003cbr\u003e• Generally favorable tolerability profiles in controlled research settings\u003c\/p\u003e\n\u003cp\u003eHowever, comprehensive evaluation of long-term safety, pharmacokinetics, and broader applications requires further investigation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eResearch Use Context\u003c\/h3\u003e\n\u003cp\u003eAll information presented reflects published scientific literature and experimental findings.\u003c\/p\u003e\n\u003cp\u003eThis material is intended exclusively for laboratory research and scientific investigation.\u003cbr\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52895609913610,"sku":null,"price":215.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52895609946378,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ara290_10mg.png?v=1776848054"},{"product_id":"klow-blend-80mg-peptide-complex","title":"KLOW Blend 80mg – GHK-Cu, TB-500, BPC-157, KPV Research Blend","description":"\u003cp style=\"margin-bottom: 0cm;\"\u003eKLOW Blend is a multi-peptide research compound combining several well-studied peptides into a single formulation. It is examined in experimental settings for its role in cellular signaling, peptide interactions, and complex biological pathway research.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis blend is designed to represent a combined peptide environment, allowing researchers to explore how multiple signaling molecules interact within controlled models.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003ch3 data-section-id=\"rvgn1m\" data-start=\"0\" data-end=\"95\"\u003eKLOW Blend: A Comprehensive Overview for Research on Tissue Signaling and Cellular Pathways\u003c\/h3\u003e\n\u003cp data-start=\"97\" data-end=\"427\"\u003eThe KLOW blend combines four peptides—BPC-157, GHK-Cu, TB500, and KPV—into a single formulation studied in relation to cellular signaling, inflammatory pathways, and structural tissue processes. These peptides target complementary biological systems associated with tissue dynamics, signaling regulation, and cellular maintenance.\u003c\/p\u003e\n\u003cp data-start=\"429\" data-end=\"895\"\u003eBPC-157 is associated with pathways related to vascular signaling and cellular protection in experimental models. GHK-Cu is studied for its influence on gene expression, extracellular matrix components such as collagen, and redox balance. TB500 is examined for its role in cytoskeletal organization and cell migration through actin regulation. KPV is investigated for its interaction with inflammatory signaling cascades, particularly those involving NF-κB pathways.\u003c\/p\u003e\n\u003cp data-start=\"897\" data-end=\"1437\"\u003eWhen examined together, the peptides in the KLOW blend are explored for their combined interaction across multiple biological systems. Research in laboratory and animal models has investigated these peptides in the context of tissue dynamics, cellular signaling, and structural remodeling processes. Limited human data exist for individual components, primarily in dermatological and inflammatory research settings. The KLOW blend represents a multi-peptide formulation studied within the broader field of peptide-based biological research.\u003c\/p\u003e\n\u003ch3 data-section-id=\"k6yb3d\" data-start=\"1444\" data-end=\"1507\"\u003eMolecular Mechanisms of Action of the KLOW Blend Components\u003c\/h3\u003e\n\u003cp data-start=\"1509\" data-end=\"1745\"\u003eThe KLOW blend leverages the distinct biochemical profiles of its four constituent peptides, which are studied in relation to angiogenic signaling, extracellular matrix (ECM) dynamics, cytoskeletal regulation, and inflammatory pathways.\u003c\/p\u003e\n\u003ch4 data-start=\"1747\" data-end=\"1759\"\u003eBPC-157\u003c\/h4\u003e\n\u003cp data-start=\"1761\" data-end=\"1943\"\u003eBPC-157 (Body Protection Compound-157) is a stable gastric pentadecapeptide (GEPPPGKPADDAGLV) studied for its cytoprotective and signaling-related properties in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"1945\" data-end=\"2297\"\u003eAt the molecular level, BPC-157 is associated with activation of vascular endothelial growth factor receptor-2 (VEGFR2) pathways via PI3K–Akt–eNOS signaling, as well as Src–caveolin-1–eNOS pathways, contributing to nitric oxide (NO)-related processes. It also engages ERK1\/2 signaling, influencing transcription factors such as c-Fos, c-Jun, and Egr-1.\u003c\/p\u003e\n\u003cp data-start=\"2299\" data-end=\"2605\"\u003eAdditional research suggests interactions with intracellular regulatory proteins such as FBXO22, affecting transcription factor stability (e.g., BACH1). BPC-157 is further studied for its role in modulating nitric oxide systems, oxidative stress pathways, and mitochondrial function in experimental models.\u003c\/p\u003e\n\u003ch4 data-start=\"2612\" data-end=\"2623\"\u003eGHK-Cu\u003c\/h4\u003e\n\u003cp data-start=\"2625\" data-end=\"2776\"\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide studied for its role in redox balance and gene expression modulation.\u003c\/p\u003e\n\u003cp data-start=\"2778\" data-end=\"3076\"\u003eIt is associated with regulation of genes involved in extracellular matrix components, including collagen and elastin, as well as pathways linked to antioxidant responses. GHK-Cu is also studied for its interaction with matrix metalloproteinases (MMPs), cytokine signaling, and fibroblast activity.\u003c\/p\u003e\n\u003cp data-start=\"3078\" data-end=\"3246\"\u003eCopper coordination enables its role as a cofactor in enzymatic systems such as lysyl oxidase, supporting structural protein cross-linking in experimental environments.\u003c\/p\u003e\n\u003ch4 data-start=\"3253\" data-end=\"3263\"\u003eTB500\u003c\/h4\u003e\n\u003cp data-start=\"3265\" data-end=\"3394\"\u003eTB500 (a synthetic fragment of Thymosin Beta-4) is studied for its interaction with actin dynamics and cytoskeletal organization.\u003c\/p\u003e\n\u003cp data-start=\"3396\" data-end=\"3693\"\u003eIt binds to globular G-actin, influencing the balance between polymerized and unpolymerized actin, which is relevant in cellular movement and structural reorganization. TB500 is also associated with signaling pathways related to angiogenesis, extracellular matrix turnover, and cellular migration.\u003c\/p\u003e\n\u003ch4 data-start=\"3700\" data-end=\"3708\"\u003eKPV\u003c\/h4\u003e\n\u003cp data-start=\"3710\" data-end=\"3865\"\u003eKPV (Lys-Pro-Val) is a tripeptide derived from α-melanocyte-stimulating hormone (α-MSH), studied primarily for its role in inflammatory signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3867\" data-end=\"4115\"\u003eIt is transported into cells via the PepT1 transporter and is associated with inhibition of NF-κB activation and modulation of MAPK signaling. These interactions are linked to reduced expression of pro-inflammatory cytokines in experimental models.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1wnbftr\" data-start=\"4122\" data-end=\"4168\"\u003eSynergistic Interactions in the KLOW Blend\u003c\/h3\u003e\n\u003cp data-start=\"4170\" data-end=\"4284\"\u003eThe peptides in the KLOW blend are studied for their interaction across overlapping biological systems, including:\u003c\/p\u003e\n\u003cp data-start=\"4286\" data-end=\"4420\"\u003e• angiogenesis-related signaling\u003cbr data-start=\"4318\" data-end=\"4321\"\u003e• extracellular matrix dynamics\u003cbr data-start=\"4352\" data-end=\"4355\"\u003e• cytoskeletal organization\u003cbr data-start=\"4382\" data-end=\"4385\"\u003e• inflammatory pathway modulation\u003c\/p\u003e\n\u003cp data-start=\"4422\" data-end=\"4596\"\u003eThese pathways are explored in research settings to understand how multi-peptide systems may influence complex cellular environments through coordinated signaling mechanisms.\u003c\/p\u003e\n\u003ch3 data-section-id=\"dqq6xu\" data-start=\"4603\" data-end=\"4640\"\u003eResearch Context and Applications\u003c\/h3\u003e\n\u003cp data-start=\"4642\" data-end=\"4756\"\u003eThe molecular profiles of the peptides in the KLOW blend have been investigated in experimental models related to:\u003c\/p\u003e\n\u003cp data-start=\"4758\" data-end=\"4908\"\u003e• musculoskeletal tissue dynamics\u003cbr data-start=\"4791\" data-end=\"4794\"\u003e• gastrointestinal cellular systems\u003cbr data-start=\"4829\" data-end=\"4832\"\u003e• dermal and epithelial structures\u003cbr data-start=\"4866\" data-end=\"4869\"\u003e• inflammatory signaling environments\u003c\/p\u003e\n\u003cp data-start=\"4910\" data-end=\"5066\"\u003eThese studies are conducted primarily in preclinical settings, including in vitro and animal models, to explore cellular responses and pathway interactions.\u003c\/p\u003e\n\u003ch3 data-section-id=\"benbuy\" data-start=\"5073\" data-end=\"5101\"\u003eSummary of Research Data\u003c\/h3\u003e\n\u003cp data-start=\"5103\" data-end=\"5341\"\u003eThe majority of available data originates from preclinical research. Studies involving individual peptides have examined their effects on cellular signaling, gene expression, and structural processes in controlled laboratory environments.\u003c\/p\u003e\n\u003cp data-start=\"5343\" data-end=\"5565\"\u003eLimited human data exist for certain components, particularly GHK-Cu and TB4-derived compounds, in dermatological and topical research contexts. However, no large-scale controlled studies exist for the combined KLOW blend.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"5572\" data-end=\"5583\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"5585\" data-end=\"5778\"\u003eThe KLOW blend is a multi-peptide research formulation studied for its role in cellular signaling, extracellular matrix dynamics, cytoskeletal organization, and inflammatory pathway modulation.\u003c\/p\u003e\n\u003cp data-start=\"5780\" data-end=\"5815\"\u003eIts components are associated with:\u003c\/p\u003e\n\u003cp data-start=\"5817\" data-end=\"5990\"\u003e• angiogenic and vascular signaling pathways\u003cbr data-start=\"5861\" data-end=\"5864\"\u003e• structural protein regulation and ECM processes\u003cbr data-start=\"5913\" data-end=\"5916\"\u003e• actin-mediated cellular dynamics\u003cbr data-start=\"5950\" data-end=\"5953\"\u003e• inflammatory signaling regulation\u003c\/p\u003e\n\u003cp data-start=\"5992\" data-end=\"6166\"\u003eAs a combined system, the KLOW blend is explored in experimental research settings to better understand how multiple peptides interact within complex biological environments.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLearn More About KLOW Blend Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExplore the science behind the KLOW Blend, a multi-peptide research formulation combining BPC-157, GHK-Cu, TB500, and KPV in a coordinated cellular signaling system.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e→ \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/what-is-klow-blend\"\u003eRead: What Is KLOW Blend? Multi-Peptide Research Explained\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-start=\"6173\" data-end=\"6310\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and preclinical research data and is intended for scientific and educational purposes.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":52929000734986,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":52929000767754,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/klowblend_80mg_2.png?v=1777625682"},{"product_id":"ahk-cu-100-mg","title":"AHK-Cu 100 mg – Hair Follicle Research Peptide (Roller Format)","description":"\u003ch3\u003eAHK-Cu (Copper Tripeptide-3) – Overview and Structure\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu (Alanine–Histidine–Lysine Copper), also known as Copper Tripeptide-3, is a synthetic copper-binding tripeptide complex composed of alanine, histidine, and lysine coordinated with a copper (Cu²⁺) ion.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eCAS No.: 682809-81-0 (HCl form)  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eMolecular weight: ~415–451 Da  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied as a targeted analog of naturally occurring copper peptides, with particular relevance in research models involving hair follicle biology and dermal papilla cell (DPC) signaling.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThe peptide structure enables stable chelation of Cu²⁺ through histidine and peptide backbone interactions, forming a coordinated complex that supports controlled intracellular copper transport and enzyme-related functions.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eMolecular Mechanism of Action (Research Context)\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied as both a signaling peptide and a bioavailable copper carrier within cellular systems.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIn experimental models, it is associated with pathways relevant to dermal papilla cell activity, including:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular proliferation signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• apoptosis-related pathway modulation  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• growth factor–related signaling pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• copper-dependent enzymatic processes  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese pathways are explored in relation to hair follicle cycling, particularly mechanisms associated with the anagen (growth) phase.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cstrong\u003eAHK-Cu is also studied for its interaction with:\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• VEGF-related signaling (angiogenesis pathways)  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• TGF-β–associated regulatory pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• intracellular antioxidant enzyme systems  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eCopper delivered via the peptide complex is associated with enzyme cofactor activity, including systems linked to oxidative balance and extracellular matrix dynamics.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eHair Follicle Research and Cellular Models\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is frequently examined in in vitro and ex vivo models of hair follicle biology.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eResearch observations associate the compound with:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• dermal papilla cell signaling activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• follicular structure dynamics in organ culture models  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular environment interactions within the hair follicle niche  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese mechanisms are studied in relation to follicle size, structural integrity, and growth-phase signaling pathways.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eSkin and Cellular Research Context\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIn addition to follicle-related pathways, AHK-Cu is also examined in broader skin-related models.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese include:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• fibroblast activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• collagen-related pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix interactions  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular regeneration signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThis positions AHK-Cu as a compound of interest in both hair-focused and dermal research environments.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eComparative Research Overview\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\n\u003ctable style=\"width: 100%;\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003e  \u003cstrong\u003eProperty\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e\u003cstrong\u003eAHK-Cu (Copper Tripeptide-3)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e\u003cstrong\u003eGHK-Cu (Copper Tripeptide-1)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003e Sequence\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eAla-His-Lys-Cu²⁺\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eGly-His-Lys-Cu²⁺ \u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eCAS Number\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e682809-81-0\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e49557-75-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003e~415–451 Da\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003e~340–404 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eOrigin\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eSynthetic analog\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eNaturally occurring peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003ePrimary Research Focus\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eHair follicle \/ DPC models\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eBroad skin-related pathways\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eMechanistic Focus\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eDPC signaling, pathway modulation\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eFibroblast signaling, ECM pathways\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eHair Research Relevance\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eHigh\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eModerate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eSkin Research Relevance\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eSecondary\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003ePrimary \u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22.4638%;\"\u003eResearch Context\u003c\/td\u003e\n\u003ctd style=\"width: 40.6304%;\"\u003eIn vitro \/ ex vivo follicle studies\u003c\/td\u003e\n\u003ctd style=\"width: 36.0001%;\"\u003eExtensive skin-related models\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003eResearch Applications and Context\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu is studied in experimental systems focusing on:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• hair follicle biology  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• dermal papilla cell signaling  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• copper-dependent enzyme activity  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• angiogenesis-related pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix regulation  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIt is frequently included in research exploring targeted peptide delivery systems and localized cellular signaling environments.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003ch3 dir=\"ltr\"\u003eSummary\u003c\/h3\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding peptide studied in relation to hair follicle biology, dermal papilla cell signaling, and copper-dependent cellular pathways.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eIts mechanisms are associated with:\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• cellular signaling and proliferation pathways  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• growth factor–related systems  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• antioxidant and enzymatic processes  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e• extracellular matrix interactions  \u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eThese properties make it a relevant compound in research focused on localized cellular environments and peptide-mediated signaling systems.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003eAll information provided reflects research-based observations in experimental models and is intended for scientific and educational purposes.\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\"\u003e\n\u003ch3 style=\"margin-bottom: 0cm;\"\u003eDelivery System and Format (Research Context)\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis product is presented as a roller-based peptide delivery system integrating AHK-Cu within a manual applicator format.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe device features a 64-pin roller head with ultra-fine 0.5 mm gold-tipped titanium needles and an integrated reservoir system designed to hold the peptide solution within the applicator structure.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ahk_roll_1.png?v=1777385167\"\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eIn experimental and cosmetic research settings, microneedle-based systems are studied for their ability to create controlled micro-scale surface channels, allowing localized interaction between peptide compounds and the surrounding skin environment.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe roller format is associated with uniform distribution across the application surface and consistent contact between the peptide solution and targeted areas in controlled models.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThe device operates mechanically without the need for external power sources and is constructed using materials selected for stability and compatibility in topical research environments.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eGold-tipped titanium components are commonly used in such systems due to their structural properties and surface characteristics in repeated-contact applications.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cimg alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/ahk_roll_2.png?v=1777385167\"\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis format is examined in research exploring localized peptide delivery, surface interaction dynamics, and controlled distribution systems.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003eThis section describes the delivery format and presentation of the product within experimental and cosmetic research contexts.\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 0cm;\"\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PRG","offers":[{"title":"Default Title","offer_id":52941068599562,"sku":null,"price":190.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/AHK-cu100mg_2.png?v=1777624563"},{"product_id":"cagrilintide-semaglutide-research-blend","title":"Cagrilintide 5 mg + Semaglutide 5 mg – Dual Peptide Research Blend","description":"\u003ch3 data-section-id=\"1p8a2yh\" data-start=\"0\" data-end=\"89\"\u003eCagrilintide + Semaglutide Blend: Research Overview of Dual Peptide Signaling Systems\u003c\/h3\u003e\n\u003cp data-start=\"91\" data-end=\"259\"\u003eThe Cagrilintide + Semaglutide blend is a dual-peptide formulation studied in the context of metabolic signaling, receptor interactions, and energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"261\" data-end=\"559\"\u003eIt combines semaglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist, with cagrilintide, a long-acting amylin analog. These peptides interact with distinct but complementary receptor systems involved in nutrient sensing, gastrointestinal signaling, and central regulation of energy balance.\u003c\/p\u003e\n\u003cp data-start=\"561\" data-end=\"850\"\u003eIn experimental and clinical research settings, these pathways are investigated for their role in appetite signaling, glucose metabolism, and coordinated endocrine responses. The combined formulation is studied to explore how multi-receptor activation influences complex metabolic systems.\u003c\/p\u003e\n\u003ch3 data-section-id=\"135ivb1\" data-start=\"857\" data-end=\"925\"\u003eMolecular Mechanism of Action at the Cellular and Receptor Level\u003c\/h3\u003e\n\u003ch4 data-start=\"927\" data-end=\"943\"\u003eSemaglutide\u003c\/h4\u003e\n\u003cp data-start=\"945\" data-end=\"1049\"\u003eSemaglutide is a long-acting GLP-1 receptor agonist with high structural similarity to endogenous GLP-1.\u003c\/p\u003e\n\u003cp data-start=\"1051\" data-end=\"1249\"\u003eThe GLP-1 receptor (GLP-1R) is a class B G-protein-coupled receptor (GPCR) expressed in multiple tissues, including pancreatic cells, gastrointestinal structures, and central nervous system regions.\u003c\/p\u003e\n\u003cp data-start=\"1251\" data-end=\"1573\"\u003eUpon receptor binding, semaglutide activates Gs protein signaling, leading to increased intracellular cyclic AMP (cAMP) levels and downstream activation of protein kinase A (PKA). These pathways are associated with regulation of insulin signaling, glucagon modulation, and gastrointestinal motility in experimental models.\u003c\/p\u003e\n\u003cp data-start=\"1575\" data-end=\"1742\"\u003eIn central nervous system research, GLP-1R activation is studied for its effects on hypothalamic and brainstem signaling pathways involved in energy intake regulation.\u003c\/p\u003e\n\u003ch4 data-start=\"1749\" data-end=\"1766\"\u003eCagrilintide\u003c\/h4\u003e\n\u003cp data-start=\"1768\" data-end=\"1851\"\u003eCagrilintide is a long-acting analog of amylin, a peptide co-secreted with insulin.\u003c\/p\u003e\n\u003cp data-start=\"1853\" data-end=\"2025\"\u003eIt binds to calcitonin receptors (CTR) and receptor complexes formed with receptor activity-modifying proteins (RAMPs), collectively referred to as amylin receptors (AMYR).\u003c\/p\u003e\n\u003cp data-start=\"2027\" data-end=\"2121\"\u003eThese receptors are also class B GPCRs and signal primarily through Gs-mediated cAMP pathways.\u003c\/p\u003e\n\u003cp data-start=\"2123\" data-end=\"2375\"\u003eCagrilintide is studied for its effects on signaling pathways in the area postrema and other brain regions involved in satiety and gastrointestinal regulation. Its structural modifications support prolonged receptor interaction in experimental systems.\u003c\/p\u003e\n\u003ch3 data-section-id=\"a0gyp9\" data-start=\"2382\" data-end=\"2431\"\u003eCoordinated Signaling and Pathway Interaction\u003c\/h3\u003e\n\u003cp data-start=\"2433\" data-end=\"2559\"\u003eThe combination of semaglutide and cagrilintide is studied for its ability to engage multiple receptor systems simultaneously.\u003c\/p\u003e\n\u003cp data-start=\"2561\" data-end=\"2575\"\u003eThese include:\u003c\/p\u003e\n\u003cp data-start=\"2577\" data-end=\"2748\"\u003e• GLP-1 receptor-mediated pathways\u003cbr data-start=\"2611\" data-end=\"2614\"\u003e• amylin receptor (CTR\/RAMP) signaling\u003cbr data-start=\"2652\" data-end=\"2655\"\u003e• central nervous system energy regulation circuits\u003cbr data-start=\"2706\" data-end=\"2709\"\u003e• gastrointestinal signaling pathways\u003c\/p\u003e\n\u003cp data-start=\"2750\" data-end=\"2902\"\u003eIn research models, these pathways are explored for their combined effects on energy intake regulation, metabolic signaling, and endocrine coordination.\u003c\/p\u003e\n\u003cp data-start=\"2904\" data-end=\"3042\"\u003eThe peptides activate overlapping but distinct neuronal and peripheral systems, allowing investigation of multi-target signaling networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1e5cefl\" data-start=\"3049\" data-end=\"3092\"\u003eMetabolic and Cellular Research Context\u003c\/h3\u003e\n\u003cp data-start=\"3094\" data-end=\"3183\"\u003eIn experimental settings, the Cagrilintide + Semaglutide blend is studied in relation to:\u003c\/p\u003e\n\u003cp data-start=\"3185\" data-end=\"3353\"\u003e• glucose signaling pathways\u003cbr data-start=\"3213\" data-end=\"3216\"\u003e• hormonal regulation systems\u003cbr data-start=\"3245\" data-end=\"3248\"\u003e• central and peripheral energy balance signaling\u003cbr data-start=\"3297\" data-end=\"3300\"\u003e• gastrointestinal motility and feedback mechanisms\u003c\/p\u003e\n\u003cp data-start=\"3355\" data-end=\"3505\"\u003eThese systems are examined to better understand how coordinated receptor activation influences metabolic processes at the cellular and systemic level.\u003c\/p\u003e\n\u003ch3 data-section-id=\"6ijocw\" data-start=\"3512\" data-end=\"3558\"\u003ePreclinical and Clinical Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"3560\" data-end=\"3684\"\u003eA substantial body of research exists for the individual components, including both preclinical and clinical investigations.\u003c\/p\u003e\n\u003cp data-start=\"3686\" data-end=\"3708\"\u003eThese studies explore:\u003c\/p\u003e\n\u003cp data-start=\"3710\" data-end=\"3841\"\u003e• receptor activation profiles\u003cbr data-start=\"3740\" data-end=\"3743\"\u003e• signaling cascade interactions\u003cbr data-start=\"3775\" data-end=\"3778\"\u003e• metabolic pathway modulation\u003cbr data-start=\"3808\" data-end=\"3811\"\u003e• endocrine system responses\u003c\/p\u003e\n\u003cp data-start=\"3843\" data-end=\"4013\"\u003eResearch involving the combined formulation focuses on understanding how dual-peptide systems influence complex biological networks compared to single-pathway approaches.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"4020\" data-end=\"4031\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"4033\" data-end=\"4177\"\u003eThe Cagrilintide + Semaglutide blend is a multi-peptide research formulation studied for its interaction with GLP-1 and amylin receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"4179\" data-end=\"4214\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"4216\" data-end=\"4396\"\u003e• G-protein-coupled receptor signaling (GPCR)\u003cbr data-start=\"4261\" data-end=\"4264\"\u003e• cAMP-mediated intracellular pathways\u003cbr data-start=\"4302\" data-end=\"4305\"\u003e• central and peripheral metabolic regulation\u003cbr data-start=\"4350\" data-end=\"4353\"\u003e• coordinated endocrine signaling systems\u003c\/p\u003e\n\u003cp data-start=\"4398\" data-end=\"4557\"\u003eAs a research compound, this blend is explored to better understand how multi-receptor peptide systems influence metabolic signaling and biological regulation.\u003c\/p\u003e\n\u003cp data-start=\"4564\" data-end=\"4703\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000209170698,"sku":null,"price":235.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000209203466,"sku":null,"price":210.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide_Semaglutide.png?v=1778073951"},{"product_id":"retatrutide-cagrilintide-research-blend","title":"Retatrutide 8 mg + Cagrilintide 2 mg – Dual Peptide Research Blend","description":"\u003ch3 data-section-id=\"1oqfgxx\" data-start=\"0\" data-end=\"93\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Research Overview of Multi-Receptor Metabolic Signaling\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"95\" data-end=\"394\"\u003eCagrilintide and retatrutide are two research peptides studied in relation to metabolic signaling, appetite regulation pathways, and energy balance systems. When examined together in a blend, they interact with complementary receptor networks involved in endocrine signaling and nutrient regulation.\u003c\/p\u003e\n\u003cp data-start=\"396\" data-end=\"705\"\u003eCagrilintide is an amylin analog studied for its interaction with satiety-related signaling pathways and gastrointestinal regulatory systems. Retatrutide is a multi-receptor peptide agonist that interacts with GIP, GLP-1, and glucagon receptor systems associated with metabolic and energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"707\" data-end=\"1189\"\u003eIn research settings, the combination is explored for its role in coordinated receptor signaling and multi-pathway metabolic regulation. Preclinical studies involving these peptide classes have examined their effects on energy intake signaling, metabolic adaptation, and body-composition-related pathways. Clinical investigations involving the individual compounds and related combinations have further expanded understanding of multi-receptor peptide systems in metabolic research.\u003c\/p\u003e\n\u003cp data-start=\"1191\" data-end=\"1339\"\u003eThe blend represents an experimental approach to studying how multiple endocrine pathways interact simultaneously within complex metabolic networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1j69wd3\" data-start=\"1346\" data-end=\"1437\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Molecular Mechanisms of Action at the Molecular Level\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4 data-start=\"1439\" data-end=\"1456\"\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"1458\" data-end=\"1626\"\u003eCagrilintide (AM833\/NN9838) is a long-acting, acylated amylin analog studied as a dual agonist of amylin receptors (AMY1R, AMY2R, AMY3R) and calcitonin receptors (CTR).\u003c\/p\u003e\n\u003cp data-start=\"1628\" data-end=\"1804\"\u003eThese receptors belong to the class B G-protein-coupled receptor (GPCR) family and are formed through interactions between CTR and receptor activity-modifying proteins (RAMPs).\u003c\/p\u003e\n\u003cp data-start=\"1806\" data-end=\"2007\"\u003eAt the molecular level, cagrilintide adopts an α-helical structure stabilized by intramolecular interactions, while lipidation enhances albumin binding and prolongs circulation in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"2009\" data-end=\"2203\"\u003eCryo-EM studies demonstrate a distinctive receptor-binding mode involving both extracellular and transmembrane receptor domains, enabling broad receptor activation across AMYR and CTR complexes.\u003c\/p\u003e\n\u003cp data-start=\"2205\" data-end=\"2395\"\u003eFollowing receptor activation, Gs protein signaling stimulates adenylate cyclase activity, elevates intracellular cyclic AMP (cAMP), and activates downstream protein kinase A (PKA) pathways.\u003c\/p\u003e\n\u003cp data-start=\"2397\" data-end=\"2587\"\u003eThese signaling pathways are studied in relation to neuronal activity within the area postrema (AP), nucleus tractus solitarius (NTS), hypothalamic regions, and peripheral metabolic systems.\u003c\/p\u003e\n\u003ch4 data-start=\"2594\" data-end=\"2610\"\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"2612\" data-end=\"2743\"\u003eRetatrutide (LY3437943) is a multi-receptor peptide agonist built on a glucose-dependent insulinotropic polypeptide (GIP) backbone.\u003c\/p\u003e\n\u003cp data-start=\"2745\" data-end=\"2781\"\u003eIt functions as a triple agonist of:\u003c\/p\u003e\n\u003cp data-start=\"2783\" data-end=\"2922\"\u003e• glucose-dependent insulinotropic polypeptide receptor (GIPR)\u003cbr data-start=\"2845\" data-end=\"2848\"\u003e• glucagon-like peptide-1 receptor (GLP-1R)\u003cbr data-start=\"2891\" data-end=\"2894\"\u003e• glucagon receptor (GCGR)\u003c\/p\u003e\n\u003cp data-start=\"2924\" data-end=\"3093\"\u003eStructural analyses show that retatrutide forms a continuous α-helix interacting with extracellular and transmembrane receptor regions across all three receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3095\" data-end=\"3222\"\u003eThese receptors primarily signal through Gs-mediated cAMP pathways and downstream activation of PKA and ERK signaling cascades.\u003c\/p\u003e\n\u003cp data-start=\"3224\" data-end=\"3483\"\u003eGLP-1R and GIPR activation are studied in relation to glucose-dependent endocrine signaling pathways, while GCGR activation is associated with metabolic signaling related to glycogenolysis, lipid metabolism, and mitochondrial activity in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"3485\" data-end=\"3617\"\u003eCentral nervous system effects involve hypothalamic and brainstem pathways associated with energy regulation and nutrient signaling.\u003c\/p\u003e\n\u003ch3 data-section-id=\"yn9qpm\" data-start=\"3624\" data-end=\"3671\"\u003e\u003cstrong\u003eCoordinated Signaling and Molecular Synergy\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3673\" data-end=\"3810\"\u003eIn research models, cagrilintide and retatrutide are studied for their complementary signaling profiles across multiple receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3812\" data-end=\"3826\"\u003eThese include:\u003c\/p\u003e\n\u003cp data-start=\"3828\" data-end=\"3962\"\u003e• amylin receptor pathways\u003cbr data-start=\"3854\" data-end=\"3857\"\u003e• GLP-1 receptor signaling\u003cbr data-start=\"3883\" data-end=\"3886\"\u003e• GIP receptor pathways\u003cbr data-start=\"3909\" data-end=\"3912\"\u003e• glucagon receptor-mediated metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"3964\" data-end=\"4118\"\u003eThe peptides engage overlapping but distinct neuronal and peripheral systems involved in energy regulation, endocrine signaling, and metabolic adaptation.\u003c\/p\u003e\n\u003cp data-start=\"4120\" data-end=\"4316\"\u003eExperimental findings suggest that simultaneous activation of these pathways may influence coordinated cAMP and PKA signaling across central nervous system nuclei and peripheral metabolic tissues.\u003c\/p\u003e\n\u003cp data-start=\"4318\" data-end=\"4456\"\u003eThe acylated structures of both peptides support prolonged receptor interaction and co-formulation stability in experimental environments.\u003c\/p\u003e\n\u003ch3 data-section-id=\"5xoxpw\" data-start=\"4463\" data-end=\"4496\"\u003e\u003cstrong\u003ePreclinical Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"4498\" data-end=\"4678\"\u003ePreclinical studies involving amylin analogs and multi-receptor incretin agonists have examined their effects in animal models related to metabolic signaling and energy regulation.\u003c\/p\u003e\n\u003cp data-start=\"4680\" data-end=\"4710\"\u003eResearch observations include:\u003c\/p\u003e\n\u003cp data-start=\"4712\" data-end=\"4924\"\u003e• modulation of energy intake pathways\u003cbr data-start=\"4750\" data-end=\"4753\"\u003e• alterations in metabolic signaling profiles\u003cbr data-start=\"4798\" data-end=\"4801\"\u003e• changes in lipid and glucose-related pathways\u003cbr data-start=\"4848\" data-end=\"4851\"\u003e• preservation of lean tissue signaling markers in experimental systems\u003c\/p\u003e\n\u003cp data-start=\"4926\" data-end=\"5074\"\u003eStudies involving related peptide combinations further support investigation into coordinated receptor activation and endocrine pathway interaction.\u003c\/p\u003e\n\u003ch3 data-section-id=\"9l10v\" data-start=\"5081\" data-end=\"5110\"\u003e\u003cstrong\u003eClinical Research Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5112\" data-end=\"5178\"\u003eClinical research involving the individual compounds has explored:\u003c\/p\u003e\n\u003cp data-start=\"5180\" data-end=\"5317\"\u003e• receptor signaling dynamics\u003cbr data-start=\"5209\" data-end=\"5212\"\u003e• metabolic pathway regulation\u003cbr data-start=\"5242\" data-end=\"5245\"\u003e• endocrine system responses\u003cbr data-start=\"5273\" data-end=\"5276\"\u003e• gastrointestinal signaling mechanisms\u003c\/p\u003e\n\u003cp data-start=\"5319\" data-end=\"5450\"\u003eAdditional investigations continue to examine how multi-receptor peptide systems influence complex metabolic and hormonal networks.\u003c\/p\u003e\n\u003cp data-start=\"5452\" data-end=\"5582\"\u003eAt present, direct combination studies specifically involving cagrilintide and retatrutide remain limited in published literature.\u003c\/p\u003e\n\u003ch3 data-section-id=\"pxh5eu\" data-start=\"5589\" data-end=\"5624\"\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5626\" data-end=\"5774\"\u003eThe molecular signaling characteristics of the cagrilintide + retatrutide blend make it relevant for experimental investigation in areas related to:\u003c\/p\u003e\n\u003cp data-start=\"5776\" data-end=\"5934\"\u003e• metabolic signaling systems\u003cbr data-start=\"5805\" data-end=\"5808\"\u003e• endocrine pathway coordination\u003cbr data-start=\"5840\" data-end=\"5843\"\u003e• gastrointestinal regulatory mechanisms\u003cbr data-start=\"5883\" data-end=\"5886\"\u003e• energy balance and nutrient sensing pathways\u003c\/p\u003e\n\u003cp data-start=\"5936\" data-end=\"6025\"\u003eThese studies are conducted primarily in preclinical and translational research settings.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"6032\" data-end=\"6043\"\u003e\u003cstrong\u003eSummary\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"6045\" data-end=\"6204\"\u003eThe cagrilintide + retatrutide blend is a dual-peptide research formulation studied for its interaction with multiple endocrine and metabolic receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"6206\" data-end=\"6241\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"6243\" data-end=\"6421\"\u003e• amylin receptor signaling\u003cbr data-start=\"6270\" data-end=\"6273\"\u003e• GLP-1, GIP, and glucagon receptor activation\u003cbr data-start=\"6319\" data-end=\"6322\"\u003e• cAMP-mediated intracellular pathways\u003cbr data-start=\"6360\" data-end=\"6363\"\u003e• coordinated central and peripheral metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"6423\" data-end=\"6581\"\u003eAs a research formulation, this blend is explored to better understand how multi-receptor peptide systems influence complex biological and metabolic networks.\u003c\/p\u003e\n\u003cp data-start=\"6588\" data-end=\"6727\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000814133514,"sku":null,"price":285.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000814166282,"sku":null,"price":260.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide_Retatrutide.png?v=1778074379"},{"product_id":"mazdutide-research-peptide","title":"Mazdutide 10 mg – Multi-Receptor Metabolic Research Peptide","description":"\u003ch3 data-section-id=\"1ga2phu\" data-start=\"0\" data-end=\"105\"\u003eMazdutide (IBI362 \/ LY3305677, CAS 2259884-03-0): Molecular Mechanism and Metabolic Research Overview\u003c\/h3\u003e\n\u003cp data-start=\"107\" data-end=\"452\"\u003eMazdutide is a synthetic dual peptide agonist studied for its interaction with glucagon-like peptide-1 receptors (GLP-1R) and glucagon receptors (GCGR). Originally developed as LY3305677 and later advanced by Innovent Biologics, it is structurally based on oxyntomodulin (OXM), an endogenous peptide associated with metabolic signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"454\" data-end=\"805\"\u003eMazdutide is engineered as a long-acting peptide analog designed to support sustained receptor interaction in experimental and clinical research settings. Its structure combines GLP-1R and GCGR agonism in a balanced signaling profile, making it relevant for studies involving energy regulation, endocrine signaling, and metabolic pathway coordination.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1y7bgok\" data-start=\"812\" data-end=\"853\"\u003eMolecular Design and Receptor Binding\u003c\/h3\u003e\n\u003cp data-start=\"855\" data-end=\"1009\"\u003eMazdutide is a linear peptide built on the mammalian oxyntomodulin backbone, which contains the glucagon sequence with an additional C-terminal extension.\u003c\/p\u003e\n\u003cp data-start=\"1011\" data-end=\"1194\"\u003eTargeted amino acid modifications and lipidation strategies enhance resistance to enzymatic degradation, improve albumin binding, and prolong circulation time in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"1196\" data-end=\"1440\"\u003eBoth GLP-1R and GCGR belong to the class B G-protein-coupled receptor (GPCR) family. Ligand binding induces conformational changes in extracellular and transmembrane receptor domains, promoting activation of intracellular Gs signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"1442\" data-end=\"1563\"\u003eMazdutide stabilizes active receptor conformations across both receptor systems, enabling coordinated signaling activity.\u003c\/p\u003e\n\u003ch3 data-section-id=\"w8vdgj\" data-start=\"1570\" data-end=\"1642\"\u003eDownstream Signaling: Cyclic Adenosine Monophosphate (cAMP) Pathways\u003c\/h3\u003e\n\u003cp data-start=\"1644\" data-end=\"1835\"\u003eThe primary signaling mechanism for both receptors involves activation of adenylyl cyclase through Gs proteins, leading to elevated intracellular cyclic adenosine monophosphate (cAMP) levels.\u003c\/p\u003e\n\u003cp data-start=\"1837\" data-end=\"1941\"\u003eIncreased cAMP activates protein kinase A (PKA), which modulates multiple downstream cellular processes.\u003c\/p\u003e\n\u003ch4 data-start=\"1943\" data-end=\"1963\"\u003eGLP-1R Pathways\u003c\/h4\u003e\n\u003cp data-start=\"1965\" data-end=\"2016\"\u003eGLP-1 receptor signaling is studied in relation to:\u003c\/p\u003e\n\u003cp data-start=\"2018\" data-end=\"2135\"\u003e• pancreatic endocrine signaling\u003cbr data-start=\"2050\" data-end=\"2053\"\u003e• gastrointestinal regulatory pathways\u003cbr data-start=\"2091\" data-end=\"2094\"\u003e• hypothalamic nutrient-sensing systems\u003c\/p\u003e\n\u003ch4 data-start=\"2142\" data-end=\"2160\"\u003eGCGR Pathways\u003c\/h4\u003e\n\u003cp data-start=\"2162\" data-end=\"2209\"\u003eGlucagon receptor signaling is associated with:\u003c\/p\u003e\n\u003cp data-start=\"2211\" data-end=\"2353\"\u003e• hepatic metabolic regulation\u003cbr data-start=\"2241\" data-end=\"2244\"\u003e• lipid metabolism pathways\u003cbr data-start=\"2271\" data-end=\"2274\"\u003e• mitochondrial fatty acid oxidation\u003cbr data-start=\"2310\" data-end=\"2313\"\u003e• energy expenditure signaling systems\u003c\/p\u003e\n\u003ch3 data-section-id=\"hocnt\" data-start=\"2360\" data-end=\"2394\"\u003eIntegrated Metabolic Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2396\" data-end=\"2511\"\u003eMazdutide is studied for its ability to engage both appetite-related and energy-regulation pathways simultaneously.\u003c\/p\u003e\n\u003cp data-start=\"2513\" data-end=\"2541\"\u003eResearch models examine how:\u003c\/p\u003e\n\u003cp data-start=\"2543\" data-end=\"2754\"\u003e• GLP-1R signaling influences nutrient-related feedback systems\u003cbr data-start=\"2606\" data-end=\"2609\"\u003e• GCGR activation affects lipid metabolism and mitochondrial activity\u003cbr data-start=\"2678\" data-end=\"2681\"\u003e• coordinated receptor activation impacts metabolic pathway integration\u003c\/p\u003e\n\u003cp data-start=\"2756\" data-end=\"2850\"\u003eThese pathways are explored in relation to complex endocrine and metabolic signaling networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"a2ux4l\" data-start=\"2857\" data-end=\"2896\"\u003eImportance of Balanced Dual Agonism\u003c\/h3\u003e\n\u003cp data-start=\"2898\" data-end=\"3022\"\u003eNative oxyntomodulin naturally interacts with both GLP-1R and GCGR but has limited stability and short duration of activity.\u003c\/p\u003e\n\u003cp data-start=\"3024\" data-end=\"3184\"\u003eMazdutide’s structural modifications enhance receptor interaction and signaling persistence while preserving balanced dual agonism across both receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3186\" data-end=\"3240\"\u003eThis balanced profile is studied for its influence on:\u003c\/p\u003e\n\u003cp data-start=\"3242\" data-end=\"3369\"\u003e• metabolic flexibility\u003cbr data-start=\"3265\" data-end=\"3268\"\u003e• mitochondrial energy signaling\u003cbr data-start=\"3300\" data-end=\"3303\"\u003e• lipid metabolism pathways\u003cbr data-start=\"3330\" data-end=\"3333\"\u003e• coordinated endocrine regulation\u003c\/p\u003e\n\u003ch3 data-section-id=\"1yoi1o1\" data-start=\"3376\" data-end=\"3437\"\u003eComparative Overview of Multi-Receptor Metabolic Peptides\u003c\/h3\u003e\n\u003ctable style=\"width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth style=\"width: 15.5235%;\"\u003eCompound\u003c\/th\u003e\n\u003cth style=\"width: 15.1625%;\"\u003eReceptors Targeted\u003c\/th\u003e\n\u003cth style=\"width: 14.2599%;\"\u003eAgonist Profile\u003c\/th\u003e\n\u003cth style=\"width: 11.9134%;\"\u003eCAS Number\u003c\/th\u003e\n\u003cth style=\"width: 19.8556%;\"\u003eResearch Stage\u003c\/th\u003e\n\u003cth style=\"width: 21.2996%;\"\u003eKey Research Focus\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 15.5235%;\"\u003eSemaglutide\u003c\/td\u003e\n\u003ctd style=\"width: 15.1625%;\"\u003eGLP-1R\u003c\/td\u003e\n\u003ctd style=\"width: 14.2599%;\"\u003eGLP-1R agonist\u003c\/td\u003e\n\u003ctd style=\"width: 11.9134%;\"\u003e910463-68-2\u003c\/td\u003e\n\u003ctd style=\"width: 19.8556%;\"\u003eApproved \/ extensively studied\u003c\/td\u003e\n\u003ctd style=\"width: 21.2996%;\"\u003eAppetite and incretin signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 15.5235%;\"\u003eTirzepatide\u003c\/td\u003e\n\u003ctd style=\"width: 15.1625%;\"\u003eGLP-1R + GIPR\u003c\/td\u003e\n\u003ctd style=\"width: 14.2599%;\"\u003eDual agonist\u003c\/td\u003e\n\u003ctd style=\"width: 11.9134%;\"\u003e2023788-19-2\u003c\/td\u003e\n\u003ctd style=\"width: 19.8556%;\"\u003eApproved \/ extensively studied\u003c\/td\u003e\n\u003ctd style=\"width: 21.2996%;\"\u003eMulti-incretin metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 15.5235%;\"\u003eRetatrutide\u003c\/td\u003e\n\u003ctd style=\"width: 15.1625%;\"\u003eGLP-1R + GIPR + GCGR\u003c\/td\u003e\n\u003ctd style=\"width: 14.2599%;\"\u003eTriple agonist\u003c\/td\u003e\n\u003ctd style=\"width: 11.9134%;\"\u003e2381089-83-2\u003c\/td\u003e\n\u003ctd style=\"width: 19.8556%;\"\u003eAdvanced clinical research\u003c\/td\u003e\n\u003ctd style=\"width: 21.2996%;\"\u003eMulti-receptor energy regulation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 15.5235%;\"\u003eMazdutide\u003c\/td\u003e\n\u003ctd style=\"width: 15.1625%;\"\u003eGLP-1R + GCGR\u003c\/td\u003e\n\u003ctd style=\"width: 14.2599%;\"\u003eDual GLP-1R \/ GCGR agonist\u003c\/td\u003e\n\u003ctd style=\"width: 11.9134%;\"\u003e2259884-03-0\u003c\/td\u003e\n\u003ctd style=\"width: 19.8556%;\"\u003eApproved in China \/ ongoing research\u003c\/td\u003e\n\u003ctd style=\"width: 21.2996%;\"\u003eEnergy expenditure and metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"4308\" data-end=\"4319\"\u003eSummary\u003c\/h3\u003e\n\u003cp data-start=\"4321\" data-end=\"4454\"\u003eMazdutide is a dual GLP-1R and GCGR agonist studied for its role in coordinated metabolic signaling and endocrine pathway regulation.\u003c\/p\u003e\n\u003cp data-start=\"4456\" data-end=\"4491\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"4493\" data-end=\"4657\"\u003e• cAMP-mediated GPCR signaling\u003cbr data-start=\"4523\" data-end=\"4526\"\u003e• GLP-1 and glucagon receptor activation\u003cbr data-start=\"4566\" data-end=\"4569\"\u003e• mitochondrial and lipid metabolism pathways\u003cbr data-start=\"4614\" data-end=\"4617\"\u003e• integrated energy regulation systems\u003c\/p\u003e\n\u003cp data-start=\"4659\" data-end=\"4850\"\u003eAs a research peptide and metabolic signaling compound, mazdutide is explored to better understand how balanced multi-receptor activation influences complex biological and endocrine networks.\u003c\/p\u003e\n\u003cp data-start=\"4857\" data-end=\"4996\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000841068810,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000841101578,"sku":null,"price":170.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Mazdutide_2.png?v=1778074824"},{"product_id":"prg-deep-sleep-blend-pinealon-epitalon-selank-research-peptide-blend","title":"PRG Deep Sleep Blend 30mg – Pinealon, Epitalon \u0026 Selank Research Peptide Blend","description":"\u003cp\u003e\u003cstrong\u003ePRG Deep Sleep Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe deep sleep peptide blend combines Pinealon, Epitalon, and Selank to support restorative sleep-associated signaling pathways. Pinealon is a short peptide studied for its role in maintaining neuronal cellular function and circadian-associated biological rhythms. Epitalon is investigated for its interaction with pineal signaling pathways and melatonin-regulation-associated systems. Selank is studied for its modulation of stress-response and GABAergic signaling pathways without strong sedative-like activity. Together, the three peptides interact with multiple brain and neuroendocrine systems involved in sleep depth, sleep architecture, and circadian regulation. The blend supports endogenous biological mechanisms associated with transition into and maintenance of deep-sleep-associated stages. Rather than acting through direct sedative suppression, it primarily targets intracellular signaling pathways and neuroregulatory systems within neuronal cells. Animal research has demonstrated changes in sleep-pattern-associated behavior and calmer cortical signaling activity following administration of these peptides. Human observational studies, particularly in older adult populations, have reported improvements in sleep-regularity-associated parameters and morning-restoration-associated observations. The overall research focus of the blend centers on promoting more stable, high-quality deep-sleep-associated signaling through endogenous regulatory pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMolecular Mechanisms of Action at the Cellular and Subcellular Level\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePinealon (Glu-Asp-Arg) is a tripeptide bioregulator whose small size allows passive diffusion across lipid bilayers, including the plasma membrane and nuclear envelope. Once inside the nucleus it interacts directly with specific DNA sequences, modulating transcription of genes involved in neuronal differentiation, repair, and antioxidant defense. In cerebellar granule neurons and cortical cell models this leads to upregulated expression of proteins such as nestin and β-tubulin III, while simultaneously enhancing transcription of genes encoding superoxide dismutase isoforms and glutathione peroxidase.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe peptide restricts accumulation of reactive oxygen species (ROS) generated by receptor-dependent or independent oxidative stressors, delays ERK1\/2 phosphorylation kinetics, and reduces necrotic and apoptotic signaling under hypoxic or toxin-associated stress conditions. By stabilizing mitochondrial function and limiting caspase-3 and p53-mediated pathways in stressed neurons, Pinealon preserves synaptic integrity and supports serotonin biosynthetic capacity in cortical neurons, providing an upstream substrate pool for melatonin synthesis. These actions converge on pineal-modulated circadian output because the peptide also restores pinealocyte responsiveness, indirectly reinforcing the suprachiasmatic nucleus–pineal axis without acting as a direct melatonin mimetic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEpitalon (Ala-Glu-Asp-Gly) is a tetrapeptide modeled on pineal-derived sequences that likewise crosses cellular and nuclear membranes to engage DNA regulatory elements. Its primary molecular target in pinealocytes is transcriptional activation of arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin biosynthesis, via increased phosphorylation of CREB and subsequent promoter engagement.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn parallel, Epitalon induces telomerase reverse transcriptase (hTERT) expression and enzymatic activity, contributing to telomere-maintenance-associated signaling and modulation of replicative senescence pathways. This telomerase upregulation occurs through epigenetic modulation, including altered histone-acetylation patterns at telomeric regions and suppression of p53-associated senescence signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn aged pineal tissue the peptide normalizes diurnal melatonin-associated signaling patterns by restoring nocturnal amplitude rhythms and reducing aberrant daytime cortisol-associated fluctuations, thereby re-entraining peripheral clock genes (PER, CRY, CLOCK\/BMAL1). Antioxidant effects arise from both direct ROS modulation in pineal mitochondria and indirect upregulation of endogenous antioxidant enzymes, while the peptide also modulates interleukin-2 mRNA and thymocyte-associated mitogenic signaling, linking neuroendocrine and immune circadian coordination.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe net result is reinforcement of the pineal–hypothalamic feedback loop associated with deeper non-REM sleep-state signaling through enhanced melatonin-associated GABAergic tone in thalamic and cortical networks.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSelank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), a synthetic heptapeptide analog of the immunopeptide tuftsin, exerts its effects primarily at the plasma-membrane level while also influencing nuclear transcription. It functions as a positive allosteric modulator of GABA-A receptors, altering GABA-binding kinetics without occupying the benzodiazepine site. Radioligand studies demonstrate increased specific [³H]GABA binding and shifts in receptor-subunit stoichiometry favoring inhibitory chloride conductance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis modulation is rapid and concentration-dependent, producing gene-expression changes in the frontal cortex within one hour, including upregulation of GABA receptor α- and β-subunits, GABA transporters, and ion-channel-associated genes, with transcriptional overlap resembling exogenous GABA signaling itself.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSelank simultaneously inhibits neutral endopeptidase and aminopeptidase N, prolonging synaptic persistence of endogenous enkephalins and thereby amplifying μ- and δ-opioid receptor-associated signaling that dampens stress-associated hypothalamic-pituitary-adrenal-axis activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn hippocampal and cortical neurons it rapidly elevates brain-derived neurotrophic factor (BDNF) mRNA and protein via CREB-dependent promoter IV activation, enhancing TrkB autophosphorylation, dendritic-spine density, and synaptic-plasticity-associated signaling pathways. Serotonergic and dopaminergic gene networks are also modulated, including 5-HT receptor subtypes and dopamine transporter pathways, reducing hyperarousal-associated signaling without pronounced sedative or amnestic effects.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCollectively these changes lower cortical excitability thresholds, facilitate sleep-spindle-associated oscillations, and stabilize transitions into slow-wave-sleep-associated states.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSynergistic Molecular Integration of the Blend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhen Pinealon, Epitalon, and Selank are combined, their actions converge at multiple nodes of the sleep-regulatory network. Epitalon restores pineal melatonin-associated output signaling at the enzymatic and transcriptional level, while Pinealon amplifies these effects by protecting pinealocytes and cortical neurons from oxidative stress-associated damage and by supporting serotonin availability for melatonin-associated pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSelank lowers the arousal set-point through GABA-A allosteric modulation and enkephalin stabilization, allowing melatonin-gated thalamo-cortical oscillatory signaling to propagate into deeper delta-wave-associated activity without excessive interference from stress-associated noradrenergic or CRF pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the nuclear level the two bioregulators (Pinealon and Epitalon) coordinate gene-expression programs involving telomerase maintenance, neuronal antioxidant signaling, and cellular repair pathways, while Selank contributes BDNF-associated plasticity signaling that consolidates these effects into longer-term synaptic remodeling-associated adaptations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe blend therefore does not simply suppress wakefulness-associated signaling but instead recalibrates pineal–cortical–limbic regulatory networks involved in circadian rhythm synchronization, sleep-depth-associated signaling, sleep-spindle density, and REM\/non-REM cycling at the level of ion-channel regulation, histone-acetylation-associated pathways, and neurotrophin signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePotential Research Applications in Sleep and Circadian Biology\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe molecular profile positions the blend for research involving biological systems where deep-sleep-associated signaling is disrupted by circadian dysregulation, oxidative neuronal burden, or hyperarousal-associated pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAge-associated decline in pineal melatonin signaling, telomere attrition in pinealocytes, and progressive cortical oxidative stress contribute to fragmentation of slow-wave-sleep-associated architecture; the blend addresses each of these biological nodes through distinct but convergent mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn stress-associated insomnia models, the combined GABA-A\/BDNF signaling effects of Selank alongside circadian reinforcement from Pinealon and Epitalon may support restoration of sleep-efficiency-associated signaling without reliance on direct sedative suppression pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNeurodegenerative research models may also benefit from the blend’s neuroprotective gene-expression programs and mitochondrial-stabilization-associated signaling, potentially helping preserve sleep architecture in age-associated neurobiological decline.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional exploratory research areas include shift-work-associated circadian disruption, jet-lag-associated desynchronization, maintenance of cognitive-performance-associated signaling during sleep restriction, nocturnal immune-regulation pathways, and metabolic signaling associated with growth-hormone pulsatility during deep sleep.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBecause the peptides preserve rather than override endogenous circadian rhythms, the blend aligns conceptually with precision neuroendocrine and sleep-biology peptide research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSummary of Animal and Human Investigations\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn rodent models Pinealon administration to aged or hypoxic animals improved sleep-continuity-associated behavior, reduced cortical ROS accumulation, and preserved dendritic-spine morphology in hippocampal and cortical tissue models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEpitalon studies in aged rats and mice demonstrated increased pineal AANAT activity, telomere-maintenance-associated signaling across multiple tissues, and normalization of circadian locomotor-associated behavior. Primate studies in aged rhesus monkeys demonstrated increased nocturnal melatonin-associated output amplitude and restoration of physiologic cortisol-associated nadir patterns, alongside stabilization of glucose and lipid-associated metabolic parameters.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSelank research in rodent anxiety and stress paradigms produced rapid reductions in hyperlocomotion-associated signaling, elevated hippocampal BDNF expression, and altered frontal-cortex GABAergic gene-expression patterns within hours of exposure.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCombined peptide approaches in neuroprotection-associated animal assays demonstrated additive preservation of neuronal viability under oxidative challenge conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHuman investigations, particularly involving older adult cohorts, documented that Epitalon-type pineal peptides restored nocturnal melatonin-associated profiles to levels resembling younger biological patterns, improved subjective sleep-depth-associated observations, and normalized circadian-phase markers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePinealon observational studies involving traumatic-brain-injury-associated and age-related cognitive-change-associated populations reported improvements in memory-consolidation-associated signaling and daytime-alertness-related parameters consistent with enhanced overnight neuronal repair-associated activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSelank has also been investigated in generalized-anxiety-associated populations, demonstrating reductions in Hamilton Anxiety Scale-associated observations without significant sedation, memory impairment, or withdrawal-associated patterns; secondary sleep-associated improvements were noted in subjects where insomnia-related signaling was linked to hyperarousal and stress pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSmall-scale observational datasets involving multi-peptide regimens in elderly subjects with sleep-maintenance-associated difficulties suggest additive improvements in polysomnographic slow-wave-sleep-associated percentages and next-day cognitive-performance-associated parameters.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAcross these studies the peptides demonstrated favorable tolerability profiles, with molecular readouts—including telomere-associated markers, antioxidant-enzyme activity, and GABA-binding-associated signaling—aligning with preclinical mechanistic findings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhile large-scale randomized controlled investigations focused specifically on the exact three-peptide blend remain limited, the complementary mechanistic and observational data continue to support scientific interest in the formulation for deep-sleep-associated and circadian-regulation-associated research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn summary, the Pinealon–Epitalon–Selank blend operates through an integrated network involving nuclear gene regulation, receptor allostery, antioxidant signaling, and enzymatic circadian control pathways to support deep-sleep-associated neuroendocrine homeostasis. Its relevance extends across age-associated, stress-associated, and neurodegenerative sleep-biology research models through interaction with upstream biochemical signaling systems rather than downstream symptom-suppression pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe PRG Deep Sleep formulation is a proprietary peptide blend of Pinealon (Glu-Asp-Arg \/ EDR tripeptide), Epitalon (Ala-Glu-Asp-Gly \/ AEDG tetrapeptide), and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro \/ TKPRPGP heptapeptide) supplied in acetate salt form, which is the standard presentation for these synthetic peptides to optimize aqueous solubility, lyophilization stability, and handling in biochemical and synthesis workflows.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAs a proprietary mixture of the acetate salts of Pinealon, Epitalon, and Selank, it retains no single assigned CAS number and has no unified molecular formula. The acetate salts consist of the individual peptide bases with acetate counterions incorporated according to the net positive charge contributed by basic residues and purification conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-section-id=\"1tsw56w\" data-start=\"1165\" data-end=\"1212\"\u003eNeurotrophic Peptides in Cognitive Research\u003c\/h3\u003e\n\u003cp data-start=\"1214\" data-end=\"1417\"\u003eExplore how compounds such as Epithalon, Selank, and Pinealon are discussed in cognitive and neurotrophic research in our article: \u003ca href=\"https:\/\/www.peptideregenesis.com\/blogs\/peptide-blog\/neurotrophic-peptides-cognitive-research\"\u003e\u003cstrong data-start=\"1345\" data-end=\"1416\"\u003eBest Neurotrophic Peptides for Cognitive Research and Brain Support\u003c\/strong\u003e.\u003c\/a\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53064508735754,"sku":null,"price":265.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53064508768522,"sku":null,"price":240.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/prg_deepsleep.png?v=1779964642"},{"product_id":"met-enkephalin-5mg-research-peptide","title":"Met-Enkephalin 5mg - Research Peptide","description":"\u003cp\u003e\u003cstrong\u003eMet-Enkephalin Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCAS number (sequence): 58569-55-4 (Tyr-Gly-Gly-Phe-Met; [Met⁵]-enkephalin)\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eMolecular formula: C₂₇H₃₅N₅O₇S\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eMolecular weight: 573.67 g\/mol (anhydrous free base)\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMet-enkephalin is a small peptide naturally produced in the human body that helps manage pain signals. It forms through the breakdown of a larger precursor protein inside nerve cells and certain immune cells. Once active, the peptide attaches to specific receptors on cell surfaces to reduce how strongly pain messages travel through the nervous system.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt also influences cell division rates in growing tissues and tumors by slowing the progression of cells through their growth cycle. In the immune system, met-enkephalin adjusts the behavior of white blood cells, including T cells and natural killer cells, to support balanced responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eScientists have examined its effects in animal models of cancer, where it limits uncontrolled cell multiplication. Similar tests in animals with nerve inflammation show improvements in movement and reduced tissue damage.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHuman studies have tested met-enkephalin in people with advanced cancers and certain immune-related conditions. The findings indicate that it can stabilize disease progression in some cases by working alongside the body’s own regulatory systems.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch continues to clarify its roles and ways to apply it in peptide-based applications.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBiosynthesis and Peptide Processing\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMet-enkephalin, the pentapeptide Tyr-Gly-Gly-Phe-Met, arises from proteolytic processing of proenkephalin, a 243-amino-acid precursor encoded by the PENK gene.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eProenkephalin undergoes sequential cleavage by prohormone convertases PC1\/3 and PC2 at dibasic sites, followed by carboxypeptidase E trimming of C-terminal basic residues and, in select cases, further amidation or acetylation modifications that fine-tune bioactivity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis biosynthetic pathway operates in neurons of the central and peripheral nervous systems, adrenal chromaffin cells, and various immune cell lineages, yielding multiple copies of met-enkephalin per precursor molecule alongside lesser amounts of leu-enkephalin and extended forms such as met-enkephalin-Arg-Phe.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOnce released into the extracellular space via regulated exocytosis, the peptide encounters rapid degradation by membrane-bound and soluble peptidases, primarily neutral endopeptidase (NEP, also known as enkephalinase), aminopeptidases, and carboxypeptidases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese catabolic steps limit the native peptide’s half-life to minutes, presenting a key consideration in peptide synthesis strategies aimed at research stabilization through backbone modifications, D-amino acid substitutions, or cyclization while preserving core pharmacophores.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMolecular Mechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the molecular level, met-enkephalin exerts its primary effects through activation of G-protein-coupled opioid receptors, predominantly the mu (MOR) and delta (DOR) subtypes, with lesser engagement of kappa receptors under high local concentrations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eReceptor ligation triggers Gi\/o heterotrimeric G-protein dissociation, whereupon the Gαi subunit directly inhibits adenylyl cyclase isoforms, sharply lowering intracellular cyclic AMP levels.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eConcomitant release of Gβγ subunits modulates voltage-gated ion channels:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eit inhibits N-type and P\/Q-type calcium channels at presynaptic terminals,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ecurtailing calcium influx required for vesicular neurotransmitter release,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ewhile simultaneously activating G-protein-coupled inwardly rectifying potassium (GIRK) channels that hyperpolarize the neuronal membrane.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThe net outcome is presynaptic inhibition of excitatory transmitter release — including glutamate in nociceptive pathways and substance P in spinal dorsal horn circuits — together with postsynaptic dampening of neuronal excitability.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn parallel, mitogen-activated protein kinase (MAPK\/ERK) cascades undergo transient phosphorylation downstream of receptor activation, contributing to longer-term adaptations in gene expression that reinforce analgesic signaling without invoking the profound receptor internalization or desensitization seen with many synthetic agonists.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOpioid Growth Factor Pathway\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAn independent molecular pathway operates when met-enkephalin functions as the opioid growth factor (OGF).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHere it engages the OGF receptor (OGFr), a distinct integral membrane protein that translocates to the nucleus upon ligand binding.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis interaction upregulates the cyclin-dependent kinase inhibitors p16^INK4a and p21^WAF1\/CIP1 at both transcriptional and post-translational levels.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eElevated p16 blocks cyclin D–CDK4\/6 complexes, while p21 inhibits cyclin E–CDK2, collectively stalling retinoblastoma protein phosphorylation and halting progression from G0\/G1 into S phase.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe result is a cytostatic rather than cytotoxic arrest that is fully reversible upon peptide withdrawal, serum-independent, and non-apoptotic at physiological concentrations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis growth-regulatory axis operates in both normal renewing epithelia and neoplastic cells, where OGFr density often correlates inversely with proliferation rate.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCross-talk between the classical opioid receptor pathways and the OGF–OGFr axis occurs in immune and glial cells, where reduced cAMP can synergize with p21 induction to restrain excessive lymphocyte expansion while preserving effector functions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese dual molecular mechanisms underpin diverse potential applications in peptide research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn nociception, met-enkephalin contributes to endogenous analgesia within descending inhibitory tracts originating in the periaqueductal gray and rostral ventromedial medulla, as well as within peripheral terminals of primary afferents where immune-derived peptide release modulates inflammatory pain.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts ability to inhibit neurotransmitter overflow at spinal and supraspinal synapses positions it as a template for designing peptidomimetics that achieve targeted pain signaling modulation with minimal reward pathway engagement.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn oncology research, the OGF–OGFr axis offers a non-cytotoxic strategy to restrain tumor proliferation across multiple lineages, including:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003epancreatic ductal adenocarcinoma,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ehepatocellular carcinoma,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand certain sarcomas.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThis occurs by restoring cell-cycle checkpoints that are frequently disrupted in malignant cells.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eImmunomodulatory applications stem from met-enkephalin’s capacity to down-regulate regulatory T-cell suppressive activity while enhancing natural killer cell cytotoxicity and shifting cytokine profiles away from excessive pro-inflammatory dominance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis profile suggests utility in autoimmune demyelinating research models, where unchecked T- and B-cell proliferation drives tissue damage, and in supportive recovery models following chemotherapy or viral infections where immune reconstitution is desirable.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional avenues include modulation of stress-axis hyperactivity, hepatoprotection via reduced oxidative stress and inflammatory signaling in hepatocytes, and potential adjunctive roles in metabolic syndrome through influences on adipose browning and energy homeostasis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnimal Research Findings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExtensive animal trial data illustrate these applications across rodent and other preclinical models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn xenograft models of human pancreatic cancer implanted subcutaneously or orthotopically in athymic nude mice, daily or intermittent met-enkephalin administration significantly retards tumor volume expansion, decreases DNA synthesis rates measured by BrdU incorporation, and elevates intratumoral p16 and p21 protein levels without inducing necrosis or altering host body weight.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eParallel studies in syngeneic murine models of hepatocellular carcinoma demonstrate reduced metastatic burden and prolonged host survival, accompanied by increased tumor-infiltrating NK cells and decreased Treg populations within the tumor microenvironment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExperimental autoimmune encephalomyelitis (EAE), the standard rodent model of multiple sclerosis induced by myelin oligodendrocyte glycoprotein immunization, responds robustly to met-enkephalin.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreated animals exhibit:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003edelayed disease onset,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003emarkedly lower clinical scores of paralysis,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003epreserved myelin integrity on histological sections,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003enormalized serum peptide levels,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced astrocytic activation,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand reduced microglial proliferation.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eElectrophysiological recordings in these models confirm restored conduction velocities across demyelinated fibers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn acute and chronic inflammatory pain models — including carrageenan-induced paw edema, complete Freund’s adjuvant arthritis, and bone-cancer pain induced by tibial inoculation — systemic or intrathecal met-enkephalin attenuates mechanical allodynia and thermal hyperalgesia via both peripheral opioid receptor occupancy on immune cells and central presynaptic inhibition in the dorsal horn.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStress paradigms in rodents and avian species further reveal that exogenous met-enkephalin blunts corticosterone surges and normalizes adrenal proenkephalin expression, indicating feedback regulation within the hypothalamic–pituitary–adrenal axis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCollectively, these preclinical datasets establish concentration-dependent, receptor-mediated effects across pain, neoplasia, autoimmunity, and stress-related endpoints while highlighting the peptide’s rapid clearance as the principal pharmacokinetic limitation addressed in synthetic optimization programs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHuman Research Findings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHuman trial summaries, drawn from open-label and controlled investigations, reinforce translational potential while underscoring safety in peptide research contexts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn phase I escalation studies involving patients with advanced unresectable pancreatic adenocarcinoma who had progressed on standard chemotherapy, weekly intravenous infusions of met-enkephalin proved well tolerated, with no grade 3 or 4 adverse events attributable to the peptide and no evidence of opioid-related central effects.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSubsequent phase II open-label evaluation in a cohort of 24 such patients demonstrated objective tumor stabilization or regression in a majority of participants surviving beyond two months, coupled with median survival extension approximately threefold relative to historical controls receiving best supportive care alone.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePlasma met-enkephalin levels rose transiently post-infusion and correlated with clinical benefit.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eParallel investigations in hepatocellular carcinoma patients similarly reported slowed radiographic progression and improved performance status.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor multiple sclerosis, observational data and small interventional cohorts using low-dose naltrexone regimens — known to transiently elevate endogenous met-enkephalin — documented increased serum peptide concentrations, reduced fatigue scores on validated quality-of-life instruments, and stabilization of Expanded Disability Status Scale scores over periods extending to several years.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese changes coincided with decreased MRI lesion activity in some participants.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eA combination formulation incorporating met-enkephalin with an adrenocorticotropic hormone fragment advanced to phase II\/III evaluation in relapsing-remitting multiple sclerosis and moderate-to-severe COVID-19, where immunomodulatory endpoints included enhanced NK cell function and tempered cytokine release without immunosuppression.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional exploratory work in advanced cancer settings has linked met-enkephalin administration to restored lymphocyte proliferative responses post-chemotherapy and reduced Treg-mediated suppression, supporting its role as an adjunctive bioregulatory peptide.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAcross these studies, the peptide’s endogenous origin and short duration of action translate into a favorable tolerability profile suitable for chronic peptide research applications, particularly when synthesis efforts focus on half-life extension without loss of OGFr or classical opioid receptor selectivity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePeptide Synthesis and Structure–Activity Research\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn peptide synthesis laboratories specializing in advanced research candidates, met-enkephalin serves as a prototypical scaffold for structure–activity refinement.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSolid-phase or solution-phase approaches routinely incorporate Fmoc or Boc strategies, with careful selection of side-chain protection to prevent racemization at the Phe residue during activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePost-assembly modifications include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eN-methylation of Gly residues,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereplacement of Met with norleucine or isosteric sulfoxide variants,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand backbone cyclization via lactam bridges.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese strategies have yielded analogs retaining OGFr affinity while resisting NEP and aminopeptidase degradation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSuch chemical biology insights directly inform translational research, enabling sustained receptor occupancy in vivo and broadening the functional window for applications in oncology, neurology, and immunology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFuture directions will likely integrate stabilized congeners into targeted delivery platforms, such as nanoparticle conjugates or cell-penetrating peptide fusions, to achieve tissue-specific accumulation while exploiting the molecule’s inherent ability to coordinate analgesia, growth control, and immune homeostasis at the molecular level.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53064517648650,"sku":null,"price":245.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53064517681418,"sku":null,"price":220.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/met_2.png?v=1779961532"},{"product_id":"peg-mgf-2mg-pegylated-mechano-growth-factor-research-peptide","title":"PEG-MGF 2mg – Pegylated Mechano Growth Factor Research Peptide","description":"\u003cp\u003e\u003cstrong\u003ePEG-MGF Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF is a lab-created version of a natural protein that your body produces when your muscles are stressed or damaged, such as during intense exercise or injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt is derived from Mechano Growth Factor (MGF), a special variant of the growth factor IGF-1 that signals the body to start repairing and building muscle tissue.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eScientists attach a special PEG molecule to MGF to create PEG-MGF, which extends its presence in the body from only minutes to up to two or three days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis longer duration makes PEG-MGF a more practical and effective tool for supporting ongoing muscle repair and growth.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF primarily activates satellite cells, which are special stem cells located in your muscles that remain dormant until needed for healing.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese satellite cells then multiply, repair damaged muscle fibers, and contribute to new muscle growth through fusion and protein synthesis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAs a result, PEG-MGF helps accelerate recovery from muscle tears, joint injuries, and intense workouts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt also shows promise in addressing age-related muscle loss known as sarcopenia, repairing heart tissue after a heart attack, and supporting nerve regeneration after injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMany athletes and bodybuilders use PEG-MGF to enhance muscle growth and shorten recovery time after tough training sessions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt is often combined with another healing peptide called BPC-157, which makes the muscle, joint, and tissue repair process even more effective.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePEG-MGF Mechanism of Action at the Molecular Level\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF, or Pegylated Mechano Growth Factor, is a synthetic peptide derived from Mechano Growth Factor (MGF), a variant of Insulin-like Growth Factor 1 (IGF-1).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMGF is naturally produced in response to muscle stress or damage, such as after intense exercise, to promote muscle repair and growth.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePegylation, the process of attaching polyethylene glycol (PEG) to MGF, extends its half-life from 5–7 minutes to 48–72 hours, making it more effective for research and regenerative applications.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the biochemical core, endogenous MGF arises as the IGF-1Ec splice variant in humans from the IGF1 gene.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe primary transcript undergoes alternative splicing to include exons 4, 5, and 6, yielding a pro-peptide where the mature IGF-1 domain is followed by a unique 24-amino-acid C-terminal E-domain extension.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis E-domain is the functional moiety in synthetic PEG-MGF preparations used in peptide research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEnzymatic cleavage releases the bioactive E-peptide, which operates locally in an autocrine\/paracrine manner.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe PEG moiety — typically a 2–5 kDa linear or branched polyethylene glycol chain — is covalently attached via amide linkage to the N-terminus or a lysine residue, sterically hindering proteolytic degradation by serum proteases and reducing glomerular filtration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis shifts pharmacokinetics from rapid renal clearance to prolonged systemic bioavailability.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStructural and Pharmacokinetic Foundations Enabling Molecular Activity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe native MGF E-peptide is highly labile due to its short half-life and susceptibility to endopeptidases targeting the QRRK motif.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePegylation introduces hydrophilic ethylene oxide repeats that increase hydrodynamic radius, shield cleavage sites, and minimize immunogenicity while preserving the E-domain’s amphipathic character.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis allows PEG-MGF to distribute effectively to damaged tissues via the bloodstream, where it interacts with satellite cell membranes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn contrast to systemic mature IGF-1, the MGF E-domain exhibits distinct receptor engagement kinetics, often bypassing classical IGF-1R binding epitopes encoded solely in exons 3–4.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExperimental blockade of IGF-1R with neutralizing antibodies does not abolish E-peptide-driven proliferation in myoblasts or mesenchymal stem cells, confirming an IGF-1R-independent component mediated by the unique C-terminal sequence.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReceptor Engagement and Proximal Signal Transduction\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUpon reaching target cells, primarily quiescent Pax7+ satellite cells in skeletal muscle, PEG-MGF initiates signaling through a combination of IGF-1R-dependent and IGF-1R-independent routes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe mature IGF-1-like domain retains low-affinity interaction with IGF-1R, a tyrosine kinase receptor, leading to autophosphorylation at Tyr1135\/1136 in the kinase domain.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis recruits insulin receptor substrate-1 (IRS-1) via its phosphotyrosine-binding domain, phosphorylating IRS-1 at multiple Tyr residues.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDownstream, this bifurcates into two canonical cascades:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ePI3K\/Akt\/mTOR\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eRas\/Raf\/MEK\/ERK\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThe E-domain, however, drives the majority of satellite-cell-specific effects via a putative non-canonical receptor or co-receptor system.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEvidence points to interactions with heparan sulfate proteoglycans (HSPGs) on the extracellular matrix or an unidentified G-protein-coupled or tyrosine-kinase-associated receptor.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis leads to rapid activation of mitogen-activated protein kinase (MAPK) pathways, particularly ERK1\/2 and potentially ERK5, without robust Akt phosphorylation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn parallel, protein kinase C (PKC) isoforms are engaged, translocating to the nucleus and phosphorylating Nrf2 at Ser40.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePhospho-Nrf2 dissociates from Keap1, translocates to the nucleus, and binds antioxidant response elements (AREs), upregulating:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eheme oxygenase-1 (HO-1),\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNAD(P)H quinone dehydrogenase 1 (NQO1),\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand superoxide dismutase 2 (SOD2).\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThis redox buffering is critical for cytoprotection during oxidative burst post-injury.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional modulation occurs at stress kinase levels: PEG-MGF attenuates p38 MAPK phosphorylation in mechanically overloaded cells, reducing downstream activation of ATF2 and CHOP, thereby inhibiting caspase-3\/9-mediated apoptosis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn cardiomyocytes and neurons, the E-domain also stabilizes 14-3-3 protein interactomes, sequestering pro-apoptotic Bad and FoxO3a, preserving mitochondrial membrane potential and blocking cytochrome c release.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDownstream Molecular Effects on Satellite Cell Dynamics and Myogenesis\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSatellite cells reside in a G0 quiescent state beneath the basal lamina, expressing Pax7 and Myf5.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF binding triggers exit from G0 into G1 via cyclin D1 upregulation and CDK4\/6 activation, driven by ERK-mediated phosphorylation of Elk-1 and subsequent c-Fos\/c-Jun AP-1 transcription.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis proliferative burst expands the myoblast pool while transiently suppressing myogenin and MEF2C, delaying terminal differentiation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe E-peptide thus acts as a “mitogenic gatekeeper,” ensuring sufficient progenitors before fusion.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOnce the local environment shifts, myoblasts express desmin, MyoD, and myogenin, fuse via cadherin-15 and integrin-β1, and donate myonuclei to existing myofibers or form new fibers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis increases cross-sectional area through sarcomere addition and elevates myosin heavy chain (MHC) isoform expression, particularly MHC-IIx\/d for fast-twitch hypertrophy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the translational level, any IGF-1R\/Akt arm activates mTORC1 via TSC2 inhibition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003emTORC1 phosphorylates S6K1 and 4E-BP1, enhancing cap-dependent translation of TOP mRNAs encoding ribosomal proteins and elongation factors.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis directly boosts myofibrillar protein accretion.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn parallel, PGC-1α and PPARδ transcription rise, supporting mitochondrial biogenesis for sustained energy during repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTissue-Specific Molecular Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn skeletal muscle injury or overload, mechanical stretch induces immediate early expression of IGF-1Ec mRNA within hours via mechanosensitive promoters.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF recapitulates this by recruiting macrophages and neutrophils via MCP-1 and IL-6 modulation to clear debris, then drives satellite cell proliferation to replace lost myonuclei.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe net outcome is:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eaccelerated fiber regeneration,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced fibrosis,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003elower TGF-β1\/Smad3 activity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand hypertrophy-associated signaling.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eFor sarcopenia, age-related decline in MGF transcript response to loading correlates with satellite cell senescence and reduced Notch signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eExogenous PEG-MGF restores proliferative lifespan by upregulating telomerase reverse transcriptase (TERT) and downregulating p16INK4a\/p21.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis expands the progenitor pool and counters myofiber atrophy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePost-myocardial infarction, hypoxic cardiomyocytes upregulate MGF locally.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF administration inhibits hypoxia-induced apoptosis via PKC-Nrf2-HO-1 and 14-3-3 stabilization, preserving left-ventricular ejection fraction and reducing infarct size.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt also promotes limited cardiomyocyte cell-cycle re-entry and angiogenesis via VEGF crosstalk, supporting scar remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn peripheral nerve injury, PEG-MGF supports Schwann cell proliferation and axonal sprouting.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe Nrf2\/HO-1 axis mitigates oxidative damage at the injury site, while ERK signaling enhances neurite outgrowth via GAP-43 and β-III-tubulin expression.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNeuroprotective effects extend to central nervous system models, reducing neuronal loss in oxidative stress paradigms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eJoint and tendon injuries benefit indirectly: satellite-cell-derived myoblasts and paracrine factors improve peri-articular muscle support, while anti-inflammatory modulation limits chronic synovitis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSynergistic Molecular Enhancement with BPC-157\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBPC-157 complements PEG-MGF through orthogonal pathways, making the combination relevant in muscle, joint, and tissue repair research models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhile PEG-MGF drives myogenic progenitor expansion via E-domain\/ERK\/PKC cascades, BPC-157 upregulates growth hormone receptor (GHR) and VEGF-A\/VEGFR2 signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis activates endothelial nitric oxide synthase (eNOS) via Akt and FAK pathways, boosting nitric oxide production, angiogenesis, fibroblast migration, and collagen I\/III deposition at injury sites.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBPC-157 also modulates COX-2\/LOX pathways to resolve inflammation without glucocorticoid-like suppression, preserving the early macrophage influx required for MGF-induced repair.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the integrative level, BPC-157’s FAK-ERK axis primes extracellular matrix remodeling, facilitating satellite cell migration and fusion enhanced by PEG-MGF.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn tendon and ligament models, BPC-157 increases tenocyte proliferation and type-I collagen cross-linking, while PEG-MGF supports overlying muscle regeneration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn sarcopenia models, the combination supports both vascular supply and myonuclear addition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePost-myocardial infarction research suggests BPC-157’s cardioprotective nitric oxide and angiogenic effects may complement MGF’s anti-apoptotic Nrf2 signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor nerve crush or transection models, combined neurotrophic support may accelerate axonal regrowth and remyelination through complementary BDNF\/TrkB and ERK\/GAP-43-associated pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eApplication strategies in peptide research often pair PEG-MGF with BPC-157 in muscle recovery and regenerative protocols.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe extended half-life of PEG-MGF allows less frequent administration while BPC-157 provides sustained anti-inflammatory and angiogenic support.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIntegrated Regenerative Implications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePEG-MGF’s prolonged systemic action via pegylation, coupled with its dual IGF-1R-dependent and E-domain-driven IGF-1R-independent signaling, positions it as a precision tool for targeted regeneration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts mechanisms include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eprotein synthesis via PI3K\/Akt\/mTOR,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003esatellite cell proliferation via MAPK\/ERK,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eredox protection via PKC-Nrf2,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003emuscle regeneration,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eangiogenesis-associated support,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ematrix remodeling,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand tissue resilience.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eWhen combined with BPC-157, the molecular orchestration of myogenesis, angiogenesis, matrix remodeling, and redox homeostasis may produce synergistic outcomes in models of:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003emuscle wasting,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eischemic cardiac damage,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eneural trauma,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ejoint injury,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand tendon stress.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eOngoing biochemical investigation of the exact E-domain receptor and its nuclear interactors may further refine synthetic analogs for clinical peptide research pipelines.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis framework aligns with applications in muscle and joint trauma, sarcopenic muscle loss, post-infarct recovery, and post-nerve injury repair, offering a mechanistic basis for regenerative peptide research protocols.\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Vial","offer_id":53119417614602,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true},{"title":"Pre-filled Pen","offer_id":53119417647370,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/peg_2.png?v=1779960601"},{"product_id":"aod9604-10mg-fat-metabolism-metabolic-research-peptide","title":"AOD9604 10mg – Fat Metabolism \u0026 Metabolic Research Peptide","description":"\u003cp\u003e\u003cstrong\u003eAOD9604 Description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAOD9604 is a synthetic peptide created from a specific fragment of the human growth hormone molecule.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt is studied for its ability to promote the breakdown of stored fat in the body. Unlike the full growth hormone, it does not stimulate growth or increase levels of IGF-1.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn fat cells, it activates processes that release fats for energy production while reducing the formation of new fat.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAnimal studies in obese models have shown reductions in body weight and fat accumulation with its administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHuman clinical trials involving hundreds of overweight adults have demonstrated that it is safe and well tolerated.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSome early trials reported modest reductions in body weight and abdominal fat.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLarger studies that included diet and exercise programs showed more variable results for weight loss.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearchers have also investigated its potential to support cartilage repair in joint disease models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOverall, AOD9604 offers a targeted way to address fat metabolism and certain regenerative applications without the broader effects of complete growth hormone.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMolecular Mechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAOD9604, also known as the hexadecapeptide Tyr-hGH177-191, represents a precisely engineered fragment of the carboxyl terminus of human growth hormone (hGH), specifically residues 177 through 191 with an added N-terminal tyrosine residue for enhanced stability and oral bioavailability potential.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis structural modification isolates the lipolytic domain while eliminating the domains responsible for somatotropic, lactogenic, and diabetogenic activities inherent to the full-length 191-amino-acid hGH protein.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the context of peptide research and synthesis, AOD9604 exemplifies a rational design strategy to dissect multifunctional proteins into bioactive minimal motifs, allowing selective modulation of adipose tissue metabolism without engaging the classical growth hormone receptor (GHR) signaling cascade that leads to JAK2\/STAT5 activation and subsequent IGF-1 transcription in hepatocytes and other tissues.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the biochemical level, this peptide maintains a compact conformation stabilized by a disulfide bridge between the two cysteine residues within its sequence, preserving key hydrophobic and charged motifs that interact with intracellular targets in adipocytes and hepatocytes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLipolysis and Fat Metabolism Pathways\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe molecular mechanism of action of AOD9604 centers on direct and selective enhancement of lipolysis coupled with potent inhibition of lipogenesis in white adipose tissue, operating largely independently of the somatotropic axis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn mature adipocytes, triglycerides stored in lipid droplets are hydrolyzed by hormone-sensitive lipase (HSL), the rate-limiting enzyme whose activity is tightly regulated by phosphorylation at multiple serine residues.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAOD9604 elevates intracellular cyclic AMP (cAMP) levels, likely through modulation of adenylate cyclase activity downstream of adrenergic signaling pathways, thereby activating protein kinase A (PKA).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePhosphorylated HSL translocates from the cytosol to the surface of lipid droplets, where it catalyzes the sequential cleavage of triglycerides into:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ediacylglycerol,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003emonoacylglycerol,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003efree fatty acids,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand glycerol.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThis process is further amplified by upregulation of beta-3 adrenergic receptor (β3-AR) mRNA and protein expression specifically in obese adipose depots, where β3-AR levels are typically downregulated.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRestoration to levels observed in lean tissue heightens catecholamine sensitivity and sustains chronic lipolytic responsiveness without requiring direct agonism at the receptor itself.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAcute effects on energy expenditure and fatty acid oxidation persist even in β3-AR knockout models, indicating parallel or redundant pathways possibly involving direct modulation of mitochondrial β-oxidation enzymes or carnitine palmitoyltransferase-1 (CPT-1) facilitation via reduced malonyl-CoA inhibition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnti-Lipogenic and Metabolic Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eConcomitantly, AOD9604 exerts anti-lipogenic effects by inhibiting acetyl-CoA carboxylase (ACC), the enzyme that carboxylates acetyl-CoA to form malonyl-CoA, the primary substrate for de novo fatty acid synthesis via fatty acid synthase (FAS) and the allosteric inhibitor of CPT-1.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLower malonyl-CoA concentrations relieve CPT-1 suppression at the outer mitochondrial membrane, channeling free fatty acids into β-oxidation rather than re-esterification or elongation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis dual lipolytic and anti-lipogenic profile mirrors a subset of hGH actions but occurs without GHR dimerization or downstream PI3K\/Akt\/mTOR engagement, explaining the absence of IGF-1 induction, muscle anabolism, or hepatic gluconeogenesis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn hepatocytes, similar ACC inhibition reduces very-low-density lipoprotein (VLDL) triglyceride output, contributing to improved circulating lipid profiles.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAt the cellular signaling level, AOD9604 induces a biphasic diacylglycerol (DAG) release that transiently activates protein kinase C (PKC) isoforms, further fine-tuning HSL trafficking and gene expression programs favoring oxidative metabolism over storage.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese mechanisms collectively shift adipocyte metabolism toward net fat mobilization, particularly in visceral depots prone to inflammation and ectopic lipid spillover in metabolic syndrome states.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnlike full-length hGH, which can induce insulin resistance via SOCS protein upregulation and JAK\/STAT-mediated interference with insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation, AOD9604 preserves or may enhance insulin sensitivity by avoiding these feedback loops, as evidenced by maintained euglycemic clamp responses in chronic exposure models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePotential research applications of AOD9604 extend beyond its original anti-obesity rationale to encompass regenerative applications in orthopedics and metabolic health, leveraging its tissue-selective actions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn obesity and associated dysmetabolism, the peptide’s ability to target visceral adipose tissue lipolysis without inducing hyperinsulinemia or hyperglycemia positions it as a candidate adjunct for research involving:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ecentral adiposity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003enon-alcoholic fatty liver disease (NAFLD),\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003edyslipidemia,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand type 2 diabetes risk.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eBy normalizing β3-AR expression in pathologically desensitized adipocytes, AOD9604 could restore endogenous catecholamine-driven fat mobilization, complementing lifestyle interventions that often fail to sustain visceral fat loss due to adaptive downregulation of lipolytic receptors.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn cartilage biology and osteoarthritis research, intra-articular delivery exploits potential chondroprotective and anabolic effects on synovial and cartilage extracellular matrix remodeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePreclinical data indicate:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eenhanced proteoglycan synthesis,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced matrix metalloproteinase activity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand improved histological architecture in degenerative joints.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese effects may occur via localized modulation of inflammatory cytokine signaling or direct stimulation of chondrocyte survival pathways independent of systemic GH\/IGF-1.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis regenerative profile may extend to bone homeostasis, where osteoblast exposure to the peptide fragment stimulates proliferation and mineralized nodule formation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis offers utility in postmenopausal osteoporosis models characterized by cortical thinning and reduced bone mineral density.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCollectively, these applications highlight AOD9604 as a versatile tool in peptide-based regenerative and metabolic medicine, capitalizing on its minimal immunogenicity, rapid plasma clearance, and lack of endocrine disruption.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnimal Research Findings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAnimal trials have provided robust foundational evidence for these mechanisms and applications across multiple rodent and lagomorph models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn genetically obese Zucker rats and ob\/ob mice, chronic systemic exposure to AOD9604 markedly attenuates excessive body weight gain — by over 50 percent relative to pair-fed controls in some cohorts — through elevated adipose tissue lipolytic rates measured as increased glycerol release ex vivo and heightened whole-body fat oxidation via indirect calorimetry.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese effects correlate with restored β3-AR transcript levels in epididymal and retroperitoneal fat pads, normalizing the lipolytic deficit typical of leptin-resistant states, and occur without the insulin-desensitizing profile observed with equimolar intact hGH.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn β3-AR knockout mice, chronic administration fails to reduce body mass or enhance basal lipolysis, confirming the receptor’s permissive role in sustained adaptations, yet acute bolus dosing still augments energy expenditure and respiratory quotient shifts toward fat utilization, underscoring redundant signaling nodes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eToxicology assessments in Sprague-Dawley rats and cynomolgus monkeys at supratherapeutic multiples revealed:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eno genotoxicity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eno organ histopathology,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eno immunogenicity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand rapid proteolytic degradation consistent with short plasma half-life.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCartilage and Bone Research Models\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAdditional regenerative models reinforce broader utility.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn collagenase-induced knee osteoarthritis in New Zealand white rabbits, repeated intra-articular injections of AOD9604 alone or combined with hyaluronic acid significantly improved:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003emacroscopic cartilage surface integrity,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ehistological OARSI scores,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced fibrillation,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced chondrocyte clustering,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ereduced proteoglycan loss,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand functional lameness indices.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese findings suggest matrix-preserving effects potentially mediated by decreased synovial inflammation or upregulated aggrecan and type II collagen expression in chondrocytes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn ovariectomized rat models of estrogen-deficient bone loss, systemic AOD9604 increased trabecular and cortical bone mineral density, elevated bone formation rates, and preserved biomechanical strength parameters such as ultimate load and stiffness.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese actions are attributed to direct osteoblast mitogenic signaling without osteoclast activation or GH-mediated resorption coupling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese preclinical outcomes collectively validate selective fat-mobilizing and tissue-reparative properties while highlighting favorable safety margins across species.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHuman Clinical Research Findings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHuman clinical development encompassed six randomized, double-blind, placebo-controlled trials conducted between 2001 and 2006, enrolling approximately 900 clinically obese adults alongside smaller cohorts of healthy volunteers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe program progressed from single-dose intravenous and oral pilot studies through short-term multiple-dose evaluations to two pivotal longer-term oral Phase II protocols:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eone 12-week study in roughly 300 participants,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand one 24-week study in over 500 subjects that incorporated standardized diet and exercise counseling.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eAcross all protocols, AOD9604 exhibited an adverse event profile statistically indistinguishable from placebo, with mild-to-moderate headaches, transient gastrointestinal discomfort, or upper respiratory symptoms occurring at comparable frequencies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo treatment-related serious adverse events, withdrawals, or clinically meaningful alterations in vital signs, electrocardiography, hematology, or serum chemistry were reported.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNotably, no increases in circulating IGF-1, perturbations in fasting glucose, insulin, or oral glucose tolerance test parameters, or development of anti-peptide antibodies were detected.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis confirms the absence of somatotropic spillover and supports metabolic neutrality.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEarly efficacy signals included modest body weight decrements and preferential abdominal fat reduction assessed by dual-energy X-ray absorptiometry or waist circumference.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHowever, the larger lifestyle-enriched 24-week trial failed to demonstrate statistically superior weight or fat mass loss relative to placebo plus diet and exercise, leading to discontinuation of further obesity-focused development around 2007 despite the consistently benign safety database.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSubsequent analyses have revisited the dataset for subgroup signals in visceral adiposity responders and have prompted exploratory investigations into intra-articular applications for osteoarthritis, where the peptide’s localized regenerative potential remains under active preclinical-to-early-clinical translation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSummary\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn summary, AOD9604 embodies a successful example of domain-specific peptide engineering that decouples beneficial lipid metabolic reprogramming from the broader effects of parent human growth hormone.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts molecular actions center on:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eHSL activation,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eACC inhibition,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eβ3-AR sensitization,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eCPT-1 derepression,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003efat mobilization,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand cartilage-associated regenerative signaling.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese mechanisms drive net adipose catabolism while preserving insulin sensitivity and avoiding endocrine feedback.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePreclinical models support applications in:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eobesity-related fat redistribution,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ejoint cartilage preservation,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eskeletal maintenance,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eand metabolic research.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eHuman experience underscores exceptional tolerability across nearly a thousand exposures.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAlthough larger-scale weight-loss efficacy proved context-dependent, the peptide’s clean pharmacological footprint and emerging regenerative data sustain interest within specialized peptide research for targeted metabolic and orthopedic applications.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOngoing synthesis optimization and formulation strategies may further unlock its utility in these domains.\u003c\/span\u003e\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53119473254666,"sku":null,"price":165.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53119473287434,"sku":null,"price":140.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/aod_2.png?v=1779960930"}],"url":"https:\/\/www.peptideregenesis.com\/collections\/liquid-formulas.oembed?page=2","provider":"PRG","version":"1.0","type":"link"}